data_1siy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1siy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 3.1499999999999999 111.893 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' GLY . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 3.1699999999999999 107.869 164.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 1.27 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.63 109.785 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.793 ' HG2' HD13 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.6599999999999999 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 2.1000000000000001 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.81999999999999995 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 2.2599999999999998 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.498 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 2.25 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 1.29 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.5 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.689 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.6599999999999999 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 1.0600000000000001 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.689 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 2.0600000000000001 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.559 ' HB2' HD13 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.4900000000000002 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.5099999999999998 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 2.5299999999999998 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 HG22 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 1.28 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 1.1399999999999999 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.3700000000000001 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 1.2 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.73999999999999999 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.3999999999999999 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 1.3100000000000001 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.64000000000000001 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 1.3200000000000001 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 2.0099999999999998 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.7 t30 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.1099999999999999 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.793 HD13 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 1.3100000000000001 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD12 HG23 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 2.48 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.4500000000000002 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.8600000000000001 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.9199999999999999 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 5.0800000000000001 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 2.1000000000000001 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 2.1800000000000002 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.8400000000000001 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 3.1200000000000001 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 4.0899999999999999 110.984 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 1.27 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 1.27 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.6499999999999999 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.429 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.412 HD12 HD13 ' A' ' 10' ' ' LEU . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.99 110.429 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.8599999999999999 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.5 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.52 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.6399999999999999 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.1799999999999999 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.8300000000000001 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.9700000000000002 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 5.3899999999999997 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.0099999999999998 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 4.1100000000000003 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.9900000000000002 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.7799999999999998 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.52 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.3600000000000001 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.99 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.5 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.636 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.54 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.79 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.6899999999999999 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 3.0499999999999998 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.6499999999999999 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.95999999999999996 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.78 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.8199999999999998 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 2.3100000000000001 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.6200000000000001 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.6000000000000001 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.9900000000000002 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 3.0899999999999999 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.7799999999999998 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.3999999999999999 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.98 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.6000000000000001 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.3700000000000001 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 3.2200000000000002 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.5699999999999998 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.1699999999999999 110.199 176.053 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.787 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 3.1499999999999999 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 3.1699999999999999 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.787 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 1.27 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.63 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.994 HG23 HG22 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.6599999999999999 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 2.1000000000000001 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.81999999999999995 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 2.2599999999999998 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 2.25 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 1.29 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.5 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.6599999999999999 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.693 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 1.0600000000000001 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 2.0600000000000001 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 26.9 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.4900000000000002 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.5099999999999998 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 2.5299999999999998 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 1.28 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 1.1399999999999999 112.421 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.3700000000000001 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 1.2 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.73999999999999999 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.3999999999999999 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 1.3100000000000001 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.64000000000000001 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.654 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 1.3200000000000001 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 2.0099999999999998 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 10.2 m120 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.1099999999999999 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.88 HD13 ' HA ' ' A' ' 6' ' ' VAL . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 1.3100000000000001 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.801 HD23 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 2.48 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.4500000000000002 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.8600000000000001 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.9199999999999999 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 5.0800000000000001 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 2.1000000000000001 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 2.1800000000000002 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.8400000000000001 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 3.1200000000000001 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 4.0899999999999999 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 1.27 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.994 HG22 HG23 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 1.27 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.684 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.6499999999999999 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.1100000000000001 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.99 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.8599999999999999 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.5 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.52 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.6399999999999999 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.1799999999999999 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.8300000000000001 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.838 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.9700000000000002 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 5.3899999999999997 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.0099999999999998 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 4.1100000000000003 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.9900000000000002 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.7799999999999998 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.52 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.3600000000000001 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.99 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.5 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.54 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.79 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.6899999999999999 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 3.0499999999999998 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.6499999999999999 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.95999999999999996 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.801 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.78 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.8199999999999998 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 2.3100000000000001 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.6200000000000001 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.6000000000000001 110.348 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.9900000000000002 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.402 HG22 ' HG ' ' A' ' 51' ' ' LEU . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 3.0899999999999999 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.7799999999999998 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.3999999999999999 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.98 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.6000000000000001 109.428 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.3700000000000001 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 3.2200000000000002 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.5699999999999998 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.1699999999999999 112.382 179.156 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 3.1499999999999999 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.587 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 3.1699999999999999 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 1.27 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.63 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HG2' HD13 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.6599999999999999 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 2.1000000000000001 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.81999999999999995 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 2.2599999999999998 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 2.25 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.29 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.5 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.755 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.6599999999999999 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 1.0600000000000001 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 2.0600000000000001 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.973 ' HB2' HG13 ' A' ' 61' ' ' ILE . 7.3 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.4900000000000002 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.5099999999999998 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 2.5299999999999998 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 1.1399999999999999 112.448 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.3700000000000001 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 1.2 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.73999999999999999 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.3999999999999999 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 1.3100000000000001 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.64000000000000001 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 1.3200000000000001 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 2.0099999999999998 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.1099999999999999 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 2.48 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.4500000000000002 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.8600000000000001 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.9199999999999999 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 5.0800000000000001 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 2.1000000000000001 110.824 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 2.1800000000000002 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.8400000000000001 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 3.1200000000000001 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 4.0899999999999999 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 1' ' ' MET . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 1.27 111.454 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 1.27 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.6499999999999999 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.579 ' HB3' HG23 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.1100000000000001 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.99 111.27 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.8599999999999999 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.5 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.52 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.6399999999999999 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.1799999999999999 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.8300000000000001 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.846 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.9700000000000002 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 5.3899999999999997 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.0099999999999998 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.973 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 4.1100000000000003 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.9900000000000002 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.7799999999999998 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.52 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.529 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.3600000000000001 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.99 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.5 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.54 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.79 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.6899999999999999 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 3.0499999999999998 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.95999999999999996 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.78 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.8199999999999998 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 2.3100000000000001 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.6200000000000001 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.6000000000000001 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.9900000000000002 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 3.0899999999999999 110.37 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.7799999999999998 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.3999999999999999 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.98 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.6000000000000001 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.3700000000000001 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 3.2200000000000002 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.5699999999999998 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt . . . . . 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.1699999999999999 112.315 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.947 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 3.1499999999999999 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 3.1699999999999999 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 1.27 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.63 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.503 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.6599999999999999 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 2.1000000000000001 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.81999999999999995 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 2.2599999999999998 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 2.25 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 1.29 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.472 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.5 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' SG ' HD13 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.6599999999999999 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 1.0600000000000001 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.782 HD22 HD13 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 2.0600000000000001 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 8.1 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.4900000000000002 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.5099999999999998 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 2.5299999999999998 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 1.28 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 1.1399999999999999 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.3700000000000001 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.73999999999999999 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.3999999999999999 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 1.3100000000000001 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.64000000000000001 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 1.3200000000000001 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 2.0099999999999998 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.1099999999999999 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.686 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 1.3100000000000001 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' HG21 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 2.48 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.8600000000000001 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.9199999999999999 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.887 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 5.0800000000000001 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.887 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 2.1000000000000001 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 2.1800000000000002 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.8400000000000001 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 3.1200000000000001 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 4.0899999999999999 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 1.27 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.947 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 1.27 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.6499999999999999 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.99 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.8599999999999999 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.5 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.52 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.6399999999999999 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.1799999999999999 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.8300000000000001 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.9700000000000002 110.166 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 5.3899999999999997 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.0099999999999998 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.782 HD13 HD22 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 4.1100000000000003 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.9900000000000002 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.7799999999999998 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.52 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.5 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.54 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.79 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.6899999999999999 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 3.0499999999999998 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.6499999999999999 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.95999999999999996 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.78 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.8199999999999998 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 2.3100000000000001 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.6200000000000001 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.446 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.6000000000000001 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.9900000000000002 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 3.0899999999999999 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.7799999999999998 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.3999999999999999 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.98 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.6000000000000001 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.771 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.3700000000000001 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.533 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 3.2200000000000002 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.5699999999999998 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 87' ' ' CYS . 30.8 pt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.1699999999999999 111.026 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.843 ' HE2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 3.1499999999999999 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 3.1699999999999999 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 1.27 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.63 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.646 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 47' ' ' VAL . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.6599999999999999 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.553 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 2.1000000000000001 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.81999999999999995 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.847 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 2.2599999999999998 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 2.25 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 1.29 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.5 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HG11 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.6599999999999999 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 1.0600000000000001 110.366 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 2.0600000000000001 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.651 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.4900000000000002 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.5099999999999998 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 2.5299999999999998 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG11 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 1.28 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 1.1399999999999999 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.3700000000000001 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 1.2 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.73999999999999999 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 1.3100000000000001 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.64000000000000001 112.179 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.847 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 1.3200000000000001 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 2.0099999999999998 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 110.023 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 2.48 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.4500000000000002 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.9199999999999999 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 5.0800000000000001 112.768 -164.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 2.1000000000000001 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 2.1800000000000002 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.8400000000000001 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 3.1200000000000001 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 4.0899999999999999 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 1.27 110.173 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 1.27 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.6499999999999999 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.59 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.1100000000000001 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.99 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.8599999999999999 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.5 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.506 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.52 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.6399999999999999 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.1799999999999999 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.8300000000000001 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.9700000000000002 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 5.3899999999999997 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.651 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.0099999999999998 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 4.1100000000000003 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.9900000000000002 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.7799999999999998 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.52 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.99 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.5 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.54 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.79 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.6899999999999999 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 3.0499999999999998 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.6499999999999999 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.95999999999999996 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.78 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.8199999999999998 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 2.3100000000000001 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.6200000000000001 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' CE2' HD12 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.6000000000000001 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.9900000000000002 111.568 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 3.0899999999999999 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.7799999999999998 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.524 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.3999999999999999 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.98 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.6000000000000001 111.607 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.462 ' O ' HG21 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.3700000000000001 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 3.2200000000000002 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.5699999999999998 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt . . . . . 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.1699999999999999 112.572 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.691 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 3.1499999999999999 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 3.1699999999999999 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 1.27 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.63 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.6599999999999999 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 2.1000000000000001 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.81999999999999995 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.78 HD21 ' HA ' ' A' ' 31' ' ' VAL . 18.7 t-20 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 2.2599999999999998 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 2.25 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 1.29 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 2.1 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.5 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HD21 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.6599999999999999 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 1.0600000000000001 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.657 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 2.0600000000000001 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.4900000000000002 111.058 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.5099999999999998 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 21' ' ' GLY . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 2.5299999999999998 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG11 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 1.28 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 1.1399999999999999 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.3700000000000001 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 1.2 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.73999999999999999 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.3999999999999999 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 1.3100000000000001 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.64000000000000001 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.78 ' HA ' HD21 ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 1.3200000000000001 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 2.0099999999999998 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.1099999999999999 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.603 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 1.3100000000000001 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 2.48 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.637 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.8600000000000001 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.9199999999999999 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 5.0800000000000001 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 2.1000000000000001 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 2.1800000000000002 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.8400000000000001 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.549 ' O ' HG11 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 3.1200000000000001 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 4.0899999999999999 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.691 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 1.27 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.61 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 1.27 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.6499999999999999 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.1100000000000001 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.681 HD23 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.99 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.8599999999999999 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.5 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.52 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.6399999999999999 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.1799999999999999 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.8300000000000001 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.933 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.9700000000000002 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 5.3899999999999997 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.0099999999999998 111.364 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 4.1100000000000003 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.9900000000000002 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.7799999999999998 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.52 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.3600000000000001 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.99 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.728 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.5 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.54 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.624 HD21 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.79 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.6899999999999999 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 3.0499999999999998 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.6499999999999999 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.95999999999999996 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.78 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.8199999999999998 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 2.3100000000000001 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.6200000000000001 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.483 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.6000000000000001 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.9900000000000002 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 3.0899999999999999 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.7799999999999998 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.3999999999999999 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.98 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.6000000000000001 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.3700000000000001 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 3.2200000000000002 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.5699999999999998 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.1699999999999999 113.094 173.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.686 ' HG2' ' HB1' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 3.1499999999999999 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.549 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 3.1699999999999999 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 1.27 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.63 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 1.026 HG23 HG22 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.6599999999999999 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 2.1000000000000001 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.81999999999999995 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 2.2599999999999998 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 2.25 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 1.29 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.5 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.658 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.6599999999999999 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 1.0600000000000001 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 2.0600000000000001 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.4900000000000002 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.5099999999999998 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 2.5299999999999998 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 1.28 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 1.1399999999999999 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.3700000000000001 112.385 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 1.2 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.73999999999999999 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.3999999999999999 112.195 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 1.3100000000000001 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.64000000000000001 112.406 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 1.3200000000000001 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 2.0099999999999998 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.1099999999999999 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 1.3100000000000001 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.601 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 2.48 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.8600000000000001 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.9199999999999999 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 5.0800000000000001 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 2.1000000000000001 109.527 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 2.1800000000000002 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.8400000000000001 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 3.1200000000000001 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 4.0899999999999999 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.686 ' HB1' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 1.27 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 1.27 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.6499999999999999 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.528 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.1100000000000001 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.99 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' HD3' ' SG ' ' A' ' 87' ' ' CYS . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.8599999999999999 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.5 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.52 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.6399999999999999 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.1799999999999999 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.8300000000000001 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.9700000000000002 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 5.3899999999999997 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.0099999999999998 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 4.1100000000000003 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.644 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.9900000000000002 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.7799999999999998 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.52 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.3600000000000001 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 81' ' ' ILE . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.99 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.5 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.54 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.79 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.6899999999999999 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 3.0499999999999998 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.6499999999999999 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.95999999999999996 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.78 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' H ' HG21 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.8199999999999998 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 2.3100000000000001 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.6200000000000001 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.6000000000000001 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.9900000000000002 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 3.0899999999999999 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.7799999999999998 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.3999999999999999 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.98 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.6000000000000001 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.462 ' O ' HG21 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.3700000000000001 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.528 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 3.2200000000000002 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.5699999999999998 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.1699999999999999 110.172 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 3.1499999999999999 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 3.1699999999999999 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 1.27 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.63 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.549 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.6599999999999999 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 2.1000000000000001 109.958 173.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.81999999999999995 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.609 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 2.2599999999999998 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 2.25 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 7' ' ' GLN . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 1.29 111.208 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.5 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.652 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.6599999999999999 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 1.0600000000000001 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 2.0600000000000001 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.449 HE21 ' HG3' ' A' ' 59' ' ' ARG . 14.8 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.4900000000000002 111.98 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.5099999999999998 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 2.5299999999999998 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.563 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 1.28 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 1.1399999999999999 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.3700000000000001 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 1.2 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.73999999999999999 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 1.3100000000000001 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.64000000000000001 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.609 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 1.3200000000000001 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 2.0099999999999998 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.1099999999999999 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 5' ' ' GLN . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 1.3100000000000001 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.443 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 2.48 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.4500000000000002 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.8600000000000001 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.9199999999999999 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 5.0800000000000001 113.403 -161.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 2.1000000000000001 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 2.1800000000000002 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.8400000000000001 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 3.1200000000000001 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 4.0899999999999999 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 1.27 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG23 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 1.27 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.6499999999999999 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.1100000000000001 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.99 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.8599999999999999 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.5 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.52 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.6399999999999999 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.1799999999999999 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.8300000000000001 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 61' ' ' ILE . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.9700000000000002 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HG3' HE21 ' A' ' 18' ' ' GLN . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 5.3899999999999997 107.354 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.0099999999999998 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 4.1100000000000003 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.9900000000000002 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.7799999999999998 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.52 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.3600000000000001 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.99 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.54 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.79 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.6899999999999999 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 3.0499999999999998 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.6499999999999999 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.95999999999999996 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.78 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.8199999999999998 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.681 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 2.3100000000000001 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.6200000000000001 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.6000000000000001 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.9900000000000002 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 3.0899999999999999 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.7799999999999998 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.3999999999999999 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.98 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.6000000000000001 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.3700000000000001 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 3.2200000000000002 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.5699999999999998 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.805 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.1699999999999999 108.087 163.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HE1' ' O ' ' A' ' 46' ' ' ALA . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 3.1499999999999999 109.841 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.599 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 3.1699999999999999 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.63 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.6599999999999999 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 2.1000000000000001 110.611 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.81999999999999995 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.634 ' ND2' HG22 ' A' ' 31' ' ' VAL . 1.7 t-20 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 2.2599999999999998 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 2.25 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 1.29 111.942 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.5 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.6599999999999999 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.753 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 1.0600000000000001 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.726 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.0600000000000001 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.769 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.4900000000000002 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.5099999999999998 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 2.5299999999999998 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 1.28 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 1.1399999999999999 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.3700000000000001 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 1.2 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.695 ' O ' HG21 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.73999999999999999 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 1.3100000000000001 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.64000000000000001 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 1.3200000000000001 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 2.0099999999999998 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.1099999999999999 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.725 HG23 HG22 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 1.3100000000000001 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 2.48 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.8600000000000001 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.9199999999999999 107.8 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 5.0800000000000001 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.471 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 2.1000000000000001 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 2.1800000000000002 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.8400000000000001 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.471 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.618 ' O ' HG13 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 3.1200000000000001 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 4.0899999999999999 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HE1' ' A' ' 1' ' ' MET . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 1.27 110.152 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.6499999999999999 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.537 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.1100000000000001 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.99 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.8599999999999999 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.52 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.6399999999999999 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.1799999999999999 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.8300000000000001 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.9700000000000002 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 5.3899999999999997 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.0099999999999998 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 4.1100000000000003 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.9900000000000002 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.7799999999999998 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.52 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HB2' HD23 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.3600000000000001 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.99 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.5 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.54 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.527 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.79 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.6899999999999999 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 3.0499999999999998 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.6499999999999999 110.877 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.95999999999999996 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.78 111.609 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.8199999999999998 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 HD13 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 2.3100000000000001 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.6200000000000001 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.6000000000000001 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.9900000000000002 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 3.0899999999999999 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.7799999999999998 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.3999999999999999 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.98 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.6000000000000001 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.3700000000000001 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.684 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 3.2200000000000002 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.5699999999999998 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.68 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.1699999999999999 113.628 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.6 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 3.1499999999999999 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 3.1699999999999999 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 1.27 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.63 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.6 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.679 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.6599999999999999 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 2.1000000000000001 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 2.2599999999999998 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 2.25 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 1.29 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.912 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.5 110.879 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 31' ' ' VAL . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.6599999999999999 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 1.0600000000000001 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 2.0600000000000001 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.741 ' HB2' HG13 ' A' ' 61' ' ' ILE . 8.1 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.4900000000000002 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.5099999999999998 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 2.5299999999999998 111.359 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 1.28 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 1.1399999999999999 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.3700000000000001 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 1.2 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.73999999999999999 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.3999999999999999 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 1.3100000000000001 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.64000000000000001 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.809 HG12 HD22 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 1.3200000000000001 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 2.0099999999999998 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.1099999999999999 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.771 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 1.3100000000000001 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 2.48 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.4500000000000002 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.77 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.8600000000000001 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.568 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.9199999999999999 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 5.0800000000000001 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 2.1000000000000001 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 2.1800000000000002 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.8400000000000001 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.604 ' O ' HG11 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 3.1200000000000001 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 4.0899999999999999 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 1.27 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.771 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 1.27 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.728 ' HA ' HD13 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.6499999999999999 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.1100000000000001 110.712 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD13 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.99 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.8599999999999999 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.5 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.52 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.6399999999999999 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.1799999999999999 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.8300000000000001 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.782 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.9700000000000002 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 5.3899999999999997 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.0099999999999998 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.782 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 4.1100000000000003 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.9900000000000002 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.7799999999999998 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.52 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.3600000000000001 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.99 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.5 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.54 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 HG12 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.79 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.6899999999999999 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 3.0499999999999998 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.6499999999999999 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.95999999999999996 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.78 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.8199999999999998 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.613 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 2.3100000000000001 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.6200000000000001 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.699 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.6000000000000001 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.698 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.9900000000000002 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.699 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 3.0899999999999999 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 80' ' ' LYS . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.7799999999999998 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.3999999999999999 112.34 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.98 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.6000000000000001 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.3700000000000001 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 3.2200000000000002 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.5699999999999998 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.1699999999999999 109.453 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.567 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 3.1499999999999999 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 3.1699999999999999 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 1.27 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.63 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.899 HG22 HG22 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.6599999999999999 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 2.1000000000000001 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.81999999999999995 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 2.2599999999999998 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 2.25 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 1.29 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.511 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.5 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.646 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.6599999999999999 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 1.0600000000000001 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.646 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 2.0600000000000001 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.861 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.4900000000000002 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.861 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.5099999999999998 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.899 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 2.5299999999999998 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 1.28 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 1.1399999999999999 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.3700000000000001 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.73999999999999999 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.3999999999999999 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 1.3100000000000001 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.64000000000000001 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 1.3200000000000001 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 2.0099999999999998 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.1099999999999999 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' HD21 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 1.3100000000000001 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 2.48 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.4500000000000002 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.8600000000000001 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.9199999999999999 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 5.0800000000000001 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 2.1000000000000001 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 2.1800000000000002 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.8400000000000001 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 3.1200000000000001 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 4.0899999999999999 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 1.27 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.899 HG22 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.6499999999999999 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.564 ' HB3' HG23 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.1100000000000001 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.5 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.52 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.6399999999999999 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.1799999999999999 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.8300000000000001 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.855 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.9700000000000002 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 5.3899999999999997 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.0099999999999998 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.855 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 4.1100000000000003 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.496 ' H ' HG13 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.9900000000000002 110.409 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.7799999999999998 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.52 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.3600000000000001 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.99 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.5 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.54 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.79 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.6899999999999999 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 3.0499999999999998 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.6499999999999999 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.95999999999999996 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.728 HG12 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.78 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.8199999999999998 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.491 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 2.3100000000000001 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.6200000000000001 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.6000000000000001 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.9900000000000002 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.658 HG12 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 3.0899999999999999 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.7799999999999998 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.3999999999999999 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.98 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.6000000000000001 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.3700000000000001 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 3.2200000000000002 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.5699999999999998 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.1699999999999999 110.048 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.515 ' HE1' ' N ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 3.1499999999999999 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 3.1699999999999999 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.52 ' HA ' HG23 ' A' ' 6' ' ' VAL . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 1.27 110.584 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' N ' ' HE1' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.63 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 2' ' ' THR . 26.8 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.892 HG21 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.6599999999999999 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.81999999999999995 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 2.2599999999999998 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 2.25 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 1.29 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.5 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.724 ' SG ' HD21 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.6599999999999999 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 1.0600000000000001 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 2.0600000000000001 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.4900000000000002 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.5099999999999998 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 2.5299999999999998 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 1.28 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 1.1399999999999999 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.3700000000000001 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 1.2 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.73999999999999999 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.3999999999999999 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.64000000000000001 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 1.3200000000000001 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 2.0099999999999998 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.1099999999999999 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 6' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 1.3100000000000001 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 2.48 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.4500000000000002 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.8600000000000001 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.9199999999999999 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 5.0800000000000001 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 2.1000000000000001 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 2.1800000000000002 110.539 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.8400000000000001 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 3.1200000000000001 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 4.0899999999999999 109.853 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.824 ' HB2' HG22 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.892 HG23 HG21 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 1.27 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.6499999999999999 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.576 ' HB3' HG22 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.1100000000000001 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.99 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.8599999999999999 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.5 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.52 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.6399999999999999 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.1799999999999999 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.8300000000000001 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.9700000000000002 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 5.3899999999999997 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 111.824 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' HG12 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 4.1100000000000003 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.9900000000000002 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.7799999999999998 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.52 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.3600000000000001 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.99 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.5 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.54 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.724 HD21 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.79 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.6899999999999999 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 3.0499999999999998 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.6499999999999999 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.95999999999999996 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.78 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.8199999999999998 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 2.3100000000000001 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.6200000000000001 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.9900000000000002 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 3.0899999999999999 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.7799999999999998 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.3999999999999999 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.98 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.777 HG21 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.6000000000000001 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.3700000000000001 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 3.2200000000000002 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.5699999999999998 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.1699999999999999 110.444 -179.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 3.1499999999999999 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 3.1699999999999999 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 1.27 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.63 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.411 ' N ' HG21 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.6599999999999999 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 2.1000000000000001 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.81999999999999995 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 2.2599999999999998 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.62 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 2.25 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 1.29 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 10.8 mm100 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.5 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HB3' HD21 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.6599999999999999 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 1.0600000000000001 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 2.0600000000000001 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.4900000000000002 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.5099999999999998 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 2.5299999999999998 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 1.28 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 26' ' ' SER . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 1.1399999999999999 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.3700000000000001 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 1.2 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.73999999999999999 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.3999999999999999 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.64000000000000001 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 1.3200000000000001 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 2.0099999999999998 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.883 HD21 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 2.48 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.4500000000000002 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.8600000000000001 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.9199999999999999 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 5.0800000000000001 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 2.1000000000000001 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 2.1800000000000002 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.8400000000000001 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.579 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 3.1200000000000001 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 4.0899999999999999 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 1.27 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 1.27 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.6499999999999999 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.555 ' HB3' HG22 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.1100000000000001 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.99 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.495 ' HB2' HG21 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.5 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.52 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.6399999999999999 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.1799999999999999 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.8300000000000001 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.9700000000000002 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 5.3899999999999997 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.0099999999999998 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 4.1100000000000003 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.9900000000000002 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.7799999999999998 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.52 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.616 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.3600000000000001 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.99 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.5 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.54 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.79 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.6899999999999999 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 3.0499999999999998 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.95999999999999996 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.883 ' HB ' HD21 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.78 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.8199999999999998 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.518 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 2.3100000000000001 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.6200000000000001 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.6000000000000001 110.781 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.9900000000000002 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 3.0899999999999999 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.7799999999999998 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.3999999999999999 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.98 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.6000000000000001 112.044 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.3700000000000001 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 3.2200000000000002 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.5699999999999998 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.704 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.1699999999999999 110.709 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.799 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 3.1499999999999999 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.639 HG21 ' HB3' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 3.1699999999999999 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HA ' HG13 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 1.27 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.63 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.6599999999999999 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 2.1000000000000001 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 2.2599999999999998 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.714 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 2.25 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 1.29 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 5.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.5 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.6599999999999999 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 1.0600000000000001 109.964 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 2.0600000000000001 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG11 ' A' ' 58' ' ' VAL . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.4900000000000002 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.5099999999999998 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 2.5299999999999998 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 1.28 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 1.1399999999999999 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.3700000000000001 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 1.2 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.73999999999999999 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 1.3100000000000001 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.64000000000000001 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 1.3200000000000001 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 2.0099999999999998 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.695 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.1099999999999999 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.889 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 1.3100000000000001 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.626 ' HG ' HG21 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 2.48 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.695 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.8600000000000001 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.9199999999999999 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 5.0800000000000001 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 2.1000000000000001 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 2.1800000000000002 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.8400000000000001 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 3.1200000000000001 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 4.0899999999999999 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 1.27 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 1.27 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.6499999999999999 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.1100000000000001 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.99 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.8599999999999999 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.5 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.714 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.52 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.6399999999999999 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.1799999999999999 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.8300000000000001 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 18' ' ' GLN . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.9700000000000002 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 5.3899999999999997 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.0099999999999998 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 4.1100000000000003 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.9900000000000002 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.7799999999999998 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.52 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.3600000000000001 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.99 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.5 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.54 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.79 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.6899999999999999 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 72' ' ' LYS . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 3.0499999999999998 112.489 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.95999999999999996 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.78 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.8199999999999998 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.626 HG21 ' HG ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 2.3100000000000001 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.6200000000000001 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.6000000000000001 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.9900000000000002 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 51' ' ' LEU . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 3.0899999999999999 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.7799999999999998 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.3999999999999999 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.98 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.6000000000000001 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.3700000000000001 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 3.2200000000000002 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.54 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.5699999999999998 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 45' ' ' ARG . 1.6 pt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.1699999999999999 113.964 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' HG21 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 3.1499999999999999 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.723 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 3.1699999999999999 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HA ' HG21 ' A' ' 6' ' ' VAL . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 1.27 108.384 168.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.63 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.904 ' HG3' HD13 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 HG22 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 2.1000000000000001 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.81999999999999995 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 2.2599999999999998 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.564 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 2.25 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 1.29 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.5 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 16' ' ' PHE . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.6599999999999999 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 1.0600000000000001 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 2.0600000000000001 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.4900000000000002 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.5099999999999998 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 2.5299999999999998 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG11 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 1.28 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 1.1399999999999999 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.3700000000000001 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 1.2 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.621 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.73999999999999999 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.3999999999999999 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 1.3100000000000001 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.64000000000000001 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 1.3200000000000001 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 2.0099999999999998 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.79 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.1099999999999999 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.904 HD13 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 1.3100000000000001 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 2.48 112.06 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.4500000000000002 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.8600000000000001 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.9199999999999999 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 5.0800000000000001 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 2.1000000000000001 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 2.1800000000000002 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.8400000000000001 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.432 ' HA ' HG11 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 3.1200000000000001 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 4.0899999999999999 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 1.27 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG21 HG22 ' A' ' 34' ' ' ILE . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 1.27 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 87' ' ' CYS . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.6499999999999999 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.56 ' HB3' HG23 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.1100000000000001 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.99 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.8599999999999999 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.5 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.52 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.6399999999999999 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.1799999999999999 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.8300000000000001 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 1.013 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.9700000000000002 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 5.3899999999999997 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.0099999999999998 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 4.1100000000000003 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.9900000000000002 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.7799999999999998 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.52 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.3600000000000001 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.99 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.5 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.54 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 81' ' ' ILE . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.79 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.6899999999999999 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 3.0499999999999998 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.538 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.6499999999999999 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.95999999999999996 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.78 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.8199999999999998 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 2.3100000000000001 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.6200000000000001 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.6000000000000001 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.9900000000000002 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 3.0899999999999999 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.7799999999999998 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.3999999999999999 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.98 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.6000000000000001 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.3700000000000001 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 3.2200000000000002 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.5699999999999998 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.688 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 3.1499999999999999 111.893 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' GLY . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 3.1699999999999999 107.869 164.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 1.27 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.63 109.785 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.793 ' HG2' HD13 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.6599999999999999 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 2.1000000000000001 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.81999999999999995 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 2.2599999999999998 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.498 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 2.25 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 1.29 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.5 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.689 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.6599999999999999 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 1.0600000000000001 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.689 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 2.0600000000000001 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.559 ' HB2' HD13 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.4900000000000002 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.5099999999999998 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 2.5299999999999998 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG22 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 1.28 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 1.1399999999999999 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.3700000000000001 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 1.2 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.73999999999999999 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.3999999999999999 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 1.3100000000000001 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.64000000000000001 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 1.3200000000000001 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 2.0099999999999998 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.7 t30 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.1099999999999999 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.793 HD13 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 1.3100000000000001 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD12 HG23 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 2.48 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.4500000000000002 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.8600000000000001 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.9199999999999999 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 5.0800000000000001 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 2.1000000000000001 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 2.1800000000000002 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.8400000000000001 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 3.1200000000000001 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' NH2' ' HA ' ' A' ' 91' ' ' ASN . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 4.0899999999999999 110.984 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 1.27 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 1.27 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.6499999999999999 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.429 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.412 HD12 HD13 ' A' ' 10' ' ' LEU . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.99 110.429 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.8599999999999999 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.5 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.52 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.6399999999999999 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.1799999999999999 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.8300000000000001 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.9700000000000002 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 5.3899999999999997 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.0099999999999998 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 4.1100000000000003 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.9900000000000002 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.7799999999999998 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.52 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.3600000000000001 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.99 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.5 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.636 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.54 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.79 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.6899999999999999 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 3.0499999999999998 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.6499999999999999 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.95999999999999996 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.78 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.8199999999999998 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 2.3100000000000001 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.6200000000000001 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.6000000000000001 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.9900000000000002 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 3.0899999999999999 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.506 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.7799999999999998 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.3999999999999999 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.98 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.6000000000000001 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.3700000000000001 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 3.2200000000000002 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.5699999999999998 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.2 pt -80.9 -25.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.1699999999999999 110.199 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' HA ' ' NH2' ' A' ' 45' ' ' ARG . 4.0 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.799 -1.092 . . . . 5.3700000000000001 111.762 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.787 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 3.1499999999999999 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 3.1699999999999999 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.787 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 1.27 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.63 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.994 HG23 HG22 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.6599999999999999 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 2.1000000000000001 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.81999999999999995 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 2.2599999999999998 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.598 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 2.25 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 1.29 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.5 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.6599999999999999 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.693 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 1.0600000000000001 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 2.0600000000000001 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 26.9 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.4900000000000002 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.5099999999999998 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 2.5299999999999998 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 1.28 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 1.1399999999999999 112.421 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.3700000000000001 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 1.2 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.73999999999999999 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.3999999999999999 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 1.3100000000000001 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.64000000000000001 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.654 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 1.3200000000000001 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 2.0099999999999998 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 10.2 m120 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.1099999999999999 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.88 HD13 ' HA ' ' A' ' 6' ' ' VAL . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 1.3100000000000001 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.801 HD23 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 2.48 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.4500000000000002 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.8600000000000001 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.9199999999999999 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 5.0800000000000001 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 2.1000000000000001 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 2.1800000000000002 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.8400000000000001 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 3.1200000000000001 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 4.0899999999999999 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 1.27 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.994 HG22 HG23 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 1.27 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.684 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.6499999999999999 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.1100000000000001 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.99 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.8599999999999999 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.5 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.52 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.6399999999999999 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.1799999999999999 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.8300000000000001 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.838 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.9700000000000002 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 5.3899999999999997 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.0099999999999998 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 4.1100000000000003 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.9900000000000002 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.7799999999999998 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.52 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.3600000000000001 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.99 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.5 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.54 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.79 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.6899999999999999 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 3.0499999999999998 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.6499999999999999 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.95999999999999996 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.801 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.78 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.8199999999999998 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 2.3100000000000001 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.6200000000000001 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.6000000000000001 110.348 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.9900000000000002 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.402 HG22 ' HG ' ' A' ' 51' ' ' LEU . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 3.0899999999999999 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.7799999999999998 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.3999999999999999 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.98 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.6000000000000001 109.428 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.3700000000000001 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 3.2200000000000002 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.5699999999999998 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt 36.71 -135.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.1699999999999999 112.382 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.3 -0.63 . . . . 5.3700000000000001 109.3 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 3.1499999999999999 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.587 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 3.1699999999999999 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 1.27 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.63 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HG2' HD13 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.886 HG22 HG21 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.6599999999999999 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 2.1000000000000001 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.81999999999999995 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 2.2599999999999998 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 2.25 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.29 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.5 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.755 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.6599999999999999 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 1.0600000000000001 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 2.0600000000000001 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.973 ' HB2' HG13 ' A' ' 61' ' ' ILE . 7.3 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.4900000000000002 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.5099999999999998 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 2.5299999999999998 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 1.1399999999999999 112.448 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.3700000000000001 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 1.2 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.73999999999999999 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.3999999999999999 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 1.3100000000000001 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.64000000000000001 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 1.3200000000000001 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 2.0099999999999998 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.1099999999999999 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 HG21 HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 1.3100000000000001 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 2.48 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.4500000000000002 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.8600000000000001 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.9199999999999999 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 5.0800000000000001 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 2.1000000000000001 110.824 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 2.1800000000000002 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.8400000000000001 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 3.1200000000000001 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 4.0899999999999999 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' A' ' 1' ' ' MET . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 1.27 111.454 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.886 HG21 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 1.27 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.6499999999999999 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.579 ' HB3' HG23 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.1100000000000001 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.99 111.27 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.8599999999999999 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.5 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.52 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.6399999999999999 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.1799999999999999 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.8300000000000001 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.846 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.9700000000000002 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 5.3899999999999997 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.0099999999999998 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.973 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 4.1100000000000003 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.9900000000000002 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.7799999999999998 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.52 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.529 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.3600000000000001 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.99 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.5 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.54 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.79 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.6899999999999999 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 3.0499999999999998 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.95999999999999996 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.78 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.8199999999999998 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 2.3100000000000001 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.6200000000000001 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.6000000000000001 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.9900000000000002 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 3.0899999999999999 110.37 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.7799999999999998 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.3999999999999999 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.98 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.6000000000000001 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.3700000000000001 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 3.2200000000000002 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.5699999999999998 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt 35.25 -119.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.1699999999999999 112.315 -175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.642 -0.694 . . . . 5.3700000000000001 109.136 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.947 ' HE1' ' HA ' ' A' ' 47' ' ' VAL . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 3.1499999999999999 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 3.1699999999999999 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 1.27 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.63 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.6599999999999999 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 2.1000000000000001 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.81999999999999995 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 2.2599999999999998 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 2.25 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 1.29 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.472 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.5 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' SG ' HD13 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.6599999999999999 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 1.0600000000000001 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.782 HD22 HD13 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 2.0600000000000001 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 8.1 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.4900000000000002 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.5099999999999998 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 2.5299999999999998 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 1.28 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 1.1399999999999999 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.3700000000000001 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.581 ' O ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.73999999999999999 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.3999999999999999 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 1.3100000000000001 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.64000000000000001 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 1.3200000000000001 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 2.0099999999999998 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.1099999999999999 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.686 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 1.3100000000000001 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' HG21 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 2.48 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.8600000000000001 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.9199999999999999 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.887 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 5.0800000000000001 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.887 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 2.1000000000000001 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 2.1800000000000002 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.8400000000000001 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 3.1200000000000001 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 4.0899999999999999 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 1.27 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.947 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 1.27 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.458 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.6499999999999999 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.99 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.8599999999999999 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.5 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.52 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.6399999999999999 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.1799999999999999 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.8300000000000001 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.9700000000000002 110.166 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 5.3899999999999997 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.0099999999999998 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.782 HD13 HD22 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 4.1100000000000003 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.9900000000000002 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.7799999999999998 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.52 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.3600000000000001 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.5 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.54 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.79 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.6899999999999999 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 3.0499999999999998 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.6499999999999999 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.95999999999999996 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.78 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.8199999999999998 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 2.3100000000000001 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.6200000000000001 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.446 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.6000000000000001 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.9900000000000002 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 3.0899999999999999 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.7799999999999998 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.3999999999999999 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.98 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.6000000000000001 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.771 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.3700000000000001 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.533 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 3.2200000000000002 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.5699999999999998 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 87' ' ' CYS . 30.8 pt -75.14 -35.58 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.1699999999999999 111.026 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.3 m120 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 117.8 -1.095 . . . . 5.3700000000000001 110.747 -175.14 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.843 ' HE2' ' HA ' ' A' ' 47' ' ' VAL . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 3.1499999999999999 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 3.1699999999999999 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 1.27 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.63 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.646 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 47' ' ' VAL . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.6599999999999999 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.553 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 2.1000000000000001 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.81999999999999995 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.847 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 2.2599999999999998 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 2.25 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 1.29 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.5 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' HG11 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.6599999999999999 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 1.0600000000000001 110.366 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.627 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 2.0600000000000001 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.651 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.4900000000000002 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.5099999999999998 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 2.5299999999999998 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG11 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 1.28 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 1.1399999999999999 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.3700000000000001 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 1.2 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.73999999999999999 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 1.3100000000000001 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.64000000000000001 112.179 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.847 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 1.3200000000000001 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 2.0099999999999998 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 110.023 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 2.48 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.4500000000000002 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.9199999999999999 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 5.0800000000000001 112.768 -164.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 2.1000000000000001 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 2.1800000000000002 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.8400000000000001 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 3.1200000000000001 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 4.0899999999999999 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 1.27 110.173 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.843 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 1.27 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.6499999999999999 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.59 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.1100000000000001 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.99 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.8599999999999999 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.5 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.506 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.52 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.6399999999999999 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.1799999999999999 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.8300000000000001 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.749 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.9700000000000002 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 5.3899999999999997 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.651 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.0099999999999998 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 4.1100000000000003 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.9900000000000002 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.7799999999999998 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.52 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.99 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.5 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.54 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.79 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.6899999999999999 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 3.0499999999999998 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.6499999999999999 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.95999999999999996 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.78 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.8199999999999998 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.616 HD12 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 2.3100000000000001 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.6200000000000001 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' CE2' HD12 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.6000000000000001 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.9900000000000002 111.568 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 3.0899999999999999 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.7799999999999998 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.524 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.3999999999999999 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.98 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.6000000000000001 111.607 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.462 ' O ' HG21 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.3700000000000001 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 3.2200000000000002 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.5699999999999998 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt 35.44 -134.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.1699999999999999 112.572 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.675 -1.155 . . . . 5.3700000000000001 108.853 -179.294 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.691 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 3.1499999999999999 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 3.1699999999999999 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 1.27 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.63 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.6599999999999999 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 2.1000000000000001 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.81999999999999995 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.78 HD21 ' HA ' ' A' ' 31' ' ' VAL . 18.7 t-20 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 2.2599999999999998 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 2.25 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 1.29 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 2.1 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.5 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HD21 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.6599999999999999 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 1.0600000000000001 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.657 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 2.0600000000000001 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.4900000000000002 111.058 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.5099999999999998 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 21' ' ' GLY . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 2.5299999999999998 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG11 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 1.28 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 1.1399999999999999 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.3700000000000001 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 1.2 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.73999999999999999 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.3999999999999999 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 1.3100000000000001 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.64000000000000001 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.78 ' HA ' HD21 ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 1.3200000000000001 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 2.0099999999999998 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.1099999999999999 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.603 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 1.3100000000000001 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 2.48 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.637 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.8600000000000001 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.9199999999999999 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 5.0800000000000001 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 2.1000000000000001 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 2.1800000000000002 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.8400000000000001 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.549 ' O ' HG11 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 3.1200000000000001 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 4.0899999999999999 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.691 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 1.27 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.61 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 1.27 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.6499999999999999 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.1100000000000001 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.681 HD23 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.99 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.8599999999999999 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.5 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.52 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.6399999999999999 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.1799999999999999 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.8300000000000001 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.933 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.9700000000000002 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 5.3899999999999997 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.0099999999999998 111.364 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 4.1100000000000003 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.9900000000000002 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.7799999999999998 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.52 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.3600000000000001 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.99 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.728 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.5 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.54 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD21 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.79 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.6899999999999999 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 3.0499999999999998 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.6499999999999999 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.95999999999999996 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.78 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.8199999999999998 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 2.3100000000000001 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.6200000000000001 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.6000000000000001 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.9900000000000002 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.728 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 3.0899999999999999 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.7799999999999998 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.3999999999999999 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.98 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.6000000000000001 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.3700000000000001 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 3.2200000000000002 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.5699999999999998 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 33.9 pt 39.37 -159.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.1699999999999999 113.094 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.631 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 4.3 t30 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.21 1.004 . . . . 5.3700000000000001 109.047 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.686 ' HG2' ' HB1' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 3.1499999999999999 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.549 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 3.1699999999999999 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 1.27 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.63 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 1.026 HG23 HG22 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.6599999999999999 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 2.1000000000000001 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.81999999999999995 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 2.2599999999999998 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 2.25 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 1.29 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.5 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.658 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.6599999999999999 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 1.0600000000000001 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.658 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 2.0600000000000001 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.4900000000000002 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.5099999999999998 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 2.5299999999999998 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 1.28 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 1.1399999999999999 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.3700000000000001 112.385 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 1.2 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.73999999999999999 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.3999999999999999 112.195 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 1.3100000000000001 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.64000000000000001 112.406 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 1.3200000000000001 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 2.0099999999999998 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.1099999999999999 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 1.3100000000000001 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.601 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 2.48 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.8600000000000001 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.9199999999999999 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 5.0800000000000001 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 2.1000000000000001 109.527 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 2.1800000000000002 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.8400000000000001 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 3.1200000000000001 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 4.0899999999999999 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.686 ' HB1' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 1.27 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 1.27 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.447 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.6499999999999999 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.528 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.1100000000000001 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.99 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' HD3' ' SG ' ' A' ' 87' ' ' CYS . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.8599999999999999 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.5 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.52 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.6399999999999999 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.1799999999999999 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.8300000000000001 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.9700000000000002 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 5.3899999999999997 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.0099999999999998 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 4.1100000000000003 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.644 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.9900000000000002 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.7799999999999998 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.52 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.3600000000000001 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 81' ' ' ILE . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.99 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.5 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.54 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.79 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.6899999999999999 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 3.0499999999999998 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.6499999999999999 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.95999999999999996 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.78 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' H ' HG21 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.8199999999999998 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 2.3100000000000001 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.6200000000000001 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.436 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.6000000000000001 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.9900000000000002 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 3.0899999999999999 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.7799999999999998 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.505 HG23 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.3999999999999999 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.98 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.6000000000000001 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.462 ' O ' HG21 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.3700000000000001 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.528 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 3.2200000000000002 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.5699999999999998 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt -83.83 169.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.1699999999999999 110.172 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.901 -1.045 . . . . 5.3700000000000001 109.068 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 3.1499999999999999 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 3.1699999999999999 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 1.27 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.63 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.549 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.6599999999999999 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 2.1000000000000001 109.958 173.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.81999999999999995 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.609 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 2.2599999999999998 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 2.25 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 7' ' ' GLN . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 1.29 111.208 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.5 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.652 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.6599999999999999 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 1.0600000000000001 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 2.0600000000000001 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.449 HE21 ' HG3' ' A' ' 59' ' ' ARG . 14.8 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.4900000000000002 111.98 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.5099999999999998 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 2.5299999999999998 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.563 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 1.28 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 1.1399999999999999 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.3700000000000001 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 1.2 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.73999999999999999 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 1.3100000000000001 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.64000000000000001 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.609 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 1.3200000000000001 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 2.0099999999999998 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.1099999999999999 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 5' ' ' GLN . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 1.3100000000000001 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.443 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 2.48 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.4500000000000002 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.8600000000000001 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.9199999999999999 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 5.0800000000000001 113.403 -161.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 2.1000000000000001 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 2.1800000000000002 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.8400000000000001 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 3.1200000000000001 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 4.0899999999999999 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 1.27 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG23 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 1.27 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.6499999999999999 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.1100000000000001 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.99 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.8599999999999999 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.5 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.52 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.6399999999999999 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.1799999999999999 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.8300000000000001 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 61' ' ' ILE . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.9700000000000002 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HG3' HE21 ' A' ' 18' ' ' GLN . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 5.3899999999999997 107.354 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.0099999999999998 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 4.1100000000000003 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.9900000000000002 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.7799999999999998 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.52 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.3600000000000001 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.99 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.54 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.79 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.6899999999999999 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 3.0499999999999998 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.6499999999999999 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.95999999999999996 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.78 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.8199999999999998 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.681 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 2.3100000000000001 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.6200000000000001 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.6000000000000001 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.9900000000000002 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 3.0899999999999999 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.7799999999999998 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.3999999999999999 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.98 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.6000000000000001 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.3700000000000001 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.766 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 3.2200000000000002 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.5699999999999998 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.805 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -82.62 -77.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.1699999999999999 108.087 163.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.766 ' HA ' ' HB3' ' A' ' 87' ' ' CYS . 28.5 t-20 . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.254 -0.879 . . . . 5.3700000000000001 112.103 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HE1' ' O ' ' A' ' 46' ' ' ALA . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 3.1499999999999999 109.841 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.599 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 3.1699999999999999 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.63 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.6599999999999999 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 2.1000000000000001 110.611 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.81999999999999995 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.634 ' ND2' HG22 ' A' ' 31' ' ' VAL . 1.7 t-20 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 2.2599999999999998 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 2.25 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 1.29 111.942 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.5 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.726 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.6599999999999999 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.753 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 1.0600000000000001 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.726 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 2.0600000000000001 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.769 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.4900000000000002 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.5099999999999998 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 2.5299999999999998 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 1.28 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 1.1399999999999999 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.3700000000000001 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 1.2 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.695 ' O ' HG21 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.73999999999999999 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 1.3100000000000001 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.64000000000000001 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.73 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 1.3200000000000001 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 2.0099999999999998 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.1099999999999999 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.725 HG23 HG22 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 1.3100000000000001 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 2.48 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.8600000000000001 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.9199999999999999 107.8 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 5.0800000000000001 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 2.1000000000000001 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 2.1800000000000002 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.8400000000000001 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.471 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.618 ' O ' HG13 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 3.1200000000000001 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 4.0899999999999999 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HE1' ' A' ' 1' ' ' MET . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 1.27 110.152 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.725 HG22 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.6499999999999999 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.537 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.1100000000000001 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.99 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.8599999999999999 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.52 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.6399999999999999 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.1799999999999999 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.8300000000000001 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.9700000000000002 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 5.3899999999999997 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.0099999999999998 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.769 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 4.1100000000000003 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.9900000000000002 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.7799999999999998 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.52 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HB2' HD23 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.3600000000000001 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.99 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.5 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.54 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.527 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.79 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.6899999999999999 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 3.0499999999999998 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.6499999999999999 110.877 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.95999999999999996 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.78 111.609 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.8199999999999998 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 HD13 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 2.3100000000000001 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.6200000000000001 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.6000000000000001 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.9900000000000002 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 3.0899999999999999 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.7799999999999998 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.3999999999999999 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.98 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.6000000000000001 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.3700000000000001 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.684 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 3.2200000000000002 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.504 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.5699999999999998 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.68 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt 54.11 131.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.1699999999999999 113.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.312 -1.025 0 CA-C-N 114.599 -1.182 . . . . 5.3700000000000001 109.753 175.05 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.6 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 3.1499999999999999 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 3.1699999999999999 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 1.27 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.63 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.6 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.679 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.6599999999999999 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 2.1000000000000001 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 2.2599999999999998 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 2.25 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 1.29 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.912 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.5 110.879 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 31' ' ' VAL . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.6599999999999999 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 1.0600000000000001 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 2.0600000000000001 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.741 ' HB2' HG13 ' A' ' 61' ' ' ILE . 8.1 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.4900000000000002 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.5099999999999998 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 2.5299999999999998 111.359 -175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 1.28 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 1.1399999999999999 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.3700000000000001 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 1.2 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.73999999999999999 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.3999999999999999 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 1.3100000000000001 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.64000000000000001 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.809 HG12 HD22 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 1.3200000000000001 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 2.0099999999999998 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.77 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.1099999999999999 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.771 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 1.3100000000000001 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 2.48 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.4500000000000002 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.77 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.8600000000000001 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.568 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.9199999999999999 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 5.0800000000000001 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 2.1000000000000001 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 2.1800000000000002 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.8400000000000001 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.604 ' O ' HG11 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 3.1200000000000001 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 4.0899999999999999 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 1.27 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.771 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 1.27 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.728 ' HA ' HD13 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.6499999999999999 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.1100000000000001 110.712 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD13 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.99 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.8599999999999999 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.5 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.52 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.6399999999999999 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.1799999999999999 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.8300000000000001 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.782 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.9700000000000002 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 5.3899999999999997 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.0099999999999998 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.782 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 4.1100000000000003 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.9900000000000002 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.7799999999999998 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.52 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.3600000000000001 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.99 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.5 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.54 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.809 HD22 HG12 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.79 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.6899999999999999 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 3.0499999999999998 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.6499999999999999 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.95999999999999996 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.78 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.8199999999999998 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.613 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 2.3100000000000001 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.613 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.6200000000000001 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.699 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.6000000000000001 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.698 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.9900000000000002 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.699 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 3.0899999999999999 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 80' ' ' LYS . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.7799999999999998 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.3999999999999999 112.34 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.98 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.6000000000000001 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.3700000000000001 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 3.2200000000000002 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.5699999999999998 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt -109.24 -30.78 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.1699999999999999 109.453 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-N 114.414 -1.266 . . . . 5.3700000000000001 111.136 -172.448 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.567 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 3.1499999999999999 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 3.1699999999999999 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 1.27 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.63 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.899 HG22 HG22 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.6599999999999999 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 2.1000000000000001 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.81999999999999995 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 2.2599999999999998 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 2.25 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 1.29 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.5 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.646 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.6599999999999999 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 1.0600000000000001 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.646 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 2.0600000000000001 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.861 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.4900000000000002 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.861 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.5099999999999998 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.899 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 2.5299999999999998 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 1.28 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 1.1399999999999999 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.3700000000000001 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 1.2 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.73999999999999999 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.3999999999999999 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 1.3100000000000001 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.64000000000000001 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 1.3200000000000001 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 2.0099999999999998 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.1099999999999999 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' HB ' HD21 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 1.3100000000000001 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.728 HD21 HG12 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 2.48 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.4500000000000002 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.8600000000000001 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.9199999999999999 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 5.0800000000000001 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 2.1000000000000001 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 2.1800000000000002 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.8400000000000001 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 3.1200000000000001 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 4.0899999999999999 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 1.27 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.899 HG22 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.6499999999999999 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.564 ' HB3' HG23 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.1100000000000001 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD12 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.99 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.5 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.52 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.6399999999999999 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.1799999999999999 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.8300000000000001 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.855 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.9700000000000002 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 5.3899999999999997 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.0099999999999998 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.855 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 4.1100000000000003 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.496 ' H ' HG13 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.9900000000000002 110.409 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.7799999999999998 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.52 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.3600000000000001 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.99 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.5 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.54 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.79 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.6899999999999999 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 3.0499999999999998 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.6499999999999999 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.95999999999999996 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.728 HG12 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.78 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.8199999999999998 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.491 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 2.3100000000000001 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.6200000000000001 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.6000000000000001 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.9900000000000002 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.658 HG12 HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 3.0899999999999999 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.7799999999999998 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.3999999999999999 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.98 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.6000000000000001 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.3700000000000001 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 3.2200000000000002 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.5699999999999998 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt -67.9 -19.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.1699999999999999 110.048 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.591 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.115 -0.945 . . . . 5.3700000000000001 110.804 177.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HE1' ' N ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 3.1499999999999999 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 3.1699999999999999 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.52 ' HA ' HG23 ' A' ' 6' ' ' VAL . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 1.27 110.584 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' N ' ' HE1' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.63 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 2' ' ' THR . 26.8 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.892 HG21 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.6599999999999999 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 2.1000000000000001 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.81999999999999995 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 2.2599999999999998 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 2.25 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 1.29 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.5 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.724 ' SG ' HD21 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.6599999999999999 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 1.0600000000000001 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 2.0600000000000001 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.4900000000000002 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.5099999999999998 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 2.5299999999999998 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 1.28 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 1.1399999999999999 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.3700000000000001 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 1.2 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.73999999999999999 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.3999999999999999 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.64000000000000001 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 1.3200000000000001 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 2.0099999999999998 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.1099999999999999 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 6' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 1.3100000000000001 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 2.48 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.4500000000000002 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.8600000000000001 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.9199999999999999 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 5.0800000000000001 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 2.1000000000000001 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 2.1800000000000002 110.539 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.8400000000000001 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 3.1200000000000001 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 4.0899999999999999 109.853 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.824 ' HB2' HG22 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.892 HG23 HG21 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 1.27 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.6499999999999999 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.576 ' HB3' HG22 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.1100000000000001 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.99 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.8599999999999999 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.5 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.52 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.6399999999999999 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.1799999999999999 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.8300000000000001 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.78 HG12 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.9700000000000002 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 5.3899999999999997 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 111.824 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.78 ' HB ' HG12 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 4.1100000000000003 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.9900000000000002 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.7799999999999998 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.52 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.3600000000000001 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.99 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.5 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.54 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.724 HD21 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.79 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.6899999999999999 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 3.0499999999999998 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.6499999999999999 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.95999999999999996 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.78 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.8199999999999998 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 2.3100000000000001 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.6200000000000001 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.6000000000000001 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.9900000000000002 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 3.0899999999999999 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.7799999999999998 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.3999999999999999 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.98 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.777 HG21 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.6000000000000001 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.3700000000000001 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 3.2200000000000002 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.5699999999999998 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 91' ' ' ASN . 47.1 pt -132.21 -41.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.1699999999999999 110.444 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.541 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 t-20 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.672 -0.68 . . . . 5.3700000000000001 109.654 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 3.1499999999999999 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 3.1699999999999999 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 1.27 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.63 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.411 ' N ' HG21 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.6599999999999999 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 2.1000000000000001 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.81999999999999995 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 2.2599999999999998 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.62 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 2.25 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 1.29 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 10.8 mm100 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.5 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HB3' HD21 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.6599999999999999 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 1.0600000000000001 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 2.0600000000000001 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.4900000000000002 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.5099999999999998 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 2.5299999999999998 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 1.28 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 26' ' ' SER . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 1.1399999999999999 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.3700000000000001 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 1.2 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.73999999999999999 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.3999999999999999 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.64000000000000001 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 1.3200000000000001 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 2.0099999999999998 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 1.3100000000000001 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.883 HD21 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 2.48 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.4500000000000002 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.8600000000000001 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.9199999999999999 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 5.0800000000000001 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 2.1000000000000001 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 2.1800000000000002 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.8400000000000001 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.579 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 3.1200000000000001 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 4.0899999999999999 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 1.27 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.915 HG21 HG21 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 1.27 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.6499999999999999 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.555 ' HB3' HG22 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.1100000000000001 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.99 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.495 ' HB2' HG21 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.5 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.52 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.6399999999999999 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.1799999999999999 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.8300000000000001 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.9700000000000002 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 5.3899999999999997 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.0099999999999998 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 4.1100000000000003 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.9900000000000002 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.7799999999999998 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.52 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.616 ' HB2' HD12 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.3600000000000001 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.99 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.5 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.54 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.79 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.6899999999999999 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 3.0499999999999998 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.95999999999999996 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.883 ' HB ' HD21 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.78 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.8199999999999998 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.518 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 2.3100000000000001 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.6200000000000001 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.6000000000000001 110.781 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.9900000000000002 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 3.0899999999999999 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.7799999999999998 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.3999999999999999 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.98 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.6000000000000001 112.044 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.3700000000000001 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 3.2200000000000002 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.5699999999999998 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.704 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt -63.03 -31.35 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.1699999999999999 110.709 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.507 -0.759 . . . . 5.3700000000000001 110.408 -175.167 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.799 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 3.1499999999999999 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.639 HG21 ' HB3' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 3.1699999999999999 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HA ' HG13 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 1.27 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.63 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.6599999999999999 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 2.1000000000000001 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 2.2599999999999998 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.714 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 2.25 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 1.29 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 5.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.5 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.6599999999999999 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 1.0600000000000001 109.964 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 2.0600000000000001 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' HG11 ' A' ' 58' ' ' VAL . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.4900000000000002 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.5099999999999998 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 2.5299999999999998 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 1.28 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 1.1399999999999999 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.3700000000000001 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 1.2 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' O ' HG22 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.73999999999999999 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 1.3100000000000001 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.64000000000000001 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 1.3200000000000001 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 2.0099999999999998 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.695 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.1099999999999999 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.889 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 1.3100000000000001 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.626 ' HG ' HG21 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 2.48 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.695 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.8600000000000001 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.9199999999999999 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 5.0800000000000001 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 2.1000000000000001 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 2.1800000000000002 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.8400000000000001 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 3.1200000000000001 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 4.0899999999999999 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 1.27 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 1.27 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.6499999999999999 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.1100000000000001 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.99 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.691 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.8599999999999999 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.5 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.714 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.52 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.6399999999999999 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.1799999999999999 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.8300000000000001 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 18' ' ' GLN . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.9700000000000002 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 5.3899999999999997 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.0099999999999998 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 4.1100000000000003 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.9900000000000002 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.7799999999999998 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.52 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.3600000000000001 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.99 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.5 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.54 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.79 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.6899999999999999 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 72' ' ' LYS . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 3.0499999999999998 112.489 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.95999999999999996 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.78 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.8199999999999998 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.626 HG21 ' HG ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 2.3100000000000001 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.6200000000000001 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.6000000000000001 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.9900000000000002 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 51' ' ' LEU . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 3.0899999999999999 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.7799999999999998 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.691 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.3999999999999999 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.98 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.6000000000000001 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.3700000000000001 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 3.2200000000000002 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.54 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.5699999999999998 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 91' ' ' ASN . 1.6 pt 29.91 -93.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.1699999999999999 113.964 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' H ' HG13 ' A' ' 90' ' ' ILE . 6.7 t30 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.527 0.731 . . . . 5.3700000000000001 110.711 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' HG21 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 3.1499999999999999 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.723 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 3.1699999999999999 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.484 ' HA ' HG21 ' A' ' 6' ' ' VAL . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 1.27 108.384 168.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.63 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.904 ' HG3' HD13 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 HG22 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 2.1000000000000001 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.81999999999999995 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 2.2599999999999998 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.564 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 2.25 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 1.29 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.5 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 16' ' ' PHE . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.6599999999999999 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 1.0600000000000001 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 2.0600000000000001 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.4900000000000002 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.5099999999999998 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 2.5299999999999998 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG11 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 1.28 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 1.1399999999999999 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.3700000000000001 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 1.2 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.621 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.73999999999999999 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.3999999999999999 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 1.3100000000000001 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.64000000000000001 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 1.3200000000000001 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 2.0099999999999998 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.79 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.1099999999999999 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.904 HD13 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 1.3100000000000001 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 2.48 112.06 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.4500000000000002 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.8600000000000001 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.9199999999999999 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 5.0800000000000001 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 2.1000000000000001 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 2.1800000000000002 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.8400000000000001 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' HA ' HG11 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 3.1200000000000001 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 4.0899999999999999 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 1.27 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG21 HG22 ' A' ' 34' ' ' ILE . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 1.27 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 87' ' ' CYS . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.6499999999999999 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.56 ' HB3' HG23 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.1100000000000001 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.99 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.8599999999999999 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.5 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.52 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.6399999999999999 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.1799999999999999 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.8300000000000001 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 1.013 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.9700000000000002 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 5.3899999999999997 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.0099999999999998 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 4.1100000000000003 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.9900000000000002 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.7799999999999998 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.52 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.3600000000000001 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.99 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.5 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.54 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 81' ' ' ILE . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.79 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.6899999999999999 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 3.0499999999999998 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.538 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.6499999999999999 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.95999999999999996 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.78 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.8199999999999998 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.674 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 2.3100000000000001 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.6200000000000001 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.674 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.6000000000000001 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.9900000000000002 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 3.0899999999999999 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.7799999999999998 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.3999999999999999 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.98 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.6000000000000001 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.3700000000000001 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 3.2200000000000002 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.5699999999999998 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt 47.99 -171.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.688 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-N 114.578 -1.192 . . . . 5.3700000000000001 109.839 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 2.91 111.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 2.63 107.869 164.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.81 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.843 ' HG2' HD11 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.12 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 1.97 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.82 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 1.86 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 1.73 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.77 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.18 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.11 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 0.91 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 1.43 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.0 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.09 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 1.92 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 0.71 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 0.81 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.03 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 0.91 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.74 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.4 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 0.79 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.57 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.68 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 1.54 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 22.8 t-20 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.11 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.843 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 0.65 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 1.93 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.45 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.55 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.43 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 4.47 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 1.59 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 1.79 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.41 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 2.7 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 90' ' ' ILE . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 3.54 110.984 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 0.64 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 0.7 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.41 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.11 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.33 110.429 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.3 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.1 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.16 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.11 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.08 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.53 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.36 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 4.65 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.01 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 3.54 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.655 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.41 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.43 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.1 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.34 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.43 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.41 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.14 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.29 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.36 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 2.61 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.65 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.96 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.7 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.31 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 1.83 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.35 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.38 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.48 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 2.55 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.45 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.04 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.76 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.05 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.05 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 2.76 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.21 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.17 110.199 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.825 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 2.91 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 2.63 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.825 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 0.81 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.57 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.482 ' O ' HD11 ' A' ' 34' ' ' ILE . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.12 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 1.97 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.82 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 1.86 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.606 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 1.73 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 0.77 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.18 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.11 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 0.91 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.921 ' HG ' HG23 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 1.43 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 89.1 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.0 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.09 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 1.92 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.71 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 0.81 112.421 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.03 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 0.91 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.74 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.4 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.79 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.57 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 0.68 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 1.54 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 93.2 m-20 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.11 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' GLN . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.817 HD22 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 1.93 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.45 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.55 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.43 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 4.47 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 1.59 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 1.79 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.41 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 2.7 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 3.54 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 0.64 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.009 HG23 HG22 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 0.7 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.697 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.41 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.11 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.33 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.3 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.1 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.16 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.11 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.08 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.53 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.849 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.36 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 4.65 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.01 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.921 HG23 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 3.54 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.41 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.43 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.1 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.34 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.43 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.41 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.14 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.29 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.36 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 2.61 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.65 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.96 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.817 ' HB ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.7 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.31 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 1.83 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.35 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' H ' HG12 ' A' ' 77' ' ' ILE . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.38 110.348 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.48 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 2.55 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.45 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.76 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.05 109.428 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.05 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 2.76 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.21 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.17 112.382 179.156 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 2.91 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 2.63 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.81 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.57 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG2' HD11 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.069 HG22 HG23 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.12 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 1.97 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.82 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 1.86 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 1.73 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.77 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.18 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.804 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.11 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 0.91 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 1.43 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.981 ' HB2' HG13 ' A' ' 61' ' ' ILE . 45.6 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.09 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 1.92 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.71 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 0.81 112.448 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.03 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 0.91 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.74 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.4 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 0.79 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.57 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.68 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 1.54 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.11 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.65 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 1.93 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.45 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.55 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.43 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 4.47 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 43' ' ' ASP . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 1.59 110.824 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 1.79 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.41 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 2.7 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' HA ' HD11 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 3.54 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 0.64 111.454 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.069 HG23 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 0.7 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.41 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.687 ' HB3' HG21 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.11 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 81' ' ' ILE . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.33 111.27 176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.3 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.1 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.16 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.11 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.08 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.53 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.84 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.36 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 4.65 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.01 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.981 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 3.54 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.41 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.43 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.1 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.559 ' HB2' HD12 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.34 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.43 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.41 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.14 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.29 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.36 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 2.61 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.65 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.96 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.7 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.31 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 1.83 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.35 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.38 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.48 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 HD21 ' A' ' 51' ' ' LEU . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 2.55 110.37 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.45 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.04 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.76 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.05 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.05 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 2.76 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.21 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt . . . . . 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.17 112.315 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 2.91 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 2.63 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 0.81 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.57 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.12 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 1.97 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.82 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 1.86 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 1.73 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 0.77 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.18 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.11 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 1.43 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 55.3 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.0 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.09 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 1.92 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 0.71 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 0.81 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.03 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 0.91 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.594 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.74 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.4 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 0.79 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.57 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 0.68 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.11 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.693 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 0.65 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 1.93 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.45 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.55 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.43 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.87 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 4.47 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.87 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 1.59 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 1.79 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.41 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 40' ' ' THR . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 2.7 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 3.54 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 0.64 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.693 ' CG2' HG13 ' A' ' 34' ' ' ILE . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 0.7 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.41 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.11 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.33 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.3 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.1 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.16 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.11 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.08 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.53 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.36 110.166 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 4.65 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.01 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 3.54 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.41 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.43 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.1 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.34 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.43 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.41 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.14 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.36 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 2.61 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.65 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.96 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.7 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.31 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 1.83 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.35 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.38 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.48 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 2.55 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.45 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.04 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.76 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.05 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.05 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.536 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 2.76 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.21 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 86' ' ' ASN . 30.8 pt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.17 111.026 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.662 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 2.91 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 2.63 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 0.81 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.57 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.662 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 50' ' ' CYS . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.12 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 1.97 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.82 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 1.86 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 1.73 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 0.77 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.694 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.18 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.11 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.403 ' HA ' ' C ' ' A' ' 20' ' ' GLY . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 0.91 110.366 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 1.43 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.661 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.0 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.09 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' HA ' ' A' ' 16' ' ' PHE . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 1.92 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 0.71 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 0.81 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.03 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 0.91 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.74 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.4 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 0.79 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.57 112.179 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 0.68 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 1.54 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.11 110.023 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 0.65 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 1.93 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.45 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.55 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.43 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 4.47 112.768 -164.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 1.59 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 1.79 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.41 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.587 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 2.7 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 3.54 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' O ' ' HE3' ' A' ' 1' ' ' MET . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 0.64 110.173 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 34' ' ' ILE . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 0.7 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.41 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.686 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.11 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.33 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.3 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.1 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.16 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.11 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.08 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.53 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.758 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.36 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 4.65 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.01 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.758 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 3.54 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.41 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.43 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.1 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.43 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.41 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.14 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.716 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.29 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.36 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.598 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 2.61 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.65 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.96 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.7 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.31 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 1.83 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.35 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.627 ' CE2' HD11 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.38 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.48 111.568 -175.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 2.55 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.45 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.539 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.04 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.76 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.05 111.607 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.05 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 2.76 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.21 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt . . . . . 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.17 112.572 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.705 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 2.91 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 2.63 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 0.81 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.57 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.12 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 1.97 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.82 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 2.9 t30 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 1.86 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.536 HD12 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 1.73 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 0.77 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 9.9 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.18 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.11 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 0.91 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 1.43 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 76.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.0 111.058 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.09 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 1.92 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.71 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 0.81 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.03 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 0.91 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.74 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.4 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 0.79 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.57 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 0.68 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 1.54 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.11 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 0.65 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.788 HD22 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 1.93 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.45 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.643 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.55 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.43 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 4.47 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 1.59 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 1.79 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.41 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.664 ' HA ' HG12 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 2.7 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 3.54 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 0.64 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 44' ' ' ARG . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 0.7 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.41 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.584 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.11 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.33 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.3 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.1 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.16 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.11 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.08 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.53 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.94 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.36 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 4.65 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.01 111.364 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 3.54 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.41 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.43 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.1 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.34 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.43 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.41 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.14 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.29 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.36 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 2.61 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.65 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.96 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.788 ' HB ' HD22 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.7 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.31 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 1.83 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.35 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.509 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.38 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.48 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 2.55 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.45 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.04 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.76 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.05 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.05 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 2.76 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.21 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.17 113.094 173.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 2.91 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 2.63 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 0.81 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.57 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.02 HG22 HG23 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.12 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 1.97 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.82 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 1.86 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 1.73 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 0.77 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.18 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.11 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 0.91 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 1.43 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.0 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.09 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 1.92 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.71 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 0.81 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.03 112.385 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 0.91 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.74 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.4 112.195 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 0.79 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.57 112.406 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 0.68 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 1.54 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.11 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 0.65 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 1.93 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.45 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.55 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.43 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 4.47 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 1.59 109.527 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 1.79 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.41 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 40' ' ' THR . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 2.7 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 3.54 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 0.64 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.02 HG23 HG22 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 0.7 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.41 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.568 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.11 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.33 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 83' ' ' THR . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.3 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.1 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.16 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.11 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.08 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.53 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.81 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.36 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 4.65 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.01 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 3.54 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.41 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.43 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.1 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.34 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 70' ' ' PRO . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.43 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.41 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.14 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.29 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.36 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 2.61 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.65 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.96 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.7 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.31 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 1.83 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.604 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.35 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.444 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.38 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.48 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 2.55 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.45 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.04 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.76 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.05 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.05 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 2.76 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.21 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.17 110.172 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 2.91 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 2.63 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 0.81 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.57 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.12 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 1.97 109.958 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.82 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 1.86 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 1.73 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 0.77 111.208 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.18 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.11 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 0.91 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 1.43 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.0 111.98 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.09 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 1.92 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 0.71 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 0.81 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.03 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 0.91 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.74 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.4 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 0.79 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.57 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 0.68 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 1.54 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.11 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 47' ' ' VAL . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 0.65 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 1.93 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.45 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.55 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.43 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 39' ' ' ARG . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 4.47 113.403 -161.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 1.59 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 1.79 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.41 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 2.7 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 3.54 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 0.64 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 0.7 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.41 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.11 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.33 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.3 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.1 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.505 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.16 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.11 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.08 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.53 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 62' ' ' ASN . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.36 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 4.65 107.354 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.01 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 3.54 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.41 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.43 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.1 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.34 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.43 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.41 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.14 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.29 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.36 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 2.61 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.65 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.96 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.7 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.31 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 1.83 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.35 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.38 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.48 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 2.55 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.45 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.04 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.76 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.05 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.05 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 2.76 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.21 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.819 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.17 108.087 163.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 2.91 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 2.63 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 0.81 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.57 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 34' ' ' ILE . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.12 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.611 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.82 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 31' ' ' VAL . 13.2 t30 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 1.86 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 1.73 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 0.77 111.942 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.18 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.762 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.11 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.743 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 0.91 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.762 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 1.43 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.785 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.0 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.09 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 1.92 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 0.71 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 0.81 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.03 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 0.91 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.697 ' O ' HG23 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.74 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.4 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.79 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.57 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 0.68 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 1.54 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.11 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 0.65 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 1.93 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.45 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.55 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.43 107.8 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 4.47 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.534 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 1.59 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 1.79 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.41 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.534 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.617 ' HA ' HG12 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 2.7 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 3.54 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 0.64 110.152 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.7 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.41 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.11 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.33 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.3 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.1 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.16 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.11 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.08 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.53 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.36 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 4.65 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.01 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.785 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 3.54 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.41 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.43 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.1 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.34 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.43 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.41 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.14 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.29 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.36 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 2.61 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 75' ' ' VAL . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.65 110.877 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.96 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 73' ' ' CYS . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.7 111.609 -175.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.31 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.83 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.35 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.38 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.48 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 2.55 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.45 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.04 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.76 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.05 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.05 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.698 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 2.76 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.21 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.17 113.628 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 2.91 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 2.63 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 0.81 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.57 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.585 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.12 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 1.97 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.82 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 1.86 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 1.73 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 0.77 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.1 mm-40 -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.18 110.879 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.11 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 0.91 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 1.43 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.734 ' HB2' HG13 ' A' ' 61' ' ' ILE . 48.3 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.0 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.09 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 1.92 111.359 -175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 0.71 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.745 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 0.81 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.03 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 0.91 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.74 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.4 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 0.79 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.57 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.793 HG11 HD21 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 0.68 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 1.54 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.747 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.11 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 0.65 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 1.93 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.45 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.55 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.43 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 4.47 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 1.59 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 1.79 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.41 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 2.7 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 3.54 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.64 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 0.7 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.41 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG21 ' A' ' 6' ' ' VAL . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.11 110.712 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.33 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.3 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.1 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.16 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.11 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.08 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.36 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 4.65 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.01 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 3.54 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.41 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.43 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.1 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.43 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.41 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.793 HD21 HG11 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.29 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.36 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 2.61 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.65 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.96 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.7 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.31 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 1.83 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.35 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.72 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.38 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.711 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.48 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.72 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 2.55 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 85' ' ' THR . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.45 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.04 112.34 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.76 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.05 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.05 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 2.76 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.21 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.572 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.17 109.453 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 2.91 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 2.63 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 0.81 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.57 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.974 HG22 HG23 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.12 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 1.97 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.512 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.82 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.536 HD22 ' HB ' ' A' ' 34' ' ' ILE . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 1.86 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 1.73 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 0.77 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.512 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.18 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.11 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.937 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 0.91 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 1.43 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.874 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.0 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.09 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 1.92 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 0.71 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 0.81 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.03 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 0.91 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.74 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.4 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 0.79 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.57 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 0.68 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 1.54 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.11 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' HB ' HD22 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 0.65 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.736 HD21 HG13 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 1.93 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.45 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.55 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.43 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 4.47 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 1.59 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 1.79 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.41 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 47' ' ' VAL . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 2.7 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 3.54 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 0.64 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 0.7 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.11 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.33 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.3 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.1 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.16 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.11 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.08 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.53 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.862 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.36 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 4.65 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.01 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.862 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 3.54 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.4 m-20 -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.41 110.409 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.43 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.1 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.43 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.41 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.14 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.29 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.36 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 2.61 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.65 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.96 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG13 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.7 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.31 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.83 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.35 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.38 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.48 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 2.55 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.45 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.04 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.76 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.05 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.05 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 2.76 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.21 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.17 110.048 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 2.91 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 2.63 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 0.81 110.584 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.57 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 2' ' ' THR . 5.2 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.965 HG22 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.12 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 1.97 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.82 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 1.86 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.675 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 1.73 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 0.77 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.18 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.11 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 0.91 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 1.43 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.09 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 1.92 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 0.71 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 0.81 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.03 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 0.91 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.74 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.4 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 0.79 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.57 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 0.68 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 1.54 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.11 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 HD12 ' CG2' ' A' ' 47' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 0.65 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 1.93 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.45 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.55 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.43 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 4.47 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 1.59 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.539 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.41 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 2.7 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 41' ' ' THR . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 3.54 109.853 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.64 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.965 HG23 HG22 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 0.7 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.41 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' HB3' HG21 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.11 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.33 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.3 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.1 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.16 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.11 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.08 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.53 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.809 HG13 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.36 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 4.65 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.01 111.824 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.809 ' HB ' HG13 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 3.54 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.41 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.43 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.1 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.34 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.43 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.41 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.14 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.29 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.36 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 2.61 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.65 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.96 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.7 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.31 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 1.83 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.35 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.38 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HG2' HG23 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.48 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 2.55 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.45 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.04 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.76 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.05 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.05 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 2.76 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.21 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.17 110.444 -179.717 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 2.91 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 2.63 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 0.81 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.57 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' HG23 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.972 HG22 HG23 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.12 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 1.97 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.82 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 1.86 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.625 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 1.73 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 0.77 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 68.3 mm-40 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.18 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HD23 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.11 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 0.91 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 1.43 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.0 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.09 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 1.92 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 72' ' ' LYS . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.71 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 0.81 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.03 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 0.91 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.74 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.4 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.79 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.57 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 0.68 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.54 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 0.65 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 1.93 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.45 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.55 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.43 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.817 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 4.47 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 1.59 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 1.79 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.41 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 2.7 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 3.54 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 0.64 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.972 HG23 HG22 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 0.7 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.41 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' HB3' HG21 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.11 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.33 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.3 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.1 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.16 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.11 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.08 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.53 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.36 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 4.65 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.01 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 3.54 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.41 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.43 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.1 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.647 ' HB2' HD13 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.34 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.43 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.41 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.14 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.29 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.36 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 2.61 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.65 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.96 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.89 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.7 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.31 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 1.83 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.35 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' HB2' ' CG2' ' A' ' 85' ' ' THR . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.38 110.781 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.48 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 2.55 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.45 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.04 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.76 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 79' ' ' TYR . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.05 112.044 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.05 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.708 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 2.76 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.21 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.17 110.709 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.821 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 2.91 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.661 HG23 ' HB1' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 2.63 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HA ' HG12 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 0.81 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.57 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.821 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.906 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.12 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.82 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 1.86 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.725 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 1.73 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 0.77 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 27.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.18 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.636 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.11 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' CA ' ' A' ' 20' ' ' GLY . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 0.91 109.964 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 1.43 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 60' ' ' GLY . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.0 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.09 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 16' ' ' PHE . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 16' ' ' PHE . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 1.92 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 0.71 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 0.81 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.03 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 0.91 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.74 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.4 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 0.79 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.57 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.673 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 0.68 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 1.54 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.11 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.906 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 0.65 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 1.93 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.45 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.55 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.43 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 4.47 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 1.59 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 1.79 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.41 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 2.7 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 3.54 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 0.64 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 0.7 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.41 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.11 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.33 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.678 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.1 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.725 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.16 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.11 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.08 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.53 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 58' ' ' VAL . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.36 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 4.65 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.01 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 3.54 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.41 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.43 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.1 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.34 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.43 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.41 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.14 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.29 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.36 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 2.61 112.489 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.65 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.96 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.7 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.31 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 1.83 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.35 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.38 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.48 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 66' ' ' ALA . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 2.55 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.45 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.678 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.04 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.76 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.05 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 2.76 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.541 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.21 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 45' ' ' ARG . 1.6 pt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.17 113.964 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 2.91 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 2.63 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 0.81 108.384 168.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.57 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.868 ' HG3' HD11 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 HG23 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.12 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 1.97 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.82 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 1.86 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 1.73 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 0.77 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.18 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.11 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 0.91 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 1.43 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.0 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.09 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 1.92 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 0.71 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 0.81 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.03 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 0.91 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.74 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.4 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 0.79 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.57 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 0.68 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.54 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.802 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.11 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 0.65 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 1.93 112.06 174.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.45 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.802 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.55 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.43 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 4.47 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 1.59 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 1.79 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.41 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 2.7 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 3.54 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 0.64 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.908 HG23 HG22 ' A' ' 6' ' ' VAL . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 0.7 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.41 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.766 ' HB3' HG21 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.11 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.33 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.3 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.1 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.16 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.11 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.08 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.53 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.032 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.36 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 4.65 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.01 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.032 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 3.54 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.41 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.43 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.1 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.34 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.43 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.41 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.14 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 10' ' ' LEU . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.29 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.36 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 2.61 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.65 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.96 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.7 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.31 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 1.83 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.35 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.38 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 2.55 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.45 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.04 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.76 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.05 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.05 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 2.76 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.21 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.17 112.688 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 2.91 111.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 2.63 107.869 164.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.81 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.843 ' HG2' HD11 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.12 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 1.97 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.82 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 1.86 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 1.73 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.77 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.18 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.11 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 0.91 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 1.43 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.0 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.09 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 1.92 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 0.71 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 0.81 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.03 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 0.91 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.74 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.4 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 0.79 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.57 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.68 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 1.54 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 22.8 t-20 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.11 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.843 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 0.65 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 1.93 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.45 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.55 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.43 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 4.47 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 1.59 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 1.79 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.41 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 2.7 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 91' ' ' ASN . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 3.54 110.984 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 0.64 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 0.7 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.41 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.11 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.33 110.429 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.3 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.1 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.16 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.11 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.08 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.53 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.36 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 4.65 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.01 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 3.54 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.655 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.41 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.43 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.1 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.34 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.43 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.41 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.14 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.29 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.36 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 2.61 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.65 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.96 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.7 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.31 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 1.83 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.35 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.38 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.48 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 2.55 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.45 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.04 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.76 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.05 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.05 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 2.76 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.21 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -80.9 -25.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.17 110.199 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' NH2' ' A' ' 45' ' ' ARG . 4.0 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.799 -1.092 . . . . 4.78 111.762 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.825 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 2.91 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 2.63 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.825 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 0.81 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.57 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.482 ' O ' HD11 ' A' ' 34' ' ' ILE . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.12 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 1.97 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.82 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 1.86 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.606 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 1.73 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 0.77 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.18 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.11 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 0.91 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.921 ' HG ' HG23 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 1.43 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 89.1 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.0 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.09 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 1.92 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.71 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 0.81 112.421 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.03 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 0.91 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.74 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.4 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.79 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.57 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 0.68 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 1.54 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 93.2 m-20 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.11 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' GLN . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.817 HD22 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 1.93 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.45 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.55 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.43 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 4.47 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 1.59 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 1.79 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.41 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 2.7 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 3.54 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 0.64 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.009 HG23 HG22 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 0.7 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.697 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.41 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.11 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.33 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.3 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.1 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.16 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.11 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.08 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.53 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.849 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.36 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 4.65 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.01 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.921 HG23 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 3.54 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.41 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.43 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.1 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.34 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.43 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.41 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.14 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.29 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.36 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 2.61 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.65 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.96 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.817 ' HB ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.7 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.31 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 1.83 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.35 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' H ' HG12 ' A' ' 77' ' ' ILE . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.38 110.348 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.48 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 2.55 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.45 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.76 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.05 109.428 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.05 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 2.76 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.21 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt 36.71 -135.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.17 112.382 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.3 -0.63 . . . . 4.78 109.3 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 2.91 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 2.63 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.81 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.57 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG2' HD11 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.069 HG22 HG23 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.12 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 1.97 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.82 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 1.86 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 1.73 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.77 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.18 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.804 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.11 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 0.91 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 1.43 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.981 ' HB2' HG13 ' A' ' 61' ' ' ILE . 45.6 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.09 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 1.92 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.71 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 0.81 112.448 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.03 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 0.91 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.74 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.4 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 0.79 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.57 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.68 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 1.54 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.11 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.65 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 1.93 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.45 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.55 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.43 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 4.47 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 43' ' ' ASP . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 1.59 110.824 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 1.79 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.41 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 2.7 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' HA ' HD11 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 3.54 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 0.64 111.454 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.069 HG23 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 0.7 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.41 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.687 ' HB3' HG21 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.11 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 81' ' ' ILE . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.33 111.27 176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.3 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.1 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.16 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.11 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.08 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.53 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.84 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.36 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 4.65 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.01 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.981 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 3.54 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.41 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.43 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.1 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.559 ' HB2' HD12 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.34 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.43 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.41 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.14 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.29 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.36 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 2.61 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.65 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.96 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.7 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.31 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 1.83 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.35 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.38 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.48 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 HD21 ' A' ' 51' ' ' LEU . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 2.55 110.37 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.45 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.04 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.76 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.05 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.05 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 2.76 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.21 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt 35.25 -119.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.17 112.315 -175.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 t30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.642 -0.694 . . . . 4.78 109.136 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 2.91 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 2.63 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 0.81 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.57 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.12 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 1.97 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.82 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 1.86 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 1.73 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 0.77 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.18 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.11 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 1.43 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 55.3 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.0 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.09 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 1.92 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 0.71 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 0.81 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.03 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 0.91 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.594 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.74 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.4 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 0.79 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.57 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 0.68 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.11 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.693 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 0.65 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 1.93 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.45 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.55 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.43 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.87 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 4.47 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.87 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 1.59 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 1.79 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.41 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 40' ' ' THR . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 2.7 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 3.54 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 0.64 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.693 ' CG2' HG13 ' A' ' 34' ' ' ILE . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 0.7 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.41 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.11 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.33 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.3 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.1 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.16 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.11 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.08 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.53 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.36 110.166 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 4.65 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.01 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 3.54 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.41 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.43 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.1 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.34 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.43 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.41 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.14 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.36 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 2.61 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.65 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.96 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.7 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.31 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 1.83 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.35 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.38 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.48 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 2.55 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.45 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.04 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.76 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.05 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.05 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.536 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 2.76 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.21 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 86' ' ' ASN . 30.8 pt -75.14 -35.58 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.17 111.026 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 45' ' ' ARG . 83.6 m-20 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 117.8 -1.095 . . . . 4.78 110.747 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.662 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 2.91 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 2.63 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 0.81 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.57 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.662 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 50' ' ' CYS . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.12 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 1.97 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.82 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 1.86 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 1.73 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 0.77 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.694 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.18 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.11 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.403 ' HA ' ' C ' ' A' ' 20' ' ' GLY . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 0.91 110.366 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 1.43 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.661 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.0 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.09 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' HA ' ' A' ' 16' ' ' PHE . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 1.92 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 0.71 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 0.81 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.03 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 0.91 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.74 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.4 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 0.79 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.57 112.179 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 0.68 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 1.54 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.11 110.023 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 0.65 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 1.93 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.45 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.55 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.43 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 4.47 112.768 -164.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 1.59 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 1.79 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.41 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.587 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 2.7 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 3.54 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' O ' ' HE3' ' A' ' 1' ' ' MET . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 0.64 110.173 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 34' ' ' ILE . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 0.7 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.41 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.686 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.11 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.33 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.3 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.1 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.16 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.11 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.08 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.53 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.758 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.36 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 4.65 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.01 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.758 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 3.54 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.41 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.43 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.1 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.43 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.41 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.14 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.716 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.29 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.36 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.598 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 2.61 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.65 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.96 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.7 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.31 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 1.83 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.35 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.627 ' CE2' HD11 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.38 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.48 111.568 -175.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 2.55 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.45 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.539 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.04 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.76 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.05 111.607 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.05 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 2.76 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.21 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt 35.44 -134.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.17 112.572 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.675 -1.155 . . . . 4.78 108.853 -179.294 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.705 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 2.91 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 2.63 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 0.81 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.57 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.12 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 1.97 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.82 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 2.9 t30 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 1.86 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.536 HD12 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 1.73 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 0.77 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 9.9 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.18 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.11 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 0.91 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 1.43 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 76.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.0 111.058 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.09 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 1.92 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.71 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 0.81 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.03 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 0.91 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.74 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.4 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 0.79 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.57 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 0.68 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 1.54 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.11 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 0.65 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.788 HD22 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 1.93 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.45 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.643 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.55 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.43 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 4.47 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 1.59 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 1.79 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.41 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.664 ' HA ' HG12 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 2.7 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 3.54 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 0.64 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 44' ' ' ARG . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 0.7 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.41 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.584 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.11 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.33 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.3 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.1 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.16 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.11 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.08 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.53 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.94 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.36 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 4.65 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.01 111.364 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 3.54 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.41 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.43 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.1 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.34 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.43 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.41 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.14 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.29 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.36 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 2.61 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.65 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.96 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.788 ' HB ' HD22 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.7 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.31 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 1.83 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.35 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.509 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.38 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.48 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 2.55 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.45 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.04 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.76 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.05 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.05 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 2.76 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.21 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 33.9 pt 39.37 -159.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.17 113.094 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 4.3 t30 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.21 1.004 . . . . 4.78 109.047 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 2.91 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 2.63 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 0.81 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.57 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.02 HG22 HG23 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.12 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 1.97 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.82 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 1.86 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 1.73 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 0.77 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.18 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.11 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 0.91 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 1.43 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.0 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.09 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 1.92 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.71 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 0.81 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.03 112.385 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 0.91 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.74 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.4 112.195 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 0.79 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.57 112.406 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 0.68 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 1.54 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.11 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 0.65 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 1.93 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.45 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.55 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.43 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 4.47 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 1.59 109.527 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 1.79 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.41 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 40' ' ' THR . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 2.7 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 3.54 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 0.64 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.02 HG23 HG22 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 0.7 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.41 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.568 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.11 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.33 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 83' ' ' THR . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.3 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.1 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.16 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.11 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.08 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.53 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.81 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.36 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 4.65 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.01 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 3.54 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.41 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.43 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.1 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.34 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 70' ' ' PRO . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.43 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.41 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.14 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.29 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.36 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 2.61 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.65 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.96 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.7 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.31 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 1.83 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.604 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.35 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.444 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.38 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.48 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 2.55 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.45 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.04 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.76 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.05 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.05 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 2.76 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.21 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt -83.83 169.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.17 110.172 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.901 -1.045 . . . . 4.78 109.068 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 2.91 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 2.63 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 0.81 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.57 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.12 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 1.97 109.958 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.82 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 1.86 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 1.73 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 0.77 111.208 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.18 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.11 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 0.91 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 1.43 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.0 111.98 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.09 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 1.92 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 0.71 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 0.81 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.03 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 0.91 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.74 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.4 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 0.79 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.57 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 0.68 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 1.54 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.11 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 47' ' ' VAL . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 0.65 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 1.93 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.45 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.55 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.43 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 39' ' ' ARG . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 4.47 113.403 -161.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 1.59 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 1.79 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.41 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 2.7 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 3.54 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 0.64 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 0.7 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.41 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.11 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.33 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.3 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.1 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.505 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.16 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.11 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.08 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.53 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 62' ' ' ASN . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.36 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 4.65 107.354 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.01 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 3.54 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.41 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.43 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.1 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.34 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.43 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.41 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.14 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.29 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.36 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 2.61 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.65 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.96 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.7 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.31 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 1.83 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.35 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.38 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.48 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 2.55 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.45 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.04 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.76 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.05 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.05 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.783 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 2.76 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.21 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.819 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -82.62 -77.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.17 108.087 163.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.783 ' HA ' ' HB3' ' A' ' 87' ' ' CYS . 28.5 t-20 . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.254 -0.879 . . . . 4.78 112.103 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 2.91 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 2.63 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 0.81 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.57 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 34' ' ' ILE . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.12 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.611 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.82 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 31' ' ' VAL . 13.2 t30 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 1.86 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 1.73 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 0.77 111.942 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.18 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.762 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.11 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.743 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 0.91 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.762 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 1.43 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.785 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.0 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.09 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 1.92 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 0.71 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 0.81 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.03 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 0.91 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' O ' HG23 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.74 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.4 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.79 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.57 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 0.68 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 1.54 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.11 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 0.65 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 1.93 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.45 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.55 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.43 107.8 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 4.47 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 1.59 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 1.79 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.41 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.534 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.617 ' HA ' HG12 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 2.7 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 3.54 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 0.64 110.152 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.7 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.41 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.11 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.33 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.3 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.1 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.16 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.11 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.08 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.53 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.36 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 4.65 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.01 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.785 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 3.54 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.41 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.43 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.1 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.34 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.43 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.41 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.14 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.29 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.36 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 2.61 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 75' ' ' VAL . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.65 110.877 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.96 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 73' ' ' CYS . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.7 111.609 -175.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.31 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.83 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.35 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.38 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.48 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 2.55 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.45 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.04 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.76 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.05 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.05 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.698 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 2.76 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.21 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt 54.11 131.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.17 113.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.312 -1.025 0 CA-C-N 114.599 -1.182 . . . . 4.78 109.753 175.05 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 2.91 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 2.63 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 0.81 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.57 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.585 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.12 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 1.97 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.82 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 1.86 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 1.73 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 0.77 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 16.1 mm-40 -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.18 110.879 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.11 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 0.91 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 1.43 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.734 ' HB2' HG13 ' A' ' 61' ' ' ILE . 48.3 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.0 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.09 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 1.92 111.359 -175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 0.71 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.745 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 0.81 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.03 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 0.91 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.74 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.4 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 0.79 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.57 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.793 HG11 HD21 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 0.68 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 1.54 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.747 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.11 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 0.65 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 1.93 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.45 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.55 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.43 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 4.47 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 1.59 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 1.79 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.41 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 2.7 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 3.54 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.64 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 0.7 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.41 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG21 ' A' ' 6' ' ' VAL . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.11 110.712 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.33 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.3 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.1 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.16 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.11 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.08 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.36 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 4.65 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.01 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 3.54 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.41 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.43 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.1 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.43 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.41 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.793 HD21 HG11 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.29 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.36 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 2.61 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.65 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.96 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.7 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.31 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 1.83 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.35 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.72 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.38 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.711 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.48 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.72 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 2.55 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 85' ' ' THR . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.45 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.04 112.34 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.76 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.05 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.05 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 2.76 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.21 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.572 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt -109.24 -30.78 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.17 109.453 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-N 114.414 -1.266 . . . . 4.78 111.136 -172.448 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 2.91 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 2.63 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 0.81 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.57 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.974 HG22 HG23 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.12 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 1.97 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.82 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.536 HD22 ' HB ' ' A' ' 34' ' ' ILE . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 1.86 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 1.73 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 0.77 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.512 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.18 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.11 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.937 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 0.91 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 1.43 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.874 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.0 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.09 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 1.92 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 0.71 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 0.81 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.03 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 0.91 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.74 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.4 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 0.79 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.57 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 0.68 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 1.54 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.11 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' HB ' HD22 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 0.65 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.736 HD21 HG13 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 1.93 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.45 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.55 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.43 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 4.47 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 1.59 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 1.79 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.41 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 2.7 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 3.54 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 0.64 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 0.7 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.41 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.11 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.33 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.3 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.1 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.16 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.11 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.08 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.53 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.862 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.36 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 4.65 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.01 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.862 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 3.54 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.4 m-20 -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.41 110.409 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.43 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.1 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.43 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.41 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.14 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.29 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.36 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 2.61 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.65 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.96 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.736 HG13 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.7 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.31 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.83 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.35 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.38 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.48 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 2.55 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.45 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.04 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.76 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.05 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.05 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 2.76 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.21 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt -67.9 -19.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.17 110.048 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.115 -0.945 . . . . 4.78 110.804 177.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 2.91 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 2.63 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 0.81 110.584 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.57 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 2' ' ' THR . 5.2 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.965 HG22 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.12 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 1.97 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.82 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 1.86 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.675 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 1.73 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 0.77 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.18 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.11 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 0.91 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 1.43 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.09 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 1.92 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 0.71 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 0.81 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.03 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 0.91 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.74 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.4 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 0.79 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.57 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 0.68 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 1.54 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.11 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 HD12 ' CG2' ' A' ' 47' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 0.65 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 1.93 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.45 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.55 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.43 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 4.47 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 1.59 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.539 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.41 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 2.7 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 41' ' ' THR . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 3.54 109.853 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.64 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.965 HG23 HG22 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 0.7 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.41 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' HB3' HG21 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.11 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.33 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.3 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.1 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.16 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.11 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.08 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.53 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.809 HG13 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.36 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 4.65 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.01 111.824 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.809 ' HB ' HG13 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 3.54 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.41 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.43 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.1 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.34 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.43 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.41 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.14 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.29 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.36 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 2.61 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.65 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.96 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.7 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.31 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 1.83 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.35 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.38 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HG2' HG23 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.48 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 2.55 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.45 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.04 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.76 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.05 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.05 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 2.76 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.21 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 91' ' ' ASN . 47.1 pt -132.21 -41.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.17 110.444 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 t-20 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.672 -0.68 . . . . 4.78 109.654 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 2.91 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 2.63 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 0.81 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.57 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' HG23 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.972 HG22 HG23 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.12 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 1.97 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.82 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 1.86 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.625 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 1.73 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 0.77 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 68.3 mm-40 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.18 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HD23 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.11 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 0.91 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 1.43 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.0 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.09 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 1.92 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 72' ' ' LYS . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.71 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 0.81 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.03 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 0.91 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.74 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.4 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.79 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.57 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 0.68 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.54 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.11 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 0.65 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 1.93 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.45 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.55 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.43 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.817 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 4.47 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 1.59 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 1.79 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.41 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 2.7 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 3.54 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 0.64 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.972 HG23 HG22 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 0.7 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.41 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' HB3' HG21 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.11 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.33 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.3 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.1 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.16 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.11 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.08 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.53 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.36 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 4.65 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.01 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 3.54 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.41 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.43 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.1 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.647 ' HB2' HD13 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.34 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.43 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.41 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.14 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.29 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.36 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 2.61 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.65 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.96 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.89 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.7 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.31 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 1.83 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.35 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' HB2' ' CG2' ' A' ' 85' ' ' THR . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.38 110.781 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.48 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 2.55 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.45 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.04 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.76 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 79' ' ' TYR . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.05 112.044 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.05 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.708 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 2.76 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.21 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt -63.03 -31.35 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.17 110.709 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.507 -0.759 . . . . 4.78 110.408 -175.167 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.821 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 2.91 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.661 HG23 ' HB1' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 2.63 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HA ' HG12 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 0.81 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.57 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.821 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.906 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.12 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.82 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 1.86 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.725 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 1.73 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 0.77 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 27.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.18 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.636 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.11 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' CA ' ' A' ' 20' ' ' GLY . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 0.91 109.964 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 1.43 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 60' ' ' GLY . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.0 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.09 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 16' ' ' PHE . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 16' ' ' PHE . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 1.92 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 0.71 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 0.81 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.03 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 0.91 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.74 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.4 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 0.79 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.57 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.673 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 0.68 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 1.54 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.11 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.906 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 0.65 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 1.93 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.45 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.55 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.43 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 4.47 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 1.59 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 1.79 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.41 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 2.7 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 3.54 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 0.64 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 0.7 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.41 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.11 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.33 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.678 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.1 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.725 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.16 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.11 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.08 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.53 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 58' ' ' VAL . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.36 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 4.65 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.01 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 3.54 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.41 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.43 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.1 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.34 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.43 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.41 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.14 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.29 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.36 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 2.61 112.489 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.65 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.96 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.7 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.31 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 1.83 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.35 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.38 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.48 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 66' ' ' ALA . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 2.55 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.45 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.678 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.04 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.76 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.05 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 2.76 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.541 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.21 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.506 HG13 ' H ' ' A' ' 91' ' ' ASN . 1.6 pt 29.91 -93.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.17 113.964 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' H ' HG13 ' A' ' 90' ' ' ILE . 6.7 t30 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.527 0.731 . . . . 4.78 110.711 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 2.91 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 2.63 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 0.81 108.384 168.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.57 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.868 ' HG3' HD11 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 HG23 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.12 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 1.97 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.82 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 1.86 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 1.73 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 0.77 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.18 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.11 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 0.91 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 1.43 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.0 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.09 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 1.92 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 0.71 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 0.81 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.03 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 0.91 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.74 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.4 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 0.79 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.57 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 0.68 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.54 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.802 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.11 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 0.65 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 1.93 112.06 174.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.45 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.802 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.55 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.43 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 4.47 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 1.59 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 1.79 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.41 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 2.7 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 3.54 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 0.64 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.908 HG23 HG22 ' A' ' 6' ' ' VAL . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 0.7 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.41 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.766 ' HB3' HG21 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.11 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.33 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.3 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.1 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.16 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.11 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.08 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.53 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.032 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.36 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 4.65 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.01 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.032 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 3.54 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.41 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.43 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.1 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.34 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.43 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.41 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.14 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 10' ' ' LEU . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.29 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.36 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 2.61 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.65 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.96 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.7 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.31 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 1.83 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.35 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.38 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 2.55 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.45 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.04 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.76 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.05 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.05 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 2.76 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.21 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt 47.99 -171.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.17 112.688 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 . . . . . 0 C--O 1.25 1.114 0 CA-C-N 114.578 -1.192 . . . . 4.78 109.839 176.713 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 2.9100000000000001 111.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 2.6299999999999999 107.869 164.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.81000000000000005 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.56999999999999995 109.785 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.843 ' HG2' HD11 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.1200000000000001 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 1.97 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.81999999999999995 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 1.8600000000000001 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 1.73 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.77000000000000002 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.1800000000000002 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.1100000000000001 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 0.91000000000000003 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 1.4299999999999999 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.0 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.0899999999999999 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 1.9199999999999999 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 0.70999999999999996 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 0.81000000000000005 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.03 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 0.91000000000000003 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.73999999999999999 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.3999999999999999 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 0.79000000000000004 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.68000000000000005 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 1.54 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.7 t30 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.1099999999999999 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.843 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 0.65000000000000002 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 1.9299999999999999 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.4500000000000002 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.55 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.4299999999999999 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 4.4699999999999998 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 1.5900000000000001 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 1.79 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.4099999999999999 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 2.7000000000000002 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 90' ' ' ILE . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 3.54 110.984 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 0.64000000000000001 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 0.69999999999999996 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.3300000000000001 110.429 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.2999999999999998 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.1000000000000001 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.1599999999999999 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.1100000000000001 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.0800000000000001 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.53 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.3599999999999999 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 4.6500000000000004 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.0099999999999998 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 3.54 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.655 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.4100000000000001 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.4300000000000002 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.1000000000000001 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.4299999999999999 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.4100000000000001 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.1399999999999999 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.29 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.3600000000000001 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 2.6099999999999999 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.6499999999999999 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.95999999999999996 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.7 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.3500000000000001 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.3799999999999999 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.48 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 2.5499999999999998 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.4500000000000002 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.04 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.7599999999999998 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.0499999999999998 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.0499999999999998 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 2.7599999999999998 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.21 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.1699999999999999 110.199 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.825 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 2.9100000000000001 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 2.6299999999999999 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.825 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 0.81000000000000005 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.56999999999999995 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.482 ' O ' HD11 ' A' ' 34' ' ' ILE . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.1200000000000001 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 1.97 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.81999999999999995 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 1.8600000000000001 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.606 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 1.73 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 0.77000000000000002 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.1800000000000002 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.1100000000000001 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 0.91000000000000003 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.921 ' HG ' HG23 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 1.4299999999999999 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 26.9 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.0 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.0899999999999999 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 1.9199999999999999 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.70999999999999996 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 0.81000000000000005 112.421 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.03 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 0.91000000000000003 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.73999999999999999 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.3999999999999999 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.79000000000000004 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.56999999999999995 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 0.68000000000000005 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 1.54 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 10.2 m120 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.1099999999999999 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' GLN . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 0.65000000000000002 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.817 HD22 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 1.9299999999999999 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.4500000000000002 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.55 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.4299999999999999 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 4.4699999999999998 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 1.5900000000000001 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 1.79 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.4099999999999999 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 2.7000000000000002 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 3.54 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 0.64000000000000001 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.009 HG23 HG22 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 0.69999999999999996 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.697 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.4099999999999999 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.1100000000000001 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.3300000000000001 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.2999999999999998 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.1000000000000001 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.1599999999999999 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.1100000000000001 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.0800000000000001 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.53 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.849 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.3599999999999999 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 4.6500000000000004 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.0099999999999998 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.921 HG23 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 3.54 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.4100000000000001 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.4300000000000002 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.1000000000000001 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.3400000000000001 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.4299999999999999 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.4100000000000001 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.1399999999999999 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.29 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.3600000000000001 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 2.6099999999999999 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.6499999999999999 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.95999999999999996 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.817 ' HB ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.7 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.3100000000000001 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 1.8300000000000001 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.3500000000000001 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' H ' HG12 ' A' ' 77' ' ' ILE . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.3799999999999999 110.348 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.48 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 2.5499999999999998 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.4500000000000002 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.7599999999999998 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.0499999999999998 109.428 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.0499999999999998 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 2.7599999999999998 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.21 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.1699999999999999 112.382 179.156 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 2.9100000000000001 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.81000000000000005 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.56999999999999995 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG2' HD11 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.069 HG22 HG23 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.1200000000000001 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 1.97 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.81999999999999995 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 1.8600000000000001 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 1.73 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.77000000000000002 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.1800000000000002 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.804 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.1100000000000001 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 0.91000000000000003 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 1.4299999999999999 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.981 ' HB2' HG13 ' A' ' 61' ' ' ILE . 7.3 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.0899999999999999 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 1.9199999999999999 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.70999999999999996 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 0.81000000000000005 112.448 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.03 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 0.91000000000000003 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.73999999999999999 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.3999999999999999 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 0.79000000000000004 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.56999999999999995 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.68000000000000005 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 1.54 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.1099999999999999 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.65000000000000002 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 1.9299999999999999 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.4500000000000002 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.55 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.4299999999999999 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 4.4699999999999998 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 43' ' ' ASP . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 1.5900000000000001 110.824 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 1.79 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.4099999999999999 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 2.7000000000000002 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' HA ' HD11 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 3.54 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 0.64000000000000001 111.454 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.069 HG23 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 0.69999999999999996 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.4099999999999999 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.687 ' HB3' HG21 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.1100000000000001 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 81' ' ' ILE . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.3300000000000001 111.27 176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.2999999999999998 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.1000000000000001 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.1599999999999999 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.1100000000000001 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.0800000000000001 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.53 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.84 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.3599999999999999 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 4.6500000000000004 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.0099999999999998 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.981 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 3.54 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.4100000000000001 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.4300000000000002 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.1000000000000001 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.559 ' HB2' HD12 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.3400000000000001 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.4299999999999999 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.4100000000000001 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.1399999999999999 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.29 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.3600000000000001 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 2.6099999999999999 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.95999999999999996 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.7 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.3100000000000001 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 1.8300000000000001 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.3500000000000001 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.3799999999999999 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.48 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 HD21 ' A' ' 51' ' ' LEU . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 2.5499999999999998 110.37 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.4500000000000002 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.04 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.7599999999999998 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.0499999999999998 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.0499999999999998 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 2.7599999999999998 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.21 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt . . . . . 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.1699999999999999 112.315 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 2.9100000000000001 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 2.6299999999999999 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 0.81000000000000005 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.56999999999999995 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.1200000000000001 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 1.97 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.81999999999999995 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 1.8600000000000001 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 1.73 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 0.77000000000000002 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.1800000000000002 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.1100000000000001 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 0.91000000000000003 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 1.4299999999999999 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 8.1 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.0 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.0899999999999999 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 1.9199999999999999 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 0.70999999999999996 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 0.81000000000000005 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.03 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 0.91000000000000003 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.594 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.73999999999999999 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.3999999999999999 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 0.79000000000000004 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.56999999999999995 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 0.68000000000000005 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.1099999999999999 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.693 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 0.65000000000000002 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 1.9299999999999999 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.55 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.4299999999999999 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.87 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 4.4699999999999998 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.87 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 1.5900000000000001 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 1.79 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.4099999999999999 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 40' ' ' THR . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 2.7000000000000002 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 3.54 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 0.64000000000000001 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.693 ' CG2' HG13 ' A' ' 34' ' ' ILE . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 0.69999999999999996 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.4099999999999999 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.3300000000000001 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.2999999999999998 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.1000000000000001 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.1599999999999999 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.1100000000000001 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.0800000000000001 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.53 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.3599999999999999 110.166 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 4.6500000000000004 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.0099999999999998 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 3.54 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.4100000000000001 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.4300000000000002 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.1000000000000001 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.3400000000000001 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.4299999999999999 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.4100000000000001 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.1399999999999999 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.3600000000000001 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 2.6099999999999999 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.6499999999999999 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.95999999999999996 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.7 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.3100000000000001 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 1.8300000000000001 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.3500000000000001 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.3799999999999999 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.48 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 2.5499999999999998 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.4500000000000002 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.04 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.7599999999999998 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.0499999999999998 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.0499999999999998 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.536 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 2.7599999999999998 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.21 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 87' ' ' CYS . 30.8 pt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.1699999999999999 111.026 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.662 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 2.9100000000000001 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 2.6299999999999999 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 0.81000000000000005 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.56999999999999995 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.662 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 50' ' ' CYS . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.1200000000000001 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 1.97 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.81999999999999995 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 1.8600000000000001 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 1.73 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 0.77000000000000002 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.694 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.1800000000000002 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.1100000000000001 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.403 ' HA ' ' C ' ' A' ' 20' ' ' GLY . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 0.91000000000000003 110.366 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 1.4299999999999999 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.661 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.0 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.0899999999999999 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' HA ' ' A' ' 16' ' ' PHE . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 1.9199999999999999 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 0.70999999999999996 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 0.81000000000000005 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.03 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 0.91000000000000003 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.73999999999999999 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 0.79000000000000004 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.179 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 0.68000000000000005 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 1.54 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 110.023 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 0.65000000000000002 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 1.9299999999999999 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.4500000000000002 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.55 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.4299999999999999 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 4.4699999999999998 112.768 -164.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 1.5900000000000001 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 1.79 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.4099999999999999 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.587 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 2.7000000000000002 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 3.54 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' O ' ' HE3' ' A' ' 1' ' ' MET . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 0.64000000000000001 110.173 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 34' ' ' ILE . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 0.69999999999999996 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.4099999999999999 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.686 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.1100000000000001 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.3300000000000001 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.2999999999999998 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.1000000000000001 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.1599999999999999 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.1100000000000001 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.0800000000000001 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.53 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.758 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.3599999999999999 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 4.6500000000000004 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.0099999999999998 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.758 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 3.54 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.4100000000000001 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.4300000000000002 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.1000000000000001 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.3400000000000001 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.4299999999999999 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.4100000000000001 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.1399999999999999 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.716 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.29 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.3600000000000001 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.598 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 2.6099999999999999 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.6499999999999999 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.95999999999999996 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.7 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.3100000000000001 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 1.8300000000000001 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.3500000000000001 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.627 ' CE2' HD11 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.3799999999999999 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.48 111.568 -175.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 2.5499999999999998 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.4500000000000002 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.539 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.04 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.7599999999999998 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.0499999999999998 111.607 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.0499999999999998 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 2.7599999999999998 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.21 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt . . . . . 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.1699999999999999 112.572 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.705 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 2.9100000000000001 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 2.6299999999999999 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 0.81000000000000005 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.1200000000000001 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 1.97 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.81999999999999995 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.854 HD22 ' HA ' ' A' ' 31' ' ' VAL . 18.7 t-20 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 1.8600000000000001 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.536 HD12 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 1.73 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 0.77000000000000002 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 2.1 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.1800000000000002 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.1100000000000001 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 0.91000000000000003 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 1.4299999999999999 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 23.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.0 111.058 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.0899999999999999 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' GLY . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 1.9199999999999999 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.70999999999999996 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 0.81000000000000005 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.03 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 0.91000000000000003 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.73999999999999999 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.3999999999999999 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 0.79000000000000004 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.56999999999999995 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.854 ' HA ' HD22 ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 0.68000000000000005 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 1.54 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.1099999999999999 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 0.65000000000000002 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.788 HD22 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 1.9299999999999999 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.643 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.55 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.4299999999999999 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 4.4699999999999998 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 1.5900000000000001 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 1.79 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.4099999999999999 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.664 ' HA ' HG12 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 2.7000000000000002 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 3.54 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 0.64000000000000001 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 44' ' ' ARG . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 0.69999999999999996 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.4099999999999999 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.584 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.1100000000000001 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.3300000000000001 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.1000000000000001 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.1599999999999999 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.1100000000000001 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.0800000000000001 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.53 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.94 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.3599999999999999 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 4.6500000000000004 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.0099999999999998 111.364 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 3.54 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.4100000000000001 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.4300000000000002 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.1000000000000001 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.3400000000000001 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.4299999999999999 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.4100000000000001 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.1399999999999999 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.29 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.3600000000000001 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 2.6099999999999999 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.6499999999999999 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.95999999999999996 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.788 ' HB ' HD22 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.7 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.3100000000000001 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 1.8300000000000001 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.3500000000000001 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.509 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.3799999999999999 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.48 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 2.5499999999999998 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.4500000000000002 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.04 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.7599999999999998 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.0499999999999998 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 2.7599999999999998 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.21 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.1699999999999999 113.094 173.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 2.9100000000000001 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 2.6299999999999999 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 0.81000000000000005 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.56999999999999995 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.02 HG22 HG23 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.1200000000000001 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 1.97 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.81999999999999995 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 1.8600000000000001 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 1.73 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 0.77000000000000002 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.1800000000000002 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.1100000000000001 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 0.91000000000000003 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 1.4299999999999999 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.0 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.0899999999999999 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 1.9199999999999999 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.70999999999999996 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 0.81000000000000005 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.03 112.385 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 0.91000000000000003 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.73999999999999999 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.3999999999999999 112.195 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 0.79000000000000004 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.56999999999999995 112.406 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 0.68000000000000005 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 1.54 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.1099999999999999 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 0.65000000000000002 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 1.9299999999999999 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.55 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.4299999999999999 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 4.4699999999999998 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 1.5900000000000001 109.527 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 1.79 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.4099999999999999 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 40' ' ' THR . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 2.7000000000000002 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 3.54 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 0.64000000000000001 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.02 HG23 HG22 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 0.69999999999999996 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.4099999999999999 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.568 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.1100000000000001 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.3300000000000001 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 83' ' ' THR . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.2999999999999998 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.1000000000000001 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.1599999999999999 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.1100000000000001 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.0800000000000001 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.53 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.81 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.3599999999999999 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 4.6500000000000004 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.0099999999999998 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.81 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 3.54 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.4100000000000001 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.4300000000000002 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.1000000000000001 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.3400000000000001 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 70' ' ' PRO . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.4100000000000001 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.1399999999999999 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.29 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.3600000000000001 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 2.6099999999999999 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.6499999999999999 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.95999999999999996 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.7 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.3100000000000001 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 1.8300000000000001 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.604 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.3500000000000001 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.444 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.3799999999999999 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.48 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 2.5499999999999998 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.4500000000000002 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.04 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.7599999999999998 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.0499999999999998 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.0499999999999998 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 2.7599999999999998 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.21 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.1699999999999999 110.172 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 2.9100000000000001 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 2.6299999999999999 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 0.81000000000000005 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.56999999999999995 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.1200000000000001 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 1.97 109.958 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.81999999999999995 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 1.8600000000000001 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 1.73 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 0.77000000000000002 111.208 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.1800000000000002 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.1100000000000001 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 0.91000000000000003 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 1.4299999999999999 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.516 HE21 ' HG3' ' A' ' 59' ' ' ARG . 14.8 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.0 111.98 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.0899999999999999 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 1.9199999999999999 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 0.70999999999999996 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 0.81000000000000005 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.03 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 0.91000000000000003 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.73999999999999999 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 0.79000000000000004 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.56999999999999995 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 0.68000000000000005 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 1.54 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.1099999999999999 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 47' ' ' VAL . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 0.65000000000000002 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 1.9299999999999999 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.4500000000000002 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.55 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.4299999999999999 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 39' ' ' ARG . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 4.4699999999999998 113.403 -161.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 1.5900000000000001 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 1.79 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.4099999999999999 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 2.7000000000000002 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 3.54 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 0.64000000000000001 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 0.69999999999999996 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.4099999999999999 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.1100000000000001 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.3300000000000001 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.2999999999999998 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.1000000000000001 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.505 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.1599999999999999 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.1100000000000001 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.0800000000000001 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.53 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 62' ' ' ASN . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.3599999999999999 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HG3' HE21 ' A' ' 18' ' ' GLN . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 4.6500000000000004 107.354 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.0099999999999998 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 3.54 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.4100000000000001 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.4300000000000002 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.1000000000000001 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.3400000000000001 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.4299999999999999 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.4100000000000001 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.1399999999999999 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.29 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.3600000000000001 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 2.6099999999999999 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.6499999999999999 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.95999999999999996 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.7 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.3100000000000001 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 1.8300000000000001 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.3500000000000001 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.3799999999999999 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.48 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 2.5499999999999998 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.4500000000000002 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.04 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.7599999999999998 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.0499999999999998 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 2.7599999999999998 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.21 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.819 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.1699999999999999 108.087 163.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 2.9100000000000001 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 2.6299999999999999 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 0.81000000000000005 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.56999999999999995 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 34' ' ' ILE . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.1200000000000001 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.611 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.81999999999999995 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.66 ' ND2' HG22 ' A' ' 31' ' ' VAL . 1.7 t-20 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 1.8600000000000001 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 1.73 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 111.942 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.1800000000000002 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.762 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.1100000000000001 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.743 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 0.91000000000000003 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.762 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 1.4299999999999999 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.785 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.0 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.0899999999999999 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 1.9199999999999999 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 0.70999999999999996 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 0.81000000000000005 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.03 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 0.91000000000000003 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.697 ' O ' HG23 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.73999999999999999 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.79000000000000004 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.56999999999999995 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 0.68000000000000005 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 1.54 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.1099999999999999 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 0.65000000000000002 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 1.9299999999999999 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.55 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.4299999999999999 107.8 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 4.4699999999999998 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.534 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 1.5900000000000001 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 1.79 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.4099999999999999 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.534 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.617 ' HA ' HG12 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 2.7000000000000002 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 3.54 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 0.64000000000000001 110.152 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.69999999999999996 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.4099999999999999 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.1100000000000001 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.3300000000000001 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.2999999999999998 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.1000000000000001 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.1599999999999999 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.1100000000000001 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.0800000000000001 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.53 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.3599999999999999 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 4.6500000000000004 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.0099999999999998 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.785 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 3.54 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.4100000000000001 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.4300000000000002 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.1000000000000001 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.3400000000000001 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.4299999999999999 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.4100000000000001 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.1399999999999999 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.29 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.3600000000000001 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 2.6099999999999999 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 75' ' ' VAL . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.6499999999999999 110.877 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.95999999999999996 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 73' ' ' CYS . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.7 111.609 -175.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.3100000000000001 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.8300000000000001 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.3500000000000001 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.3799999999999999 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.48 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 2.5499999999999998 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.4500000000000002 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.04 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.7599999999999998 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.0499999999999998 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.0499999999999998 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.698 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 2.7599999999999998 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.21 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.1699999999999999 113.628 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 2.9100000000000001 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 2.6299999999999999 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 0.81000000000000005 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.56999999999999995 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.585 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.1200000000000001 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 1.97 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 1.8600000000000001 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 1.73 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 0.77000000000000002 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.944 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.1800000000000002 110.879 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.1100000000000001 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 0.91000000000000003 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 1.4299999999999999 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.734 ' HB2' HG13 ' A' ' 61' ' ' ILE . 8.1 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.0 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.0899999999999999 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 1.9199999999999999 111.359 -175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 0.70999999999999996 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.745 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 0.81000000000000005 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.03 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 0.91000000000000003 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.73999999999999999 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.3999999999999999 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 0.79000000000000004 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.793 HG11 HD21 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 0.68000000000000005 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 1.54 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.747 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.1099999999999999 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 0.65000000000000002 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 1.9299999999999999 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.4500000000000002 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.55 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.4299999999999999 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 4.4699999999999998 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 1.5900000000000001 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 1.79 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.4099999999999999 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 2.7000000000000002 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 3.54 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.64000000000000001 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 0.69999999999999996 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.4099999999999999 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG21 ' A' ' 6' ' ' VAL . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.1100000000000001 110.712 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.3300000000000001 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.2999999999999998 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.1000000000000001 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.1599999999999999 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.1100000000000001 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.0800000000000001 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.3599999999999999 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 4.6500000000000004 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.0099999999999998 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 3.54 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.4100000000000001 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.4300000000000002 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.1000000000000001 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.4299999999999999 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.4100000000000001 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.793 HD21 HG11 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.29 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.3600000000000001 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 2.6099999999999999 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.6499999999999999 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.95999999999999996 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.7 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.3100000000000001 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.723 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 1.8300000000000001 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.3500000000000001 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.72 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.3799999999999999 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.711 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.48 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.72 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 2.5499999999999998 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 85' ' ' THR . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.4500000000000002 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.04 112.34 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.7599999999999998 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.0499999999999998 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.0499999999999998 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 2.7599999999999998 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.21 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.572 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.1699999999999999 109.453 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 2.9100000000000001 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 2.6299999999999999 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 0.81000000000000005 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.56999999999999995 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.974 HG22 HG23 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.1200000000000001 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 1.97 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.512 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.81999999999999995 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.536 HD22 ' HB ' ' A' ' 34' ' ' ILE . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 1.8600000000000001 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 1.73 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 0.77000000000000002 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.512 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.1800000000000002 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.1100000000000001 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.937 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 0.91000000000000003 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 1.4299999999999999 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.874 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.0 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.0899999999999999 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 1.9199999999999999 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 0.70999999999999996 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 0.81000000000000005 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.03 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 0.91000000000000003 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.73999999999999999 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.3999999999999999 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 0.79000000000000004 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.56999999999999995 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 0.68000000000000005 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 1.54 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.1099999999999999 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' HB ' HD22 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 0.65000000000000002 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.736 HD21 HG13 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 1.9299999999999999 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.4500000000000002 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.55 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.4299999999999999 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 4.4699999999999998 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 1.5900000000000001 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 1.79 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.4099999999999999 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 47' ' ' VAL . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 2.7000000000000002 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 3.54 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 0.64000000000000001 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 0.69999999999999996 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.4099999999999999 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.1100000000000001 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.2999999999999998 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.1000000000000001 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.1100000000000001 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.0800000000000001 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.53 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.862 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.3599999999999999 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 4.6500000000000004 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.0099999999999998 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.862 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 3.54 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' H ' HG13 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.4100000000000001 110.409 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.4300000000000002 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.1000000000000001 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.3400000000000001 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.4299999999999999 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.4100000000000001 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.29 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.3600000000000001 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 2.6099999999999999 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.6499999999999999 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.95999999999999996 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG13 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.7 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.3100000000000001 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.3500000000000001 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.3799999999999999 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.48 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 2.5499999999999998 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.4500000000000002 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.04 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.7599999999999998 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.0499999999999998 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.0499999999999998 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 2.7599999999999998 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.21 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.1699999999999999 110.048 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 2.9100000000000001 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 2.6299999999999999 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 0.81000000000000005 110.584 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.56999999999999995 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 2' ' ' THR . 26.8 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.965 HG22 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.1200000000000001 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 1.97 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.81999999999999995 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 1.8600000000000001 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.675 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 1.73 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 0.77000000000000002 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.1800000000000002 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.1100000000000001 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 0.91000000000000003 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 1.4299999999999999 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.0899999999999999 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 1.9199999999999999 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 0.70999999999999996 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 0.81000000000000005 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.03 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 0.91000000000000003 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.73999999999999999 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.3999999999999999 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 0.79000000000000004 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.56999999999999995 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 0.68000000000000005 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 1.54 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.1099999999999999 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 HD12 ' CG2' ' A' ' 47' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 0.65000000000000002 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 1.9299999999999999 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.4500000000000002 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.55 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.4299999999999999 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 4.4699999999999998 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 1.5900000000000001 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.539 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 2.7000000000000002 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 41' ' ' THR . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 3.54 109.853 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.64000000000000001 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.965 HG23 HG22 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 0.69999999999999996 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.4099999999999999 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' HB3' HG21 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.1100000000000001 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.3300000000000001 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.1000000000000001 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.1599999999999999 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.1100000000000001 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.0800000000000001 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.53 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.809 HG13 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.3599999999999999 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 4.6500000000000004 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 111.824 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.809 ' HB ' HG13 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 3.54 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.4100000000000001 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.4300000000000002 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.1000000000000001 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.3400000000000001 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.4299999999999999 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.4100000000000001 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.1399999999999999 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.29 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.3600000000000001 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 2.6099999999999999 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.6499999999999999 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.95999999999999996 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.7 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.3100000000000001 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 1.8300000000000001 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.3500000000000001 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.3799999999999999 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HG2' HG23 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.48 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 2.5499999999999998 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.4500000000000002 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.04 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.7599999999999998 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.0499999999999998 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.0499999999999998 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 2.7599999999999998 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.21 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.1699999999999999 110.444 -179.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 2.9100000000000001 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 2.6299999999999999 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 0.81000000000000005 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.56999999999999995 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' HG23 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.972 HG22 HG23 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.1200000000000001 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 1.97 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.81999999999999995 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 1.8600000000000001 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.625 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 1.73 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 0.77000000000000002 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 10.8 mm100 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.1800000000000002 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HD23 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.1100000000000001 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 0.91000000000000003 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 1.4299999999999999 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.0 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.0899999999999999 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 1.9199999999999999 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 72' ' ' LYS . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.70999999999999996 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 0.81000000000000005 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.03 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 0.91000000000000003 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.73999999999999999 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.3999999999999999 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.79000000000000004 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 0.68000000000000005 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.54 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 0.65000000000000002 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 1.9299999999999999 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.4500000000000002 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.55 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.4299999999999999 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.817 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 4.4699999999999998 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 1.5900000000000001 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 1.79 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.4099999999999999 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 2.7000000000000002 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 3.54 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.972 HG23 HG22 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 0.69999999999999996 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.4099999999999999 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.625 ' HB3' HG21 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.1100000000000001 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.3300000000000001 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.2999999999999998 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.1000000000000001 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.1599999999999999 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.1100000000000001 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.0800000000000001 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.53 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.3599999999999999 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 4.6500000000000004 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.0099999999999998 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 3.54 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.4100000000000001 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.4300000000000002 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.1000000000000001 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.647 ' HB2' HD13 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.3400000000000001 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.4299999999999999 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.4100000000000001 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.1399999999999999 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.29 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.3600000000000001 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 2.6099999999999999 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.95999999999999996 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.89 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.7 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.3100000000000001 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 1.8300000000000001 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.3500000000000001 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' HB2' ' CG2' ' A' ' 85' ' ' THR . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.3799999999999999 110.781 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.48 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 2.5499999999999998 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.4500000000000002 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.04 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.7599999999999998 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 79' ' ' TYR . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.0499999999999998 112.044 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.0499999999999998 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.708 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 2.7599999999999998 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.21 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.1699999999999999 110.709 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.821 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 2.9100000000000001 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.661 HG23 ' HB1' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 2.6299999999999999 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HA ' HG12 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 0.81000000000000005 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.821 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.906 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.1200000000000001 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 1.8600000000000001 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.725 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 1.73 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 0.77000000000000002 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 5.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.1800000000000002 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.636 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.1100000000000001 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' CA ' ' A' ' 20' ' ' GLY . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.964 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 1.4299999999999999 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 60' ' ' GLY . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.0 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.0899999999999999 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 16' ' ' PHE . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 16' ' ' PHE . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 1.9199999999999999 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 0.70999999999999996 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 0.81000000000000005 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.03 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 0.91000000000000003 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.73999999999999999 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 0.79000000000000004 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.56999999999999995 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.673 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 0.68000000000000005 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 1.54 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.1099999999999999 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.906 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 0.65000000000000002 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 1.9299999999999999 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.55 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.4299999999999999 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 4.4699999999999998 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 1.5900000000000001 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 1.79 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.4099999999999999 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 2.7000000000000002 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 3.54 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 0.69999999999999996 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.4099999999999999 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.1100000000000001 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.3300000000000001 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.678 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.2999999999999998 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.1000000000000001 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.725 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.1599999999999999 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.1100000000000001 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.0800000000000001 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.53 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 58' ' ' VAL . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.3599999999999999 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 4.6500000000000004 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.0099999999999998 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 3.54 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.4100000000000001 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.4300000000000002 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.1000000000000001 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.3400000000000001 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.4299999999999999 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.4100000000000001 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.1399999999999999 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.29 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.3600000000000001 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 2.6099999999999999 112.489 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.95999999999999996 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.7 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.3100000000000001 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 1.8300000000000001 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.3500000000000001 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.3799999999999999 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.48 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 66' ' ' ALA . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 2.5499999999999998 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.4500000000000002 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.678 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.04 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.7599999999999998 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.0499999999999998 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.0499999999999998 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 2.7599999999999998 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.541 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.21 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 45' ' ' ARG . 1.6 pt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.1699999999999999 113.964 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 2.9100000000000001 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 2.6299999999999999 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 0.81000000000000005 108.384 168.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.56999999999999995 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.868 ' HG3' HD11 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 HG23 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.1200000000000001 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 1.97 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.81999999999999995 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 1.8600000000000001 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 1.73 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 0.77000000000000002 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.1800000000000002 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.1100000000000001 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 0.91000000000000003 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 1.4299999999999999 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.0 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.0899999999999999 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 1.9199999999999999 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 0.70999999999999996 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 0.81000000000000005 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.03 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 0.91000000000000003 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.73999999999999999 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.3999999999999999 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 0.79000000000000004 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.56999999999999995 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 0.68000000000000005 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.54 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.802 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.1099999999999999 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 0.65000000000000002 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 1.9299999999999999 112.06 174.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.4500000000000002 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.802 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.55 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.4299999999999999 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 4.4699999999999998 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 1.5900000000000001 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 1.79 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.4099999999999999 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 2.7000000000000002 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 3.54 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 0.64000000000000001 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.908 HG23 HG22 ' A' ' 6' ' ' VAL . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 0.69999999999999996 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.4099999999999999 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.766 ' HB3' HG21 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.1100000000000001 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.2999999999999998 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.1000000000000001 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.1599999999999999 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.1100000000000001 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.0800000000000001 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.53 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.032 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.3599999999999999 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 4.6500000000000004 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.0099999999999998 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.032 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 3.54 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.4100000000000001 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.4300000000000002 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.1000000000000001 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.3400000000000001 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.4299999999999999 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.4100000000000001 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.1399999999999999 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 10' ' ' LEU . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.29 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.3600000000000001 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 2.6099999999999999 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.6499999999999999 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.95999999999999996 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.7 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.3100000000000001 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 1.8300000000000001 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.3500000000000001 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.3799999999999999 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 2.5499999999999998 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.4500000000000002 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.04 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.7599999999999998 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.0499999999999998 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.0499999999999998 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 2.7599999999999998 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.21 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.688 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.602 0.715 . . . . 2.9100000000000001 111.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -129.05 172.68 11.16 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.439 -1.255 . . . . 2.6299999999999999 107.869 164.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -79.8 13.51 2.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.81000000000000005 109.191 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -23.78 6.32 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.785 -1.326 . . . . 0.56999999999999995 109.785 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.843 ' HG2' HD11 ' A' ' 34' ' ' ILE . 25.4 tt0 -63.66 -45.78 88.59 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.741 -0.837 . . . . 1.25 108.741 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 9' ' ' ASN . 69.9 t -64.25 -30.53 50.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.329 -0.85 . . . . 1.1200000000000001 110.723 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.93 -42.92 99.66 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 120.669 -0.412 . . . . 1.97 110.161 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.38 -10.21 47.18 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.792 -1.194 . . . . 0.81999999999999995 112.234 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 27.6 t-20 -85.77 -68.51 0.73 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.065 -0.717 . . . . 1.8600000000000001 109.065 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 54' ' ' ALA . 25.4 mt -78.44 -29.59 47.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.11 0.782 . . . . 1.73 113.11 -169.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.12 71.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.77000000000000002 110.325 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 82.8 mm-40 -75.09 -40.76 59.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.767 -0.651 . . . . 2.1800000000000002 110.309 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -77.15 -23.74 51.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.479 -0.782 . . . . 1.23 111.711 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 3.8 mt -49.54 -34.91 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 O-C-N 123.206 0.316 . . . . 1.1100000000000001 111.622 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 20.23 2.5 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.678 -0.772 . . . . 1.45 113.17 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 2.5 t80 -146.71 -43.91 0.19 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.774 -1.195 . . . . 0.91000000000000003 107.774 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 29.6 tp -50.93 -46.15 60.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.398 -1.728 . . . . 1.4299999999999999 111.277 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' HB2' HD12 ' A' ' 61' ' ' ILE . 36.6 tt0 -90.87 -53.54 4.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.394 0.616 . . . . 2.0 109.856 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -121.2 100.23 6.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.294 -0.866 . . . . 4.0899999999999999 109.703 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . -68.73 78.54 0.26 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.792 -0.64 . . . . 1.99 114.467 -172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.72 -56.74 2.56 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.638 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 p -173.02 152.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.697 -0.482 . . . . 1.9199999999999999 109.697 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 72' ' ' LYS . 94.2 t -91.98 109.11 35.05 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.044 0.45 . . . . 0.70999999999999996 110.553 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 26' ' ' SER . 85.9 Cg_endo -76.94 159.4 34.28 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.146 2.564 . . . . 0.81000000000000005 112.227 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.3 4.95 1.7 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.772 2.315 . . . . 1.03 111.583 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 24' ' ' PRO . 1.4 m -90.64 -56.63 3.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.3 -1.0 . . . . 0.91000000000000003 108.3 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.1 t -49.89 -53.58 24.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.071 -1.422 . . . . 0.73999999999999999 109.985 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.1 t -52.51 -54.05 37.71 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.378 -0.374 . . . . 1.3999999999999999 110.741 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 m -56.78 -45.63 82.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.167 -0.47 . . . . 0.79000000000000004 111.923 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.15 -40.8 97.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 112.306 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 27' ' ' CYS . 60.7 t -61.33 -54.28 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.68000000000000005 110.397 176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 37.4 ttmt -62.18 -27.25 68.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 1.54 110.09 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.7 t30 -66.92 -55.41 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 2.1099999999999999 110.476 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.843 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.1 mp -61.82 -24.09 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.979 0.419 . . . . 0.65000000000000002 111.8 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 75' ' ' VAL . 79.0 mt -93.41 -48.41 6.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.581 0.586 . . . . 1.9299999999999999 112.581 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -102.41 -45.98 4.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.685 0.279 . . . . 2.4500000000000002 111.63 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 50.3 m -81.21 4.29 20.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 1.55 111.852 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.7 p -61.14 -54.23 47.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.184 -0.673 . . . . 1.4299999999999999 109.184 172.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 79.47 -58.41 0.38 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.583 -1.189 . . . . 4.4699999999999998 112.475 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 p -87.84 164.56 15.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.093 0.473 . . . . 1.5900000000000001 111.662 -169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m -63.52 -43.11 98.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.603 -0.726 . . . . 1.79 110.494 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -66.18 -28.46 68.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.722 -0.672 . . . . 1.4099999999999999 109.746 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 1.3 m-20 -83.34 1.47 41.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.791 -0.64 . . . . 1.72 111.205 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' HG12 ' A' ' 47' ' ' VAL . 70.6 mtt180 -111.58 -56.49 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.181 0.515 . . . . 2.7000000000000002 110.875 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 91' ' ' ASN . 85.4 mtt180 -73.43 -42.64 61.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.204 -0.453 . . . . 3.54 110.984 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.3 -32.01 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.588 -0.278 . . . . 0.64000000000000001 110.809 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 44' ' ' ARG . 3.9 p -64.95 -36.43 77.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.957 0.408 . . . . 0.69999999999999996 110.093 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 40.1 t -69.86 -35.87 75.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.479 -0.564 . . . . 1.78 109.479 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 m -67.61 -6.53 20.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 112.066 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 6' ' ' VAL . 23.8 t -103.12 -33.47 9.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 109.798 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp -55.61 -31.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.32 -0.855 . . . . 1.3300000000000001 110.429 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.57 -48.88 78.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.471 -0.786 . . . . 2.2999999999999998 112.336 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.34 25.9 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.857 -0.337 . . . . 1.1000000000000001 111.586 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' CB ' HD12 ' A' ' 10' ' ' LEU . . . -70.33 -41.6 73.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.789 -0.449 . . . . 1.1599999999999999 109.789 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.61 1.37 46.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.564 0.697 . . . . 1.1100000000000001 109.512 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.03 -9.33 45.61 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.847 . . . . 1.0800000000000001 110.984 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.0 -0.14 50.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.476 0.655 . . . . 1.53 109.764 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.1 m -56.3 98.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.578 -1.192 . . . . 2.3599999999999999 112.794 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -109.34 102.09 11.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.605 -0.725 . . . . 4.6500000000000004 109.639 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.83 32.06 41.94 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.161 -0.776 . . . . 2.0099999999999998 111.161 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.9 tp -81.91 177.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 3.54 111.291 -174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.655 ' H ' HG13 ' A' ' 61' ' ' ILE . 4.1 m-20 -127.15 114.73 21.74 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.753 -0.658 . . . . 3.4100000000000001 110.069 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 14.3 Cg_exo -65.01 -30.21 56.73 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.959 2.439 . . . . 2.4300000000000002 112.22 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.42 -27.59 69.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.867 -0.606 . . . . 3.1000000000000001 111.086 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -82.58 -17.79 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 110.827 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.33 -36.3 79.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.907 0.384 . . . . 1.4299999999999999 111.029 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -85.15 -22.91 28.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.472 0.653 . . . . 2.4100000000000001 109.882 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -75.01 -28.77 60.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.056 -0.52 . . . . 1.1399999999999999 110.033 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 7.2 tt -48.5 -57.82 9.84 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.869 -1.06 . . . . 2.29 112.483 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 45.7 Cg_endo -68.79 -32.45 23.1 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.722 1.615 . . . . 1.2 112.115 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.11 -37.42 91.61 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.904 -0.589 . . . . 1.3600000000000001 113.061 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.5 mmmm -71.25 -26.71 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.867 0.334 . . . . 2.6099999999999999 111.899 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 33.7 t -86.88 -27.16 23.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.081 -0.648 . . . . 1.6499999999999999 110.738 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 43.69 2.73 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.457 -0.878 . . . . 0.95999999999999996 111.655 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 35' ' ' LEU . 2.2 m -130.62 85.26 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.356 0.598 . . . . 1.7 110.985 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.82 87.86 5.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 2.3100000000000001 110.065 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 79' ' ' TYR . 11.7 pt -84.57 152.75 60.83 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 111.55 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.75 -56.78 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.948 2.432 . . . . 1.3500000000000001 111.902 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CD1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -69.11 166.7 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.16 -0.682 . . . . 1.3799999999999999 109.16 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -120.87 -178.08 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.179 -0.609 . . . . 3.48 112.518 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 81' ' ' ILE . 29.3 mm -84.35 13.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.765 -1.107 . . . . 2.5499999999999998 109.427 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 48.3 t -67.02 139.7 57.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.179 -0.918 . . . . 2.4500000000000002 110.347 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 p -66.5 -15.71 63.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.931 -0.577 . . . . 2.04 111.617 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 m -134.71 48.9 2.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.241 -0.436 . . . . 2.7599999999999998 110.441 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 14.7 t -82.1 5.74 18.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.332 -0.394 . . . . 2.0499999999999998 110.992 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 65.45 109.02 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.415 0.626 . . . . 3.0499999999999998 111.028 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 34.8 m -100.15 -3.92 30.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.018 0.748 . . . . 1.71 113.018 -167.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -99.95 -30.57 11.93 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.152 -0.619 . . . . 2.7599999999999998 111.872 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.7 t -91.11 12.76 18.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.02 0.438 . . . . 2.21 111.058 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 45' ' ' ARG . 45.2 pt -80.9 -25.36 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 2.1699999999999999 110.199 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' NH2' ' A' ' 45' ' ' ARG . 4.0 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.799 -1.092 . . . . 4.7800000000000002 111.762 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.825 ' HG2' ' H ' ' A' ' 3' ' ' CYS . 4.0 ttp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.895 0.379 . . . . 2.9100000000000001 111.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 4' ' ' GLY . 17.0 p -108.46 -4.08 17.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.195 0.521 . . . . 2.6299999999999999 111.389 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.825 ' H ' ' HG2' ' A' ' 1' ' ' MET . 4.7 t 73.33 -24.06 0.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.884 -1.053 . . . . 0.81000000000000005 109.089 -169.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -80.55 -32.49 33.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.402 -1.479 . . . . 0.56999999999999995 109.402 169.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.482 ' O ' HD11 ' A' ' 34' ' ' ILE . 22.5 tt0 -53.66 -45.11 70.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.485 -0.931 . . . . 1.25 108.485 167.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 47' ' ' VAL . 6.1 t -65.77 -38.8 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.222 -0.899 . . . . 1.1200000000000001 110.32 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 35.6 tt0 -58.61 -29.33 66.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.855 -0.612 . . . . 1.97 111.15 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.6 -21.44 49.83 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.155 -0.545 . . . . 0.81999999999999995 112.38 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 31' ' ' VAL . 6.0 t30 -71.91 -54.23 10.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.092 0.473 . . . . 1.8600000000000001 110.241 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.606 ' O ' HG13 ' A' ' 14' ' ' ILE . 5.8 mp -85.35 -34.43 21.82 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.912 -0.585 . . . . 1.73 112.141 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -51.1 -31.28 18.65 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.314 0.487 . . . . 0.77000000000000002 112.314 -173.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.8 -26.97 29.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.293 -0.412 . . . . 2.1800000000000002 111.113 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 2.0 m -109.43 3.15 21.11 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.053 0.39 . . . . 1.23 112.053 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 60.1 mt -57.53 -29.43 33.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.275 -0.639 . . . . 1.1100000000000001 109.275 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.57 -61.33 7.52 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.497 -0.858 . . . . 1.45 112.314 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 16.2 t80 -58.8 -44.46 90.79 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.897 0.479 . . . . 0.91000000000000003 110.639 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.921 ' HG ' HG23 ' A' ' 61' ' ' ILE . 1.4 mp -44.68 -53.71 6.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.596 -1.184 . . . . 1.4299999999999999 110.379 171.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 26.9 mt-30 -70.32 -76.85 0.09 Allowed 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.162 0.982 . . . . 2.0 110.291 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 7.5 ttmm -150.81 84.09 1.34 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.032 -1.44 . . . . 4.0899999999999999 110.895 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -133.76 -171.55 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.577 -0.738 . . . . 1.99 111.274 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 -49.36 0.1 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.48 -0.867 . . . . 1.79 112.827 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 p -117.61 133.07 65.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.896 0.379 . . . . 1.9199999999999999 111.174 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.8 t -84.29 117.08 67.83 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.795 -0.639 . . . . 0.70999999999999996 110.242 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 73.9 Cg_endo -76.29 143.51 25.2 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.551 2.168 . . . . 0.81000000000000005 112.421 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 31.9 Cg_exo -59.08 -15.32 27.44 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.965 2.443 . . . . 1.03 111.695 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.6 m -69.85 -56.78 6.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.284 -0.871 . . . . 0.91000000000000003 108.961 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -54.05 -44.02 70.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.403 -1.271 . . . . 0.73999999999999999 109.569 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 7.0 m -60.35 -33.31 72.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 1.3999999999999999 112.346 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -62.2 -39.42 92.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.79000000000000004 109.966 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.14 -36.59 85.73 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.012 -0.614 . . . . 0.56999999999999995 112.22 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' OD1' ' A' ' 9' ' ' ASN . 21.4 t -62.04 -47.28 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.543 0.687 . . . . 0.68000000000000005 109.651 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 95.8 mttt -63.88 -19.04 64.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.31 -0.859 . . . . 1.54 110.729 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 10.2 m120 -76.59 -54.58 6.49 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 120.593 -0.443 . . . . 2.1099999999999999 110.31 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' GLN . 15.2 mm -58.44 -35.72 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.162 0.43 . . . . 0.65000000000000002 112.162 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.817 HD22 ' HB ' ' A' ' 75' ' ' VAL . 7.3 mp -81.55 -69.22 0.63 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.158 0.504 . . . . 1.9299999999999999 111.67 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 3.0 m-20 -76.4 -49.45 16.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.088 -0.505 . . . . 2.4500000000000002 111.517 -173.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 18.0 m -83.95 8.04 16.39 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.984 0.735 . . . . 1.55 112.984 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -56.78 120.14 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.687 -1.227 . . . . 1.4299999999999999 107.687 168.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -50.83 -38.07 46.67 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.631 0.582 . . . . 4.4699999999999998 112.529 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -162.67 171.32 17.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.298 -1.001 . . . . 1.5900000000000001 108.298 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 95.1 m -69.04 -22.36 64.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.412 -0.588 . . . . 1.79 109.412 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.33 -15.81 62.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.573 -0.74 . . . . 1.4099999999999999 109.527 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -101.25 -38.29 8.15 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.7 -0.852 . . . . 1.72 108.7 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 75.2 mtp85 -59.79 -40.24 87.66 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.066 -0.97 . . . . 2.7000000000000002 111.857 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -67.17 -45.41 77.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.728 -0.389 . . . . 3.54 110.397 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.6 67.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.101 -0.499 . . . . 0.64000000000000001 111.165 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.009 HG23 HG22 ' A' ' 6' ' ' VAL . 6.7 p -61.38 -34.11 59.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.544 . . . . 0.69999999999999996 110.743 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 50.1 t -78.78 -42.66 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.29 -0.413 . . . . 1.78 110.665 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.697 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 66.5 m -69.16 -23.08 63.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.938 0.348 . . . . 1.4099999999999999 111.938 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.25 -21.21 23.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.227 -0.657 . . . . 1.1100000000000001 109.227 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 59.4 tp -62.37 -39.02 91.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.781 . . . . 1.3300000000000001 110.335 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 21.3 pttp -72.53 -4.2 29.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 2.2999999999999998 111.629 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.41 -37.96 8.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.7 -0.481 . . . . 1.1000000000000001 109.7 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.94 97.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 1.1599999999999999 110.153 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -96.02 13.09 28.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.584 . . . . 1.1100000000000001 110.768 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.46 -22.52 3.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.076 -0.583 . . . . 1.0800000000000001 111.794 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.33 46.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.265 0.555 . . . . 1.53 110.527 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.849 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 29.0 m -79.47 140.63 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 2.3599999999999999 112.58 -174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.23 117.23 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.455 -0.943 . . . . 4.6500000000000004 108.455 170.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.71 3.0 64.66 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.517 -0.849 . . . . 2.0099999999999998 111.844 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.921 HG23 ' HG ' ' A' ' 17' ' ' LEU . 1.5 mp -89.34 -40.52 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 122.066 0.936 . . . . 3.54 110.201 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-20 65.15 116.41 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 113.366 -1.743 . . . . 3.4100000000000001 110.536 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_endo -66.22 -15.32 47.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.281 1.987 . . . . 2.4300000000000002 112.0 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -57.92 -40.16 79.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 3.1000000000000001 110.013 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -74.38 -31.85 62.52 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.002 -0.545 . . . . 1.3400000000000001 109.659 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.27 -34.76 70.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.455 -0.793 . . . . 1.4299999999999999 111.645 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.66 -13.27 40.2 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.1 0.476 . . . . 2.4100000000000001 110.489 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -70.67 -32.13 69.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.235 0.541 . . . . 1.1399999999999999 109.629 174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 13' ' ' CYS . 26.8 tp -56.65 -59.46 12.24 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.881 -1.054 . . . . 2.29 112.512 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.56 -20.45 64.5 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.811 1.674 . . . . 1.2 112.189 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.86 -39.01 48.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.961 -0.638 . . . . 1.3600000000000001 111.867 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.6 mmmm -69.8 -43.43 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.267 0.556 . . . . 2.6099999999999999 110.302 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.4 m -75.2 -15.32 60.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 1.6499999999999999 111.219 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.72 56.02 27.6 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.264 -0.493 . . . . 0.95999999999999996 112.773 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.817 ' HB ' HD22 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -98.8 2.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.829 0.307 . . . . 1.7 111.829 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.3 t30 48.51 71.02 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.379 0.609 . . . . 2.3100000000000001 110.357 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 15.3 tt -85.03 123.03 74.1 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 1.8300000000000001 111.309 -170.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 5.0 Cg_exo -78.65 -8.19 15.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.259 2.64 . . . . 1.3500000000000001 113.071 -177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' H ' HG12 ' A' ' 77' ' ' ILE . 25.9 p90 -134.69 -169.65 2.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.348 -0.241 . . . . 1.3799999999999999 110.348 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 27.8 mmtp -141.58 175.61 9.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.945 0.402 . . . . 3.48 111.431 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.5 pp -95.0 16.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.336 -0.847 . . . . 2.5499999999999998 111.066 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.75 142.13 55.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 2.4500000000000002 111.293 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -58.24 -40.43 81.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.511 -0.768 . . . . 2.04 111.524 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -96.43 73.41 2.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.574 0.702 . . . . 2.7599999999999998 109.925 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 88.3 m -147.12 109.96 4.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.116 -0.947 . . . . 2.0499999999999998 109.428 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -81.79 130.73 35.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.363 0.601 . . . . 3.0499999999999998 109.973 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.0 m -111.89 21.65 15.75 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.589 0.709 . . . . 1.71 109.363 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.89 -15.53 61.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.89 -1.05 . . . . 2.7599999999999998 110.714 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.0 m -118.09 -78.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.177 -0.465 . . . . 2.21 110.084 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 pt 36.71 -135.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 124.454 1.096 . . . . 2.1699999999999999 112.382 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.3 -0.63 . . . . 4.7800000000000002 109.3 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 3' ' ' CYS . 8.7 tmm? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.186 0.517 . . . . 2.9100000000000001 110.139 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 4' ' ' GLY . 18.7 p -123.08 0.28 9.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.384 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.4 t 71.35 -23.65 0.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.81000000000000005 109.876 -173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -86.43 -30.84 20.86 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.172 -1.571 . . . . 0.56999999999999995 109.172 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG2' HD11 ' A' ' 34' ' ' ILE . 34.9 tt0 -55.27 -52.89 61.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.632 -0.784 . . . . 1.25 109.214 167.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.069 HG22 HG23 ' A' ' 47' ' ' VAL . 32.3 t -61.41 -45.37 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.51 -0.768 . . . . 1.1200000000000001 111.01 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -65.42 -23.93 67.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 1.97 110.382 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.27 84.87 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.098 -0.572 . . . . 0.81999999999999995 111.939 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 31' ' ' VAL . 20.2 t30 -55.9 -58.68 6.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.216 0.531 . . . . 1.8600000000000001 110.142 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.57 -23.69 61.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 1.73 111.394 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.32 70.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.876 0.369 . . . . 0.77000000000000002 111.567 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.5 mm-40 -85.93 -37.31 19.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.521 0.677 . . . . 2.1800000000000002 110.1 177.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.7 m -78.95 -21.96 46.41 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.145 -0.934 . . . . 1.23 112.241 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.804 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.1 mt -47.91 -36.63 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 122.943 0.497 . . . . 1.1100000000000001 112.321 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.13 -19.47 59.33 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.411 -0.899 . . . . 1.45 113.335 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -110.76 -36.61 5.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.926 0.87 . . . . 0.91000000000000003 109.281 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 24.7 tp -59.68 -32.77 70.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.932 -1.485 . . . . 1.4299999999999999 111.537 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.981 ' HB2' HG13 ' A' ' 61' ' ' ILE . 7.3 tt0 -98.36 -52.09 3.76 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.163 0.506 . . . . 2.0 110.614 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -75.59 -57.69 3.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.458 -0.792 . . . . 4.0899999999999999 112.044 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.09 142.46 10.96 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.507 -0.637 . . . . 1.99 111.507 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.73 -112.01 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 1.79 112.511 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.0 m -109.89 152.27 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.911 0.386 . . . . 1.9199999999999999 111.253 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.6 t -98.71 122.38 53.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.70999999999999996 110.388 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 71.8 Cg_endo -77.94 145.0 21.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.358 2.039 . . . . 0.81000000000000005 112.448 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 33.6 Cg_exo -60.54 -13.57 26.18 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.868 2.378 . . . . 1.03 111.884 176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -73.75 -51.15 17.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.404 -0.962 . . . . 0.91000000000000003 108.404 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.637 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.9 t -52.78 -48.58 66.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.079 -1.419 . . . . 0.73999999999999999 109.165 170.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 62.3 m -61.85 -27.81 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.242 -0.89 . . . . 1.3999999999999999 112.366 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.5 m -77.88 -36.32 49.87 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.29 -0.413 . . . . 0.79000000000000004 110.117 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -68.99 -39.21 85.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.134 -0.555 . . . . 0.56999999999999995 112.388 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 27' ' ' CYS . 2.9 t -67.49 -47.14 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.68000000000000005 109.545 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 36.7 ttmt -57.33 -27.54 62.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 1.54 110.246 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 27.2 t-20 -67.94 -56.77 7.8 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.642 -0.708 . . . . 2.1099999999999999 110.547 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -59.88 -20.6 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.65000000000000002 111.635 178.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.4 -72.76 0.41 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.237 0.541 . . . . 1.9299999999999999 111.784 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -82.9 -36.42 25.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.711 0.634 . . . . 2.4500000000000002 112.711 -172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -80.9 -9.34 59.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.752 0.278 . . . . 1.55 111.752 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -59.08 -42.03 89.44 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.672 -1.233 . . . . 1.4299999999999999 107.672 170.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 88.54 -64.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.546 -1.206 . . . . 4.4699999999999998 111.606 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 43' ' ' ASP . 1.4 t -102.81 160.59 14.46 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.901 -0.59 . . . . 1.5900000000000001 110.824 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.5 m -64.78 -30.96 71.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 1.79 109.715 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.81 -19.81 66.04 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.258 -0.883 . . . . 1.4099999999999999 109.992 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -94.81 -41.89 9.0 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 175.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -58.92 -28.64 66.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.791 -1.095 . . . . 2.7000000000000002 111.569 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' HA ' HD11 ' A' ' 90' ' ' ILE . 70.2 mtt180 -89.56 -43.44 10.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 3.54 110.89 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.43 -34.75 77.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.948 -0.569 . . . . 0.64000000000000001 111.454 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.069 HG23 HG22 ' A' ' 6' ' ' VAL . 14.7 p -65.3 -30.27 49.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.367 -0.378 . . . . 0.69999999999999996 110.287 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 52.4 t -71.52 -41.69 68.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.031 0.443 . . . . 1.78 109.838 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 m -61.99 -26.97 68.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 1.4099999999999999 111.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.687 ' HB3' HG21 ' A' ' 6' ' ' VAL . 41.0 t -91.92 -34.23 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.121 -0.325 . . . . 1.1100000000000001 110.121 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 81' ' ' ILE . 44.9 tp -50.14 -42.98 51.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.368 -0.378 . . . . 1.3300000000000001 111.27 176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 23.0 pttp -65.85 -23.42 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 2.2999999999999998 111.666 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.08 -32.8 16.54 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.676 0.274 . . . . 1.1000000000000001 110.264 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.09 80.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.076 0.465 . . . . 1.1599999999999999 110.358 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.74 -12.71 60.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.828 -0.624 . . . . 1.1100000000000001 110.529 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.89 -6.32 52.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.949 -0.643 . . . . 1.0800000000000001 111.934 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.04 -6.64 59.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.346 0.593 . . . . 1.53 110.192 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.84 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.2 m -58.3 113.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.102 -0.954 . . . . 2.3599999999999999 112.165 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -113.65 92.74 4.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.188 -0.671 . . . . 4.6500000000000004 109.188 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.31 -13.11 64.84 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.434 -1.067 . . . . 2.0099999999999998 110.434 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.981 HG13 ' HB2' ' A' ' 18' ' ' GLN . 2.9 mp -87.14 150.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.795 -0.703 . . . . 3.54 109.669 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -114.91 118.26 40.87 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-N 115.458 -0.792 . . . . 3.4100000000000001 110.145 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -72.67 -11.77 26.29 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.199 1.933 . . . . 2.4300000000000002 111.361 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -58.92 -37.09 75.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 3.1000000000000001 110.222 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.559 ' HB2' HD12 ' A' ' 17' ' ' LEU . 17.1 m120 -73.96 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.953 -0.567 . . . . 1.3400000000000001 110.547 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 69' ' ' LEU . . . -72.75 -22.5 60.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.945 0.402 . . . . 1.4299999999999999 110.234 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -74.65 -23.09 58.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.706 0.765 . . . . 2.4100000000000001 109.665 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.57 -21.87 32.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.384 -0.825 . . . . 1.1399999999999999 111.093 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 66' ' ' ALA . 76.0 mt -60.23 -57.31 27.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.081 -0.509 . . . . 2.29 111.84 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 23.3 Cg_endo -59.74 -23.6 72.48 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.053 1.835 . . . . 1.2 112.791 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -75.25 -55.63 5.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.923 -0.656 . . . . 1.3600000000000001 112.279 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -20.35 61.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 2.6099999999999999 111.754 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.98 8.92 41.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.883 0.373 . . . . 1.6499999999999999 111.011 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.68 87.95 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.575 -0.738 . . . . 0.95999999999999996 114.417 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.32 -46.02 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.387 0.593 . . . . 1.7 111.816 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 50.74 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.757 0.661 . . . . 2.3100000000000001 111.975 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.4 pt -104.38 155.17 37.69 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 122.164 -0.335 . . . . 1.8300000000000001 111.599 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -73.21 -159.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.978 2.452 . . . . 1.3500000000000001 111.013 172.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 p90 47.91 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.047 0.939 . . . . 1.3799999999999999 112.685 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 3.48 110.477 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 HD21 ' A' ' 51' ' ' LEU . 42.0 pt -94.6 -4.18 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.876 -0.602 . . . . 2.5499999999999998 110.37 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 m -67.06 161.19 25.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.259 -0.882 . . . . 2.4500000000000002 111.455 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 27.2 p -73.77 -14.81 61.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.042 0.449 . . . . 2.04 111.081 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -90.38 19.42 5.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.993 -0.549 . . . . 2.7599999999999998 111.007 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.4 m -87.33 129.51 34.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 2.0499999999999998 110.274 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' ILE . 6.6 p30 -78.94 71.13 5.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.815 0.817 . . . . 3.0499999999999998 110.782 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 39.2 m -64.5 -16.95 63.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.179 -0.919 . . . . 1.71 111.424 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.55 -26.44 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 2.7599999999999998 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 m -117.62 -73.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.65 -0.25 . . . . 2.21 111.053 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 45' ' ' ARG . 22.3 pt 35.25 -119.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.235 0.959 . . . . 2.1699999999999999 112.315 -175.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.642 -0.694 . . . . 4.7800000000000002 109.136 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.6 tmt? . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.818 0.818 . . . . 2.9100000000000001 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 4' ' ' GLY . 4.1 t -134.07 162.87 30.9 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.22 -1.355 . . . . 2.6299999999999999 108.16 170.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 t -69.31 3.53 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.708 -0.849 . . . . 0.81000000000000005 108.708 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -95.92 -19.58 28.55 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.921 -1.272 . . . . 0.56999999999999995 109.921 175.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 39.2 tt0 -70.2 -46.72 63.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.505 -0.924 . . . . 1.25 108.505 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 47' ' ' VAL . 94.7 t -68.07 -28.48 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.487 -0.778 . . . . 1.1200000000000001 110.047 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 24.4 tt0 -71.81 -10.26 59.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.568 -0.53 . . . . 1.97 109.568 175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -38.01 45.41 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.379 -1.088 . . . . 0.81999999999999995 110.379 169.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 17.4 t-20 -61.22 -60.06 4.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.805 -0.813 . . . . 1.8600000000000001 108.805 168.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 7' ' ' GLN . 7.1 mp -59.16 -45.84 89.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.555 -1.202 . . . . 1.73 113.331 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.58 -28.44 67.15 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.221 0.452 . . . . 0.77000000000000002 112.221 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 28.8 mm-40 -82.65 -38.48 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.394 0.616 . . . . 2.1800000000000002 110.761 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 69' ' ' LEU . 63.2 m -84.03 -21.39 31.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.311 -0.859 . . . . 1.23 111.708 -174.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 2.9 mt -45.72 -34.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 123.526 0.516 . . . . 1.1100000000000001 111.554 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.96 27.63 2.28 Favored Glycine 0 CA--C 1.505 -0.576 0 C-N-CA 121.145 -0.55 . . . . 1.45 113.727 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.2 t80 -157.65 -42.7 0.07 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.593 -1.262 . . . . 0.91000000000000003 107.593 168.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 61' ' ' ILE . 25.5 tp -45.3 -56.79 4.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.088 -1.869 . . . . 1.4299999999999999 111.365 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 8.1 tt0 -85.13 -47.61 9.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.171 -0.468 . . . . 2.0 111.364 -173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -84.43 -79.02 0.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 4.0899999999999999 110.925 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.92 136.07 3.36 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.835 -0.698 . . . . 1.99 111.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 160.82 -108.11 0.34 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.575 -0.821 . . . . 1.79 112.254 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.09 157.08 36.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.633 0.254 . . . . 1.9199999999999999 110.654 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 48.1 t -96.53 121.97 58.55 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.401 -0.363 . . . . 0.70999999999999996 110.47 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.5 Cg_endo -83.48 138.91 8.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.152 2.568 . . . . 0.81000000000000005 112.019 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 46.8 Cg_exo -58.48 -13.13 15.83 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.175 2.583 . . . . 1.03 112.48 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -75.02 -54.04 7.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.116 -1.068 . . . . 0.91000000000000003 108.116 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.594 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -50.87 -51.19 54.03 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.044 -1.435 . . . . 0.73999999999999999 110.005 169.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 23.4 m -56.52 -39.36 73.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.138 -0.483 . . . . 1.3999999999999999 112.0 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.7 m -62.75 -44.74 95.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.362 -0.381 . . . . 0.79000000000000004 110.581 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.1 95.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.935 -0.65 . . . . 0.56999999999999995 112.82 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 27' ' ' CYS . 18.8 t -60.52 -43.28 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.047 -0.723 . . . . 0.68000000000000005 109.047 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -65.41 -30.69 71.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.584 -0.734 . . . . 1.54 110.641 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -64.61 -40.49 95.58 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 121.125 0.488 . . . . 2.1099999999999999 109.997 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.693 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -69.96 -9.29 12.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.948 0.404 . . . . 0.65000000000000002 111.918 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 34' ' ' ILE . 54.4 mt -117.99 3.57 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.474 0.654 . . . . 1.9299999999999999 111.56 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -139.36 -47.75 0.47 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 110.458 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -78.64 -1.36 33.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.125 -0.488 . . . . 1.55 111.283 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.88 96.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.525 -0.916 . . . . 1.4299999999999999 108.525 170.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.87 ' HG2' HG23 ' A' ' 40' ' ' THR . 43.7 ttp180 -55.2 -71.27 0.09 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.789 -1.096 . . . . 4.4699999999999998 113.239 -167.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.87 HG23 ' HG2' ' A' ' 39' ' ' ARG . 69.9 p -116.46 -175.29 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.562 0.579 . . . . 1.5900000000000001 112.562 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 m -60.45 -39.48 87.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.35 -0.841 . . . . 1.79 110.377 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.87 -19.05 63.44 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.489 -0.778 . . . . 1.4099999999999999 110.258 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 40' ' ' THR . 26.1 m-20 -86.86 -37.91 17.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.734 -0.666 . . . . 1.72 109.289 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 46' ' ' ALA . 77.7 mtt180 -65.51 -55.38 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.369 -0.832 . . . . 2.7000000000000002 111.406 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 69.2 mtp180 -79.91 32.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.24 1.019 . . . . 3.54 110.804 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -137.03 -43.87 0.57 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.79 -1.55 . . . . 0.64000000000000001 109.413 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.693 ' CG2' HG13 ' A' ' 34' ' ' ILE . 6.2 p -61.88 -39.91 85.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.719 -0.673 . . . . 0.69999999999999996 110.932 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 1.8 p -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.299 -0.41 . . . . 1.78 110.981 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 19.8 m -59.41 -51.27 70.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.597 -0.274 . . . . 1.4099999999999999 111.568 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 37.0 t -62.53 -43.15 99.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 1.1100000000000001 110.608 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.09 -48.64 79.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 1.3300000000000001 111.083 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 49' ' ' SER . 19.2 pttp -74.05 -27.11 60.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 2.2999999999999998 111.168 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -35.6 79.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.831 -0.348 . . . . 1.1000000000000001 110.4 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.03 66.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 1.1599999999999999 111.049 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -64.79 -29.77 70.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.342 -0.39 . . . . 1.1100000000000001 111.445 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.19 -21.72 9.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.714 -0.755 . . . . 1.0800000000000001 112.304 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.6 -40.94 22.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 1.53 110.724 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 10.6 t -105.31 114.57 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.797 -0.638 . . . . 2.3599999999999999 110.166 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -77.17 -13.98 59.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.304 1.05 . . . . 4.6500000000000004 108.786 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' GLN . . . -87.24 7.98 78.57 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.375 -1.739 . . . . 2.0099999999999998 110.661 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 17' ' ' LEU . 6.2 tp -73.95 -22.8 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.995 -1.113 . . . . 3.54 107.995 173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 40.38 98.62 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 112.763 -2.017 . . . . 3.4100000000000001 112.363 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -43.92 -39.7 11.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.235 2.623 . . . . 2.4300000000000002 113.41 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -56.3 -42.07 76.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.015 0.436 . . . . 3.1000000000000001 111.038 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -88.44 -31.86 18.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 1.3400000000000001 110.571 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.06 82.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 1.4299999999999999 110.906 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -80.4 -30.8 37.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.273 0.559 . . . . 2.4100000000000001 109.807 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.55 61.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.706 . . . . 1.1399999999999999 111.37 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 35.1 tp -58.55 -62.03 6.48 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.976 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 19.6 Cg_endo -65.09 -10.8 27.02 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.731 1.621 . . . . 1.2 112.295 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.24 -63.93 2.29 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.069 -0.586 . . . . 1.3600000000000001 111.877 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -62.14 -32.95 73.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.352 0.501 . . . . 2.6099999999999999 112.352 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.2 m -85.52 -1.23 56.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.705 0.288 . . . . 1.6499999999999999 111.629 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.3 31.7 81.72 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.36 -0.448 . . . . 0.95999999999999996 112.759 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 35' ' ' LEU . 4.0 m -112.52 72.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.669 0.747 . . . . 1.7 111.115 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -89.49 94.43 9.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 2.3100000000000001 110.4 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -104.23 163.88 16.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.567 -0.742 . . . . 1.8300000000000001 110.087 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 62.5 Cg_exo -51.96 -58.35 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.904 2.403 . . . . 1.3500000000000001 113.292 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.456 ' CD2' HG21 ' A' ' 90' ' ' ILE . 36.4 p90 -73.8 157.07 37.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.49 -0.323 . . . . 1.3799999999999999 110.152 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.55 -172.2 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.243 0.544 . . . . 3.48 112.334 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.73 -15.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.788 -1.096 . . . . 2.5499999999999998 110.447 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.2 m -58.1 130.89 48.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.187 -0.915 . . . . 2.4500000000000002 110.561 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 32.2 p -68.57 -21.33 64.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.231 -0.441 . . . . 2.04 112.17 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -94.35 13.72 22.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.52 -0.309 . . . . 2.7599999999999998 111.015 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 t -64.29 154.76 34.21 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.536 -0.302 . . . . 2.0499999999999998 110.587 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.785 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 25.7 p30 -76.68 52.7 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.187 0.517 . . . . 3.0499999999999998 111.96 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.536 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 t -52.85 -40.0 63.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.472 -0.786 . . . . 1.71 112.892 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -92.41 -1.7 56.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.167 0.508 . . . . 2.7599999999999998 110.301 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.785 ' HB2' ' HB2' ' A' ' 86' ' ' ASN . 12.4 m -112.12 0.76 16.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.971 -0.559 . . . . 2.21 111.17 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 87' ' ' CYS . 30.8 pt -75.14 -35.58 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.618 -0.265 . . . . 2.1699999999999999 111.026 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 45' ' ' ARG . 11.3 m120 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 117.8 -1.095 . . . . 4.7800000000000002 110.747 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.662 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 1.8 tmt? . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.011 0.91 . . . . 2.9100000000000001 111.419 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' GLY . 61.9 p -123.67 166.8 14.9 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.201 -1.407 . . . . 2.6299999999999999 107.201 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 t -79.26 10.91 3.21 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.482 -0.933 . . . . 0.81000000000000005 108.482 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 7' ' ' GLN . . . -101.98 -26.84 7.28 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.544 -1.422 . . . . 0.56999999999999995 109.544 174.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.662 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 52.6 tt0 -64.21 -46.21 84.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.589 -0.806 . . . . 1.25 109.295 171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 50' ' ' CYS . 13.1 p -76.06 -21.68 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.535 -0.757 . . . . 1.1200000000000001 110.894 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 4.6 mm-40 -56.7 -50.61 71.64 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.829 -0.434 . . . . 1.97 109.829 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.85 -16.58 52.32 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.81999999999999995 112.826 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.846 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.4 t-20 -71.89 -40.14 69.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.768 0.318 . . . . 1.8600000000000001 110.471 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.9 -31.19 7.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.429 0.529 . . . . 1.73 112.429 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . . . -60.39 -21.8 62.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.097 0.406 . . . . 0.77000000000000002 112.097 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.694 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 23.2 mt-30 -90.28 -23.31 21.23 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.57 -0.452 . . . . 2.1800000000000002 111.098 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -99.11 -10.73 22.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.232 -0.587 . . . . 1.23 110.664 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 11.0 tt -51.54 -27.77 7.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 O-C-N 123.819 0.7 . . . . 1.1100000000000001 112.15 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.03 -62.2 6.33 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 120.084 -1.055 . . . . 1.45 111.835 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.403 ' HA ' ' C ' ' A' ' 20' ' ' GLY . 7.5 t80 -63.11 -36.83 84.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.587 0.708 . . . . 0.91000000000000003 110.366 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.665 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 12.6 tp -57.07 -49.84 74.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.348 -1.297 . . . . 1.4299999999999999 110.541 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.661 ' HG3' ' HA3' ' A' ' 60' ' ' GLY . 5.4 tt0 -95.62 -50.19 5.06 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.989 -0.551 . . . . 2.0 111.301 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -91.33 -53.61 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 4.0899999999999999 110.423 -175.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' C ' ' HA ' ' A' ' 16' ' ' PHE . . . 129.48 170.66 12.79 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.063 -0.815 . . . . 1.99 111.063 -176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.74 -104.12 0.4 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.367 -0.921 . . . . 1.79 112.872 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.98 152.2 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 110.049 -0.352 . . . . 1.9199999999999999 110.049 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 13' ' ' CYS . 86.8 t -90.74 110.84 44.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.173 0.511 . . . . 0.70999999999999996 110.351 175.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.99 149.34 25.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.027 2.485 . . . . 0.81000000000000005 112.548 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -61.13 -11.72 19.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.812 2.342 . . . . 1.03 111.846 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -70.97 -56.8 5.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.266 -1.013 . . . . 0.91000000000000003 108.266 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 1.4 t -53.23 -43.5 67.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.43 -1.259 . . . . 0.73999999999999999 109.995 173.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 1.5 t -49.99 -45.16 51.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.306 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.5 m -62.03 -39.65 93.03 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.816 -0.629 . . . . 0.79000000000000004 111.189 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -74.47 -33.28 56.53 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.179 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 91.0 t -66.91 -49.65 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.622 0.248 . . . . 0.68000000000000005 110.536 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 31.7 ttmt -67.22 -18.15 65.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.313 0.577 . . . . 1.54 110.115 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 23.6 t-20 -64.41 -43.06 95.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 110.023 176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -81.9 -13.64 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.546 0.689 . . . . 0.65000000000000002 110.6 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.66 23.72 10.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.782 0.801 . . . . 1.9299999999999999 112.185 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 11.6 t-20 -167.95 -54.43 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.36 -1.291 . . . . 2.4500000000000002 110.632 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.7 m -78.06 -3.78 43.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.236 -0.438 . . . . 1.55 111.371 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' OD2' ' A' ' 43' ' ' ASP . 72.4 p -75.68 104.34 6.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.453 -0.944 . . . . 1.4299999999999999 108.453 173.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.56 -80.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.768 0.655 . . . . 4.4699999999999998 112.768 -164.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 62.3 p -93.32 178.61 5.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.891 -0.595 . . . . 1.5900000000000001 110.46 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.6 m -63.4 -32.09 73.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.157 0.503 . . . . 1.79 110.239 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 -13.41 62.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.152 0.501 . . . . 1.4099999999999999 110.27 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.587 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 8.3 t70 -114.94 8.05 15.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.582 0.706 . . . . 1.72 109.403 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 47' ' ' VAL . 43.5 ttt85 -131.27 -47.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 2.7000000000000002 111.018 -171.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 41.4 ttm180 -85.81 -14.12 46.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.346 0.594 . . . . 3.54 110.572 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' O ' ' HE3' ' A' ' 1' ' ' MET . . . -87.2 -27.95 22.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.094 0.473 . . . . 0.64000000000000001 110.173 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG21 HG13 ' A' ' 34' ' ' ILE . 9.9 p -81.22 -33.34 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.817 -0.629 . . . . 0.69999999999999996 111.21 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 4.3 p -66.66 -32.58 74.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.077 0.465 . . . . 1.78 110.359 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 20.4 m -58.71 -40.51 83.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.583 -0.735 . . . . 1.4099999999999999 110.769 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.686 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -84.43 -28.47 26.85 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.02 -0.272 . . . . 1.1100000000000001 110.874 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.0 -36.77 75.47 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.124 -0.695 . . . . 1.3300000000000001 109.124 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 22.5 ttpp -54.4 -39.73 67.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.784 . . . . 2.2999999999999998 111.155 174.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -44.59 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.977 -0.289 . . . . 1.1000000000000001 110.285 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . . . -59.09 -37.07 76.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.1599999999999999 111.611 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.32 68.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 1.1100000000000001 110.833 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.62 19.13 24.19 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.817 -0.629 . . . . 1.0800000000000001 111.693 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -117.06 20.11 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 1.53 110.041 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.758 ' HB ' HD13 ' A' ' 61' ' ' ILE . 36.8 t -72.68 -19.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.761 -0.654 . . . . 2.3599999999999999 111.993 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.25 30.56 19.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.33 -0.85 . . . . 4.6500000000000004 110.252 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA3' ' HG3' ' A' ' 18' ' ' GLN . . . 154.56 68.26 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.84 -1.704 . . . . 2.0099999999999998 108.84 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.758 HD13 ' HB ' ' A' ' 58' ' ' VAL . 25.3 mm -65.39 117.64 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.911 -0.644 . . . . 3.54 112.584 -164.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 65.9 m-20 -124.88 100.27 34.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.346 -0.843 . . . . 3.4100000000000001 110.138 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.67 -36.76 61.6 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.161 2.574 . . . . 2.4300000000000002 112.36 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.94 -38.74 89.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.943 -0.571 . . . . 3.1000000000000001 110.324 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.48 -26.12 51.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 1.3400000000000001 110.445 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.35 -28.26 67.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 1.4299999999999999 110.784 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.33 -23.59 26.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.268 0.556 . . . . 2.4100000000000001 110.007 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 72' ' ' LYS . . . -75.81 -21.73 57.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.793 -0.64 . . . . 1.1399999999999999 110.517 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.716 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 36.9 tp -54.85 -59.85 9.55 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.293 -0.867 . . . . 2.29 111.679 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 61.6 Cg_endo -78.37 4.27 6.44 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.832 1.688 . . . . 1.2 112.259 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.66 -55.51 2.02 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.751 -0.738 . . . . 1.3600000000000001 113.086 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.598 ' HE2' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -81.79 14.51 2.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.197 0.814 . . . . 2.6099999999999999 113.197 -171.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 32' ' ' LYS . 36.9 t -111.56 -0.42 16.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 1.6499999999999999 109.508 167.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.02 54.81 25.53 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.795 -0.639 . . . . 0.95999999999999996 112.342 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -123.18 -56.82 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.728 0.27 . . . . 1.7 111.728 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 65.04 111.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.412 0.625 . . . . 2.3100000000000001 110.426 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 79' ' ' TYR . 16.3 tt -80.25 132.33 59.78 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 1.8300000000000001 111.49 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.7 Cg_exo -66.44 -34.05 35.53 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.1 2.533 . . . . 1.3500000000000001 112.608 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.627 ' CE2' HD11 ' A' ' 77' ' ' ILE . 16.2 p90 -107.1 -174.38 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.201 -0.454 . . . . 1.3799999999999999 109.985 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -82.28 161.75 22.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.415 0.626 . . . . 3.48 111.568 -175.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.09 29.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 2.5499999999999998 109.979 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 t -110.84 -177.38 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.644 -0.707 . . . . 2.4500000000000002 110.652 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.539 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 24.3 p -82.74 -26.3 32.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.948 -0.569 . . . . 2.04 110.911 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 m -93.14 23.24 4.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 2.7599999999999998 110.957 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 91.5 m -66.09 145.19 56.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.046 -0.524 . . . . 2.0499999999999998 111.607 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 90' ' ' ILE . 22.0 p-10 -77.13 43.08 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.703 -0.681 . . . . 3.0499999999999998 111.281 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 9.5 t -55.28 -37.95 67.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.721 0.637 . . . . 1.71 112.721 -173.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -71.91 -2.81 19.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.226 0.536 . . . . 2.7599999999999998 110.987 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 t -122.1 -75.15 0.6 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.698 -0.482 . . . . 2.21 109.698 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 86' ' ' ASN . 34.2 pt 35.44 -134.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 124.22 0.95 . . . . 2.1699999999999999 112.572 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.675 -1.155 . . . . 4.7800000000000002 108.853 -179.294 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.705 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.0 tpt . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 122.343 1.068 . . . . 2.9100000000000001 112.479 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.8 t -141.09 159.28 42.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 106.37 -1.715 . . . . 2.6299999999999999 106.37 164.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 5.9 t -68.71 7.9 0.58 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.576 0.703 . . . . 0.81000000000000005 109.938 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -97.08 -21.46 20.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.909 -1.277 . . . . 0.56999999999999995 109.909 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.9 tt0 -73.66 -47.14 42.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.065 -0.717 . . . . 1.25 109.065 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 50' ' ' CYS . 9.1 p -72.38 -22.89 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.612 -0.722 . . . . 1.1200000000000001 109.979 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 34.9 tt0 -63.62 -33.51 75.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 1.97 110.084 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 12' ' ' GLN . . . -61.13 -29.69 71.75 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.002 -0.618 . . . . 0.81999999999999995 112.159 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.854 HD22 ' HA ' ' A' ' 31' ' ' VAL . 18.7 t-20 -62.65 -49.32 75.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.214 0.531 . . . . 1.8600000000000001 110.29 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.536 HD12 HD21 ' A' ' 17' ' ' LEU . 3.2 mm? -79.3 -37.02 38.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 1.73 111.139 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.52 69.59 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.894 0.701 . . . . 0.77000000000000002 112.894 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 2.1 mt-30 -87.91 -2.9 58.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.202 0.525 . . . . 2.1800000000000002 110.948 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -113.75 3.35 15.52 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.705 -0.679 . . . . 1.23 110.58 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 25.1 mt -53.36 -32.4 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.844 0.715 . . . . 1.1100000000000001 110.429 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.51 -65.26 3.7 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 120.572 -0.823 . . . . 1.45 112.389 173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 31.7 t80 -60.35 -35.15 74.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.42 0.628 . . . . 0.91000000000000003 110.786 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -55.0 -45.8 75.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.998 -1.001 . . . . 1.4299999999999999 110.623 176.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 23.1 mt-30 -87.13 -62.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 2.0 111.058 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -66.82 -36.28 82.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.496 -1.229 . . . . 4.0899999999999999 112.065 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.85 35.28 25.25 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.543 -0.837 . . . . 1.99 111.183 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' HG22 ' A' ' 22' ' ' VAL . . . -146.03 123.99 1.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.929 -0.653 . . . . 1.79 112.709 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 21' ' ' GLY . 3.5 m 62.82 126.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.602 1.561 . . . . 1.9199999999999999 114.008 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' SG ' ' A' ' 13' ' ' CYS . 57.7 t -109.43 121.26 42.99 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.70999999999999996 109.461 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.5 Cg_exo -78.86 145.81 20.24 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.818 2.346 . . . . 0.81000000000000005 112.293 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 35.9 Cg_exo -60.17 -14.99 31.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.093 2.529 . . . . 1.03 111.602 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -72.38 -53.65 11.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.239 -1.022 . . . . 0.91000000000000003 108.239 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 12' ' ' GLN . 42.8 t -54.85 -49.6 70.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.511 -1.222 . . . . 0.73999999999999999 109.331 172.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 31.1 m -54.91 -38.87 68.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.399 -0.819 . . . . 1.3999999999999999 112.208 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.1 m -62.45 -46.36 88.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.649 -0.251 . . . . 0.79000000000000004 110.337 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -67.33 -33.36 82.09 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.026 -0.607 . . . . 0.56999999999999995 112.516 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.854 ' HA ' HD22 ' A' ' 9' ' ' ASN . 87.7 t -59.96 -45.86 94.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.11 -0.7 . . . . 0.68000000000000005 109.11 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 28' ' ' CYS . 56.7 mtpt -68.68 -20.48 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.635 -0.711 . . . . 1.54 110.79 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 7.1 m120 -66.83 -49.82 64.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.875 0.369 . . . . 2.1099999999999999 110.373 173.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -66.96 -22.63 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.928 0.394 . . . . 0.65000000000000002 111.96 -178.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.788 HD22 ' HB ' ' A' ' 75' ' ' VAL . 8.1 mp -93.46 -62.63 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.281 0.562 . . . . 1.9299999999999999 111.67 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.99 -40.72 15.53 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 112.573 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.643 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 36.9 t -84.15 -6.9 59.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.7 0.259 . . . . 1.55 111.7 -173.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.9 t -58.74 110.98 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.819 -1.178 . . . . 1.4299999999999999 107.819 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -66.91 -41.99 86.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.144 0.424 . . . . 4.4699999999999998 112.144 -164.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.9 p -129.94 174.82 9.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.685 -0.234 . . . . 1.5900000000000001 110.613 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 47.5 m -67.5 -40.06 85.17 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 109.584 -0.525 . . . . 1.79 109.584 174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -19.72 64.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 1.4099999999999999 110.535 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 7.6 t70 -82.91 -45.68 13.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.496 -0.774 . . . . 1.72 109.034 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.664 ' HA ' HG12 ' A' ' 47' ' ' VAL . 51.4 ttt180 -78.38 -29.06 47.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 2.7000000000000002 110.996 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 41' ' ' THR . 21.0 ttt180 -58.7 -57.12 14.41 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.291 -0.868 . . . . 3.54 109.885 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.705 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -71.02 -35.0 71.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.291 -0.868 . . . . 0.64000000000000001 111.024 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 44' ' ' ARG . 1.7 p -63.63 -39.32 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.575 -0.284 . . . . 0.69999999999999996 110.779 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 42.7 t -76.89 -34.94 57.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.914 0.388 . . . . 1.78 110.16 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.2 t -63.43 -44.72 93.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 1.4099999999999999 110.892 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.584 ' HB3' HG11 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.64 -24.68 53.32 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.566 -0.454 . . . . 1.1100000000000001 109.833 178.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 81' ' ' ILE . 14.1 tp -58.64 -54.9 41.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.3300000000000001 110.348 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -66.67 -30.43 70.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 2.2999999999999998 110.52 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.01 87.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.351 -0.386 . . . . 1.1000000000000001 110.586 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.04 73.44 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.331 0.395 . . . . 1.1599999999999999 111.27 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' A' ' 61' ' ' ILE . . . -65.39 -32.42 74.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 1.1100000000000001 111.132 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.75 -7.45 56.59 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.758 -0.734 . . . . 1.0800000000000001 112.145 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.06 -55.31 3.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.289 0.566 . . . . 1.53 110.369 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.94 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 56.5 t -84.43 112.08 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.283 -0.871 . . . . 2.3599999999999999 110.521 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -74.62 -7.98 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.695 0.76 . . . . 4.6500000000000004 110.874 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 18' ' ' GLN . . . -109.07 5.93 32.28 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.7 -1.137 . . . . 2.0099999999999998 111.364 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.94 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 1.4 tp -86.72 -27.52 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.604 0.716 . . . . 3.54 109.721 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.76 97.48 0.04 OUTLIER Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 113.608 -1.633 . . . . 3.4100000000000001 110.868 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 31.8 Cg_exo -42.67 -43.89 8.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.71 2.94 . . . . 2.4300000000000002 113.405 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.02 -33.6 74.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 3.1000000000000001 111.395 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -79.24 -34.29 42.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.766 -0.457 . . . . 1.3400000000000001 109.766 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 1.4299999999999999 111.087 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.757 ' HB3' ' HB ' ' A' ' 81' ' ' ILE . 10.0 pt-20 -91.48 8.44 36.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.158 0.504 . . . . 2.4100000000000001 111.039 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.97 -13.93 22.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.875 -0.602 . . . . 1.1399999999999999 110.107 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 13' ' ' CYS . 42.1 mt -60.38 -51.87 77.05 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 2.29 111.62 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 10.1 Cg_endo -53.62 -31.22 58.92 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.27 1.98 . . . . 1.2 112.443 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.55 -23.84 74.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.125 -0.559 . . . . 1.3600000000000001 112.669 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.22 -5.87 26.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.12 0.415 . . . . 2.6099999999999999 112.12 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.4 m -120.26 14.51 12.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.567 0.58 . . . . 1.6499999999999999 112.567 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.41 26.81 67.02 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.122 -0.561 . . . . 0.95999999999999996 113.822 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.788 ' HB ' HD22 ' A' ' 35' ' ' LEU . 2.4 m -131.0 81.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.344 0.592 . . . . 1.7 111.972 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.3 93.04 8.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 2.3100000000000001 111.07 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -98.06 152.39 38.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.916 -0.314 . . . . 1.8300000000000001 110.952 171.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.46 -17.17 43.82 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.096 2.531 . . . . 1.3500000000000001 112.677 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.509 ' OH ' ' HG ' ' A' ' 35' ' ' LEU . 18.6 p90 -85.95 139.94 30.77 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.153 -0.619 . . . . 1.3799999999999999 110.056 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 12.3 mmmm -110.86 156.97 20.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.314 0.578 . . . . 3.48 111.076 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 2.0 mp -77.16 0.94 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.262 1.029 . . . . 2.5499999999999998 108.749 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 m -61.53 144.16 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.103 -0.953 . . . . 2.4500000000000002 110.444 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.1 p -68.22 -11.84 59.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.259 0.466 . . . . 2.04 112.259 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.4 p -82.57 -11.11 58.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.913 0.387 . . . . 2.7599999999999998 111.606 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.4 m -74.78 139.03 43.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 110.85 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.28 106.96 17.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.781 0.801 . . . . 3.0499999999999998 109.214 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 46.9 m -94.25 5.68 51.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.457 -0.792 . . . . 1.71 110.757 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.69 18.3 3.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.852 -0.613 . . . . 2.7599999999999998 110.281 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p -134.22 -89.18 0.37 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.304 -0.999 . . . . 2.21 108.304 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 33.9 pt 39.37 -159.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.651 1.22 . . . . 2.1699999999999999 113.094 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 4.3 t30 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.21 1.004 . . . . 4.7800000000000002 109.047 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.673 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 12.7 tpt . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 122.044 0.926 . . . . 2.9100000000000001 113.022 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' GLY . 35.2 p -145.1 162.32 37.3 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 105.754 -1.943 . . . . 2.6299999999999999 105.754 161.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.2 t -70.51 5.25 1.89 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.603 -0.888 . . . . 0.81000000000000005 108.603 173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.33 -29.1 5.82 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.221 -1.152 . . . . 0.56999999999999995 110.221 176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -63.93 -42.57 97.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.814 -1.18 . . . . 1.25 107.814 171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.02 HG22 HG23 ' A' ' 47' ' ' VAL . 46.8 t -63.01 -39.45 85.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.36 -1.291 . . . . 1.1200000000000001 110.509 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -58.95 -26.99 64.91 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.839 -0.619 . . . . 1.97 111.179 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -27.93 66.87 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.526 -0.845 . . . . 0.81999999999999995 112.036 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 38.2 t-20 -75.44 -62.9 1.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.059 -0.719 . . . . 1.8600000000000001 109.059 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 mm? -58.58 -46.33 87.17 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.392 -0.822 . . . . 1.73 112.565 -173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.99 -35.52 61.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.351 0.5 . . . . 0.77000000000000002 112.351 -172.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 36.4 mt-30 -91.87 -29.68 16.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.204 0.526 . . . . 2.1800000000000002 111.129 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m -93.69 -15.92 24.78 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.563 -0.744 . . . . 1.23 111.891 -172.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 7.8 mt -55.33 -25.42 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.272 0.358 . . . . 1.1100000000000001 111.464 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -67.92 1.97 Allowed Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.642 -0.79 . . . . 1.45 112.412 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 20' ' ' GLY . 23.6 t80 -62.6 -35.09 78.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.278 0.561 . . . . 0.91000000000000003 110.512 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 mp -50.23 -44.16 53.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.335 -0.848 . . . . 1.4299999999999999 110.929 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.0 tt0 -89.95 -55.48 3.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.103 0.478 . . . . 2.0 110.239 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HG2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -115.0 93.66 4.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.838 -0.619 . . . . 4.0899999999999999 109.967 175.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 16' ' ' PHE . . . -63.77 109.76 2.98 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.775 -0.648 . . . . 1.99 112.962 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.05 -60.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.704 -0.558 . . . . 1.79 111.704 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.15 134.63 57.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 1.9199999999999999 110.73 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.84 116.58 60.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.70999999999999996 110.217 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 59.7 Cg_endo -74.28 136.72 22.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.567 2.178 . . . . 0.81000000000000005 112.192 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 46.0 Cg_exo -58.27 -15.91 25.94 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.118 2.545 . . . . 1.03 112.385 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -74.95 -51.1 14.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.55 -0.907 . . . . 0.91000000000000003 108.55 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -50.42 -49.3 55.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.26 -1.337 . . . . 0.73999999999999999 109.256 169.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 14.3 m -60.11 -33.86 72.71 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.739 -0.664 . . . . 1.3999999999999999 112.195 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.7 m -64.05 -38.68 91.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.945 0.403 . . . . 0.79000000000000004 110.249 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -71.09 -35.38 64.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.868 -0.682 . . . . 0.56999999999999995 112.406 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 27' ' ' CYS . 6.6 t -63.09 -46.54 95.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.144 -0.687 . . . . 0.68000000000000005 109.144 174.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -60.48 -26.65 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.39 -0.823 . . . . 1.54 110.978 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 7.3 m-20 -69.81 -50.62 41.18 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.033 0.444 . . . . 2.1099999999999999 110.52 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -65.63 -19.1 25.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.121 0.486 . . . . 0.65000000000000002 111.964 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 8.5 mp -92.52 -70.97 0.67 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 1.9299999999999999 111.333 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -77.97 -44.48 26.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 112.336 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 68.7 m -76.48 -2.85 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 1.55 112.644 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -54.19 119.39 5.05 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.525 -0.917 . . . . 1.4299999999999999 108.525 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -62.18 -29.32 70.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.496 -0.775 . . . . 4.4699999999999998 112.825 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 43' ' ' ASP . 7.2 t -174.76 -173.83 0.75 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.527 -0.546 . . . . 1.5900000000000001 109.527 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 25.0 m -72.53 -33.28 66.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.965 0.412 . . . . 1.79 110.001 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.18 -21.29 64.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.279 0.562 . . . . 1.4099999999999999 109.825 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 40' ' ' THR . 10.9 t70 -86.51 -44.16 12.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.138 -1.06 . . . . 1.72 108.138 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' HD2' ' HE2' ' A' ' 79' ' ' TYR . 15.9 tpp180 -55.12 -48.17 74.0 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.903 -1.044 . . . . 2.7000000000000002 111.859 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' THR . 60.6 mtt180 -61.46 -51.3 69.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 3.54 110.279 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -69.62 -41.59 75.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.403 -0.817 . . . . 0.64000000000000001 111.743 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.02 HG23 HG22 ' A' ' 6' ' ' VAL . 12.2 p -59.08 -37.7 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 110.036 -0.357 . . . . 0.69999999999999996 110.036 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HA ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 t -68.54 -45.05 73.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 1.78 109.881 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.465 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 59.6 m -60.93 -36.92 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 1.4099999999999999 111.067 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.568 ' HB3' HG21 ' A' ' 6' ' ' VAL . 9.2 t -75.76 -45.41 36.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.682 -0.235 . . . . 1.1100000000000001 110.856 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 48' ' ' CYS . 4.3 pp -65.35 -31.17 72.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.294 -0.562 . . . . 1.3300000000000001 111.008 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 83' ' ' THR . 21.2 pttp -74.03 -23.82 59.46 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 120.954 -0.298 . . . . 2.2999999999999998 110.592 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.83 -31.93 45.95 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.716 -0.476 . . . . 1.1000000000000001 109.716 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -68.15 -43.47 78.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.836 -0.431 . . . . 1.1599999999999999 109.836 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.87 -10.28 59.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.795 -0.638 . . . . 1.1100000000000001 110.944 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.54 -11.35 29.16 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.537 -0.625 . . . . 1.0800000000000001 111.537 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.3 -1.76 55.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 1.53 109.949 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.81 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 16.2 m -61.77 133.44 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.155 -0.929 . . . . 2.3599999999999999 112.81 -172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -126.32 99.76 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.116 -0.947 . . . . 4.6500000000000004 109.734 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.27 16.47 66.79 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.955 -0.64 . . . . 2.0099999999999998 111.648 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.81 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 39.4 mm -89.14 -81.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.072 0.463 . . . . 3.54 111.309 -175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 64.4 m-20 99.3 106.21 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.166 1.786 . . . . 3.4100000000000001 109.957 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -70.82 -8.91 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.658 2.238 . . . . 2.4300000000000002 111.714 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.85 -39.1 62.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 3.1000000000000001 109.595 168.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -77.45 -30.3 53.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.593 . . . . 1.3400000000000001 110.174 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' A' ' 70' ' ' PRO . . . -73.98 -28.15 61.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 110.66 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 40.6 tt0 -87.31 -21.16 25.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.196 0.522 . . . . 2.4100000000000001 109.758 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.48 -24.58 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.686 -0.688 . . . . 1.1399999999999999 109.809 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 53.9 tp -55.09 -51.31 80.67 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 114.8 -1.091 . . . . 2.29 112.565 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 51.0 Cg_exo -55.04 -28.34 59.6 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.384 2.056 . . . . 1.2 112.426 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.79 -41.61 33.6 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.864 -0.684 . . . . 1.3600000000000001 111.964 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.21 -40.42 86.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 2.6099999999999999 111.201 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 57.6 m -86.95 6.71 30.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 1.6499999999999999 110.959 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.19 49.11 77.92 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-N 115.701 -0.682 . . . . 0.95999999999999996 113.566 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -123.89 -88.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 121.011 -0.276 . . . . 1.7 111.338 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 75' ' ' VAL . 18.9 t-20 68.8 134.45 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.641 0.776 . . . . 2.3100000000000001 111.299 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -133.99 169.81 12.94 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 115.52 -0.764 . . . . 1.8300000000000001 110.212 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.604 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 80.3 Cg_exo -50.63 -55.5 4.02 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.871 2.381 . . . . 1.3500000000000001 112.825 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.444 ' O ' HG12 ' A' ' 77' ' ' ILE . 26.1 p90 -75.52 164.97 25.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.632 -0.507 . . . . 1.3799999999999999 109.632 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -127.03 -179.15 4.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.699 0.285 . . . . 3.48 111.158 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 66' ' ' ALA . 40.0 mm -82.8 -16.95 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.828 -0.623 . . . . 2.5499999999999998 109.822 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -59.01 130.65 48.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.734 . . . . 2.4500000000000002 109.505 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -76.52 35.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.69 0.626 . . . . 2.04 112.69 -172.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.1 p -106.22 -12.86 15.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.358 -0.383 . . . . 2.7599999999999998 111.172 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.3 t -83.38 146.4 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 2.0499999999999998 110.455 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 90' ' ' ILE . 34.3 t30 -96.58 98.94 10.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 3.0499999999999998 110.272 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 46.5 m -66.03 -20.18 66.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.436 -0.802 . . . . 1.71 112.292 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -83.26 8.39 13.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.062 0.458 . . . . 2.7599999999999998 110.632 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.3 m -148.68 18.62 1.02 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.786 -0.45 . . . . 2.21 109.786 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 87' ' ' CYS . 42.4 pt -83.83 169.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.154 -0.476 . . . . 2.1699999999999999 110.172 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.901 -1.045 . . . . 4.7800000000000002 109.068 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 14.0 tpt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 122.251 1.024 . . . . 2.9100000000000001 111.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' GLY . 2.9 t -157.75 161.18 38.46 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.001 -1.909 . . . . 2.6299999999999999 105.991 168.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -71.3 9.39 0.78 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.548 0.69 . . . . 0.81000000000000005 109.502 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -104.97 -16.83 15.62 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.39 -1.084 . . . . 0.56999999999999995 110.39 172.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 34' ' ' ILE . 29.7 tt0 -71.02 -45.14 64.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.684 -0.858 . . . . 1.25 108.684 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 51' ' ' LEU . 56.4 t -65.48 -31.68 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.514 -0.767 . . . . 1.1200000000000001 110.238 174.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -59.73 -41.32 90.62 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.247 -0.433 . . . . 1.97 109.958 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.32 -10.24 40.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 119.912 -1.137 . . . . 0.81999999999999995 112.516 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.619 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 35.7 t-20 -88.9 -65.24 1.04 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.556 0.694 . . . . 1.8600000000000001 109.569 171.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 54' ' ' ALA . 90.9 mt -87.85 -14.99 38.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.325 -0.852 . . . . 1.73 113.283 -166.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.27 57.23 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.062 -0.399 . . . . 0.77000000000000002 111.208 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 27' ' ' CYS . 34.4 mt-30 -85.23 -41.4 15.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.113 0.482 . . . . 2.1800000000000002 109.991 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.9 m -90.17 -3.55 57.8 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 1.23 111.95 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.699 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 12.1 tt -55.16 -24.12 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.366 0.416 . . . . 1.1100000000000001 111.049 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.19 -64.42 3.79 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.63 -0.795 . . . . 1.45 112.156 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -55.4 -38.81 69.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.449 0.642 . . . . 0.91000000000000003 110.37 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.699 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -55.77 -41.88 74.7 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.571 -1.195 . . . . 1.4299999999999999 111.365 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.516 HE21 ' HG3' ' A' ' 59' ' ' ARG . 14.8 tt0 -89.26 -61.32 1.73 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.104 -0.498 . . . . 2.0 111.98 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -94.07 -20.99 19.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.445 -0.343 . . . . 4.0899999999999999 111.816 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.83 92.86 0.54 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.642 -0.789 . . . . 1.99 112.483 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.35 -112.59 1.19 Allowed Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 121.063 -0.589 . . . . 1.79 111.958 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.84 157.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.674 0.273 . . . . 1.9199999999999999 110.682 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG13 ' SG ' ' A' ' 13' ' ' CYS . 87.5 t -107.86 114.49 60.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.324 -0.398 . . . . 0.70999999999999996 110.332 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 2.2 Cg_endo -83.8 152.67 13.1 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.299 2.666 . . . . 0.81000000000000005 112.325 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.607 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 19.1 Cg_endo -62.13 -13.05 29.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.685 2.257 . . . . 1.03 111.902 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -70.99 -57.98 4.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.486 -0.931 . . . . 0.91000000000000003 108.486 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.3 t -53.88 -44.02 70.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.545 -1.207 . . . . 0.73999999999999999 109.905 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 24.6 m -61.49 -25.96 67.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.951 -0.568 . . . . 1.3999999999999999 112.037 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -78.58 -33.88 47.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.732 -0.47 . . . . 0.79000000000000004 109.732 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -67.15 -38.92 92.48 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.104 -0.569 . . . . 0.56999999999999995 111.829 175.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 24.3 t -63.79 -48.56 85.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.449 -0.574 . . . . 0.68000000000000005 109.449 174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -59.81 -32.27 70.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.0 -0.546 . . . . 1.54 110.289 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 16.3 t-20 -58.64 -52.27 66.4 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 121.316 0.579 . . . . 2.1099999999999999 109.884 175.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 47' ' ' VAL . 6.1 mm -64.7 -12.65 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.657 -0.702 . . . . 0.65000000000000002 112.475 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 75' ' ' VAL . 6.3 mp -88.51 -63.82 1.24 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.577 0.703 . . . . 1.9299999999999999 111.222 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -77.18 -49.03 16.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.105 -0.952 . . . . 2.4500000000000002 112.59 -173.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -80.31 -12.61 59.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.308 -0.405 . . . . 1.55 111.59 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 p -73.06 90.75 1.54 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.283 -1.377 . . . . 1.4299999999999999 107.283 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 39' ' ' ARG . 17.8 tpt180 -92.41 -68.06 0.82 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.403 0.89 . . . . 4.4699999999999998 113.403 -161.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 81.0 p -85.46 -176.99 6.33 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.316 -0.402 . . . . 1.5900000000000001 111.545 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -65.72 -42.14 91.42 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.866 -0.42 . . . . 1.79 109.866 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -19.16 65.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.247 0.546 . . . . 1.4099999999999999 110.662 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -87.36 -45.55 10.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.755 . . . . 1.72 110.606 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 40' ' ' THR . 41.5 mtp180 -92.74 20.65 6.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.882 -0.599 . . . . 2.7000000000000002 110.327 -175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -145.7 47.85 1.26 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.983 1.373 . . . . 3.54 107.591 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -163.35 -33.36 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 112.535 -2.12 . . . . 0.64000000000000001 108.877 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 34' ' ' ILE . 10.8 p -63.3 -39.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.285 -0.87 . . . . 0.69999999999999996 112.173 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' HB2' HG13 ' A' ' 90' ' ' ILE . 10.8 t -72.17 -37.25 69.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.15 -0.685 . . . . 1.78 109.15 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 m -54.47 -52.05 63.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.948 -0.569 . . . . 1.4099999999999999 110.782 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.8 t -73.86 -32.13 63.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 1.1100000000000001 111.34 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' HA ' HG11 ' A' ' 6' ' ' VAL . 27.9 tp -52.99 -44.92 67.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 1.3300000000000001 110.938 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -66.54 -40.49 89.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 2.2999999999999998 111.33 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.38 -37.51 71.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.786 -0.366 . . . . 1.1000000000000001 110.862 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.505 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -68.45 -45.29 72.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.603 -0.271 . . . . 1.1599999999999999 110.893 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.3 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 1.1100000000000001 110.817 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.2 1.89 63.03 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.914 -0.66 . . . . 1.0800000000000001 112.243 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.33 -3.96 58.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.362 0.601 . . . . 1.53 110.188 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG11 ' OD1' ' A' ' 62' ' ' ASN . 30.2 m -69.24 173.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.204 -0.907 . . . . 2.3599999999999999 112.414 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HG3' HE21 ' A' ' 18' ' ' GLN . 15.8 ptm180 -145.85 136.31 24.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.354 -1.35 . . . . 4.6500000000000004 107.354 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -36.55 3.42 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 108.885 -1.686 . . . . 2.0099999999999998 108.885 -163.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 30.6 mm 79.24 140.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-N 113.888 -1.156 . . . . 3.54 112.874 166.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -105.84 90.5 4.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.869 -1.06 . . . . 3.4100000000000001 111.908 176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 5.7 Cg_exo -78.83 -57.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.091 1.861 . . . . 2.4300000000000002 111.064 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -80.54 -32.87 36.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.194 -0.457 . . . . 3.1000000000000001 110.601 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 23.4 m-20 -71.62 -31.39 66.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 1.3400000000000001 111.411 -171.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.27 -46.51 76.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.973 0.416 . . . . 1.4299999999999999 110.585 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -78.88 -9.46 59.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.014 -0.539 . . . . 2.4100000000000001 110.569 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -85.13 -38.11 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.486 . . . . 1.1399999999999999 111.443 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.3 tp -50.76 -54.33 37.51 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 113.162 0.801 . . . . 2.29 113.162 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 21.5 Cg_endo -60.06 -25.0 78.59 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 121.8 1.667 . . . . 1.2 111.829 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -43.76 29.5 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.813 -0.708 . . . . 1.3600000000000001 111.841 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 28.4 mmmt -59.66 -46.72 88.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.847 0.459 . . . . 2.6099999999999999 111.423 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.2 m -89.19 7.9 32.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.366 -0.379 . . . . 1.6499999999999999 111.814 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 33.86 83.73 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.346 -0.454 . . . . 0.95999999999999996 113.021 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HB ' HD21 ' A' ' 35' ' ' LEU . 18.7 m -124.0 77.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.893 0.854 . . . . 1.7 111.196 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -77.58 94.44 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.346 -0.843 . . . . 2.3100000000000001 110.004 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -98.81 155.39 36.72 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.503 -1.226 . . . . 1.8300000000000001 110.904 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.21 -54.25 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.947 2.432 . . . . 1.3500000000000001 113.299 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.0 p90 -75.37 171.57 13.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.888 0.375 . . . . 1.3799999999999999 110.851 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 68.2 mmtt -118.0 128.69 55.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.636 0.731 . . . . 3.48 112.928 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -73.66 -16.75 17.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.581 -1.191 . . . . 2.5499999999999998 109.73 173.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -72.97 32.63 0.07 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.427 -0.806 . . . . 2.4500000000000002 112.637 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 81' ' ' ILE . 70.9 p 56.33 18.6 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.254 1.021 . . . . 2.04 113.294 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.6 t -134.5 82.87 1.99 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 2.7599999999999998 109.783 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 t -162.17 160.7 27.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 2.0499999999999998 110.34 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -82.14 92.95 6.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 111.152 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.783 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 72.1 m -87.3 63.73 7.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -134.73 -22.82 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.913 0.387 . . . . 2.7599999999999998 111.208 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 p -99.75 -39.97 7.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.239 -1.023 . . . . 2.21 108.239 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.819 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -82.62 -77.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.74 -1.118 . . . . 2.1699999999999999 108.087 163.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.783 ' HA ' ' HB3' ' A' ' 87' ' ' CYS . 28.5 t-20 . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.254 -0.879 . . . . 4.7800000000000002 112.103 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.841 -0.429 . . . . 2.9100000000000001 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 4' ' ' GLY . 6.8 p -133.32 5.86 3.8 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.866 -0.606 . . . . 2.6299999999999999 112.252 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.1 t 71.09 -30.25 0.2 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.914 -0.773 . . . . 0.81000000000000005 108.914 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.05 -30.3 55.65 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.782 -1.327 . . . . 0.56999999999999995 109.782 170.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 34' ' ' ILE . 28.1 tt0 -55.57 -43.8 76.26 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.863 -0.792 . . . . 1.25 108.863 167.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' CG2' ' A' ' 47' ' ' VAL . 71.7 t -62.67 -34.9 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.637 -0.711 . . . . 1.1200000000000001 111.186 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 11' ' ' ALA . 58.1 tt0 -56.68 -35.32 68.3 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.611 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.81 -14.22 54.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.568 -0.825 . . . . 0.81999999999999995 112.683 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.66 ' ND2' HG22 ' A' ' 31' ' ' VAL . 1.7 t-20 -88.98 -58.87 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.875 -0.417 . . . . 1.8600000000000001 109.875 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.73 -36.82 70.6 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.162 0.801 . . . . 1.73 113.162 -174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 7' ' ' GLN . . . -62.04 -32.57 73.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.367 . . . . 0.77000000000000002 111.942 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 21.2 mm-40 -76.62 -17.94 58.89 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.28 -0.418 . . . . 2.1800000000000002 111.405 -176.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.762 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 1.3 m -100.7 -3.74 29.62 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 116.533 -0.303 . . . . 1.23 111.324 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.25 -31.55 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.025 0.44 . . . . 1.1100000000000001 110.418 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.93 -69.75 1.29 Allowed Glycine 0 C--O 1.221 -0.697 0 C-N-CA 120.744 -0.741 . . . . 1.45 112.417 175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.743 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 11.2 t80 -56.16 -42.2 76.62 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.936 0.494 . . . . 0.91000000000000003 111.984 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.762 ' HG ' ' HB3' ' A' ' 13' ' ' CYS . 0.6 OUTLIER -56.13 -30.02 61.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.69 -0.687 . . . . 1.4299999999999999 110.05 178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.785 ' HG3' HG13 ' A' ' 61' ' ' ILE . 40.3 mt-30 -87.36 -77.95 0.32 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.024 0.916 . . . . 2.0 109.79 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 7.4 mmpt? -133.31 105.64 7.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.488 -1.687 . . . . 4.0899999999999999 109.905 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -148.8 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.426 -0.892 . . . . 1.99 113.228 -177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.14 -59.97 4.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.252 -0.975 . . . . 1.79 111.447 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.04 156.01 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.091 -0.555 . . . . 1.9199999999999999 110.363 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 92.6 t -91.63 128.32 46.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.832 0.349 . . . . 0.70999999999999996 110.784 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 8.2 Cg_exo -73.28 148.46 43.74 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.987 2.458 . . . . 0.81000000000000005 111.567 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 22.4 Cg_exo -64.71 -6.86 13.21 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.037 2.491 . . . . 1.03 111.985 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -82.12 -45.75 14.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.662 -0.866 . . . . 0.91000000000000003 108.662 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' O ' HG23 ' A' ' 31' ' ' VAL . 44.4 t -67.34 -44.63 78.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.026 -0.988 . . . . 0.73999999999999999 109.153 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.3 m -58.97 -38.95 80.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.211 -0.45 . . . . 1.3999999999999999 111.726 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -70.16 -34.02 72.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.79000000000000004 110.359 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.12 -36.87 72.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.56999999999999995 112.283 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t -61.33 -51.36 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.912 -1.144 . . . . 0.68000000000000005 107.912 171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -52.91 -34.57 55.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.951 -1.022 . . . . 1.54 110.39 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -62.52 -57.91 9.47 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.177 0.513 . . . . 2.1099999999999999 110.408 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 47' ' ' VAL . 6.3 mm -57.81 -31.37 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 112.564 0.579 . . . . 0.65000000000000002 112.564 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 20.9 mt -83.11 -54.34 5.11 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.817 0.303 . . . . 1.9299999999999999 111.817 -177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -90.6 -47.29 7.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.808 0.337 . . . . 2.4500000000000002 110.87 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -79.28 5.01 13.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.301 -0.409 . . . . 1.55 112.093 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 9.5 t -58.45 116.55 3.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.8 -1.185 . . . . 1.4299999999999999 107.8 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.06 -48.16 76.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 4.4699999999999998 112.121 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 ' H ' ' CB ' ' A' ' 43' ' ' ASP . 69.1 p -140.98 -178.23 5.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.308 -0.406 . . . . 1.5900000000000001 110.102 -175.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.5 m -68.83 -35.63 77.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.497 -0.557 . . . . 1.79 109.497 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 45' ' ' ARG . . . -66.08 -18.1 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 1.4099999999999999 110.135 174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.534 ' CB ' ' H ' ' A' ' 40' ' ' THR . 7.8 t70 -87.28 -38.61 16.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.869 -0.789 . . . . 1.72 108.869 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.617 ' HA ' HG12 ' A' ' 47' ' ' VAL . 41.2 ttm180 -78.28 -32.59 49.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.168 -0.924 . . . . 2.7000000000000002 111.586 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 89' ' ' SER . 12.6 ptp180 -73.65 -30.62 63.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.02 -0.672 . . . . 3.54 109.252 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.0 58.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.871 -0.604 . . . . 0.64000000000000001 110.152 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 34' ' ' ILE . 4.3 p -62.42 -35.63 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.69999999999999996 110.466 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 23.1 t -68.68 -33.41 73.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.286 0.565 . . . . 1.78 110.021 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.0 m -71.32 -38.66 71.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 1.4099999999999999 110.953 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 6' ' ' VAL . 15.2 t -72.64 -33.01 66.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.1100000000000001 110.075 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.5 tp -52.75 -34.88 54.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.347 -0.842 . . . . 1.3300000000000001 110.452 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.698 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 mmtp -57.05 -52.95 63.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.919 -0.582 . . . . 2.2999999999999998 110.867 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -76.5 -23.69 53.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.036 -0.529 . . . . 1.1000000000000001 111.257 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.49 -49.66 18.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.386 -0.37 . . . . 1.1599999999999999 110.659 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.13 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 1.1100000000000001 110.017 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.75 8.81 66.04 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.943 -0.572 . . . . 1.0800000000000001 112.397 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -91.12 -5.43 55.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.53 110.057 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 35.2 m -69.16 98.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.8 -1.091 . . . . 2.3599999999999999 111.67 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -108.83 100.77 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.543 -0.539 . . . . 4.6500000000000004 109.543 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.42 -26.27 23.68 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.779 -1.328 . . . . 2.0099999999999998 109.779 -170.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.785 HG13 ' HG3' ' A' ' 18' ' ' GLN . 2.0 mp -79.98 147.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.446 -0.877 . . . . 3.54 109.183 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 49.1 m-80 -95.19 116.93 66.79 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.187 -0.46 . . . . 3.4100000000000001 110.544 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 9.4 Cg_endo -80.17 -9.03 14.1 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.49 2.127 . . . . 2.4300000000000002 111.197 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -70.89 -22.25 62.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.662 -0.699 . . . . 3.1000000000000001 109.417 173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' HD22 ' A' ' 17' ' ' LEU . 2.5 m-20 -84.6 -24.37 29.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 1.3400000000000001 109.601 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.0 77.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.968 -0.56 . . . . 1.4299999999999999 110.797 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.109 0.481 . . . . 2.4100000000000001 110.67 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -92.48 -21.5 20.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 1.1399999999999999 109.936 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD13 ' SG ' ' A' ' 13' ' ' CYS . 48.7 tp -55.28 -55.24 41.85 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.009 -0.996 . . . . 2.29 112.803 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 12.8 Cg_endo -55.55 -36.28 94.17 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.214 1.943 . . . . 1.2 112.062 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.76 -38.89 96.17 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.372 -0.831 . . . . 1.3600000000000001 112.751 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 13.3 mmmm -75.87 -44.43 40.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.692 0.246 . . . . 2.6099999999999999 111.526 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 75' ' ' VAL . 34.5 m -73.14 -8.52 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.694 0.283 . . . . 1.6499999999999999 110.877 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.44 31.91 39.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.064 -0.588 . . . . 0.95999999999999996 111.748 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 73' ' ' CYS . 3.3 m -124.77 82.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.515 0.674 . . . . 1.7 111.609 -175.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -75.0 85.77 2.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.418 -0.81 . . . . 2.3100000000000001 109.947 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -78.13 153.2 79.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.8300000000000001 111.383 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.45 -51.87 4.68 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.056 2.504 . . . . 1.3500000000000001 112.674 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' THR . 4.3 p90 -80.09 165.35 22.58 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.156 -0.313 . . . . 1.3799999999999999 110.156 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -104.53 128.34 52.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 3.48 111.795 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' THR . 6.3 tt -69.78 -26.55 30.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.888 -1.051 . . . . 2.5499999999999998 110.817 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -69.3 22.7 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.701 -0.681 . . . . 2.4500000000000002 112.67 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 52' ' ' LYS . 43.3 p 57.23 17.79 3.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 2.04 112.9 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -97.55 22.9 8.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 2.7599999999999998 111.051 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 79' ' ' TYR . 14.0 t -134.54 166.1 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.991 0.424 . . . . 2.0499999999999998 110.758 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -85.16 151.68 23.93 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.079 -0.712 . . . . 3.0499999999999998 109.079 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.698 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 70.8 m -137.49 -10.19 1.65 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.232 0.456 . . . . 1.71 112.232 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -73.37 -8.81 57.44 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.649 -0.421 . . . . 2.7599999999999998 110.767 -176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 10.4 p -136.5 -59.76 0.72 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.283 -0.417 . . . . 2.21 110.093 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 12.4 pt 54.11 131.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.493 1.517 . . . . 2.1699999999999999 113.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.312 -1.025 0 CA-C-N 114.599 -1.182 . . . . 4.7800000000000002 109.753 175.05 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 9.9 tpt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 122.099 0.952 . . . . 2.9100000000000001 111.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 4' ' ' GLY . 1.4 t -147.57 157.11 43.42 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.766 -1.561 . . . . 2.6299999999999999 106.81 165.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.6 t -74.76 13.5 0.63 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.016 0.912 . . . . 0.81000000000000005 109.05 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -109.52 -18.32 9.15 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 109.59 -1.404 . . . . 0.56999999999999995 109.59 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.585 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 5.0 tt0 -71.25 -53.49 14.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.444 -0.947 . . . . 1.25 108.444 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 34' ' ' ILE . 59.6 t -60.52 -43.73 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.709 -1.132 . . . . 1.1200000000000001 110.298 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -59.04 -40.61 85.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.297 -0.865 . . . . 1.97 110.768 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.09 98.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 111.808 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 11.9 m120 -63.9 -51.17 65.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.717 0.294 . . . . 1.8600000000000001 110.594 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.9 mp -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.105 0.409 . . . . 1.73 112.105 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -56.26 -39.76 73.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.823 0.344 . . . . 0.77000000000000002 111.647 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.944 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -69.16 -23.8 63.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.132 0.492 . . . . 2.1800000000000002 110.879 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 74.2 m -92.39 -18.65 23.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.556 . . . . 1.23 110.783 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 41.1 mt -54.12 -27.29 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.647 0.592 . . . . 1.1100000000000001 112.357 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.21 -64.03 4.77 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.077 -1.059 . . . . 1.45 112.212 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . 19.7 t80 -61.43 -37.31 83.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.391 0.615 . . . . 0.91000000000000003 110.129 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 11.8 tp -55.11 -47.68 74.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.909 -1.041 . . . . 1.4299999999999999 110.456 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.734 ' HB2' HG13 ' A' ' 61' ' ' ILE . 8.1 tt0 -94.13 -53.69 3.86 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.71 -0.677 . . . . 2.0 111.547 -172.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.9 -34.12 9.51 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.073 0.464 . . . . 4.0899999999999999 111.013 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 16' ' ' PHE . . . 81.99 -176.44 53.94 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.852 -0.689 . . . . 1.99 112.546 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.79 -48.87 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.811 -0.709 . . . . 1.79 112.982 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 9.4 p -157.67 144.05 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.759 0.314 . . . . 1.9199999999999999 111.359 -175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.3 t -106.06 118.21 55.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.217 -0.447 . . . . 0.70999999999999996 110.258 172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.745 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 74.1 Cg_endo -77.09 147.65 26.7 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.698 2.265 . . . . 0.81000000000000005 112.262 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 12.5 Cg_exo -70.23 1.78 4.41 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.414 2.743 . . . . 1.03 111.898 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.5 m -92.93 -42.35 9.53 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.881 -1.155 . . . . 0.91000000000000003 107.881 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.745 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.15 -46.37 89.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.793 -1.549 . . . . 0.73999999999999999 109.888 174.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -72.33 -37.48 68.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.654 -0.418 . . . . 1.3999999999999999 112.065 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -66.2 -40.42 90.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.67 0.271 . . . . 0.79000000000000004 110.978 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.92 -51.76 13.86 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 113.175 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.793 HG11 HD21 ' A' ' 69' ' ' LEU . 97.8 t -63.66 -26.03 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.011 0.434 . . . . 0.68000000000000005 110.345 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -59.35 -25.57 64.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.708 -0.478 . . . . 1.54 109.708 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.747 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 25.3 t-20 -71.68 -46.88 57.46 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.047 -0.661 . . . . 2.1099999999999999 110.234 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.752 HG13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -73.54 -18.93 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.223 0.453 . . . . 0.65000000000000002 112.223 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 70' ' ' PRO . 1.2 tp -103.05 -48.11 4.14 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.221 0.534 . . . . 1.9299999999999999 111.62 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -95.81 -46.49 6.55 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.735 -0.666 . . . . 2.4500000000000002 111.658 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 25.5 m -87.24 5.09 39.9 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.521 0.563 . . . . 1.55 112.521 -171.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HG2' ' A' ' 44' ' ' ARG . 79.7 p -57.85 104.58 0.2 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.04 -1.096 . . . . 1.4299999999999999 108.04 170.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -54.44 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.465 -1.243 . . . . 4.4699999999999998 113.286 -161.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 p -104.63 178.06 4.67 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.705 -0.679 . . . . 1.5900000000000001 110.509 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -59.2 -40.22 85.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.068 -0.345 . . . . 1.79 110.068 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.89 -20.42 65.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.874 -0.603 . . . . 1.4099999999999999 111.144 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 47' ' ' VAL . 10.8 t70 -91.83 -39.07 11.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.719 -0.845 . . . . 1.72 108.719 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' OG ' ' A' ' 38' ' ' SER . 65.6 mtp85 -73.09 -45.93 54.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.48 -0.782 . . . . 2.7000000000000002 111.728 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 88' ' ' ASN . 34.6 tpt85 -74.49 -6.34 47.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.709 0.766 . . . . 3.54 110.559 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.16 -43.42 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.64000000000000001 110.945 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 34' ' ' ILE . 1.4 p -63.07 -40.94 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.806 -0.357 . . . . 0.69999999999999996 111.6 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 51' ' ' LEU . 24.8 p -57.25 -32.12 66.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.891 0.377 . . . . 1.78 110.622 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 t -69.38 -51.05 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.552 -0.749 . . . . 1.4099999999999999 110.61 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG21 ' A' ' 6' ' ' VAL . 50.2 t -62.12 -36.59 82.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.841 -0.163 . . . . 1.1100000000000001 110.712 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.748 HD12 ' HA ' ' A' ' 48' ' ' CYS . 83.3 mt -49.94 -29.61 8.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.884 0.328 . . . . 1.3300000000000001 111.884 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 35.8 mmtm -77.37 -12.97 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.782 0.29 . . . . 2.2999999999999998 111.782 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.44 -36.75 5.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.863 -0.335 . . . . 1.1000000000000001 110.397 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.55 -47.1 70.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.446 -0.343 . . . . 1.1599999999999999 110.535 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.07 -2.21 34.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.411 0.624 . . . . 1.1100000000000001 109.593 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 52' ' ' LYS . . . -94.87 -20.21 29.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.18 -0.918 . . . . 1.0800000000000001 111.811 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.76 -72.99 0.18 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.224 -0.658 . . . . 1.53 109.224 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.772 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 18.2 m 35.62 44.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.597 1.186 . . . . 2.3599999999999999 113.802 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.83 107.48 6.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.724 -0.473 . . . . 4.6500000000000004 109.724 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.53 -8.58 62.15 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.897 -0.881 . . . . 2.0099999999999998 110.897 -173.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 2.0 mp -92.96 148.53 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.379 . . . . 3.54 110.507 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 50.1 m-80 -89.19 115.19 63.02 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.863 -0.791 . . . . 3.4100000000000001 108.863 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 2.7 Cg_exo -67.54 -22.0 45.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.225 1.95 . . . . 2.4300000000000002 111.489 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.76 -33.13 71.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.481 -0.782 . . . . 3.1000000000000001 110.128 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.58 -19.41 42.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 1.3400000000000001 110.371 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -73.69 -40.58 63.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.227 -0.442 . . . . 1.4299999999999999 110.719 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -83.35 -17.25 43.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.887 0.375 . . . . 2.4100000000000001 110.337 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . -83.93 -17.16 41.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 109.9 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.793 HD21 HG11 ' A' ' 31' ' ' VAL . 8.4 tt -55.4 -49.54 91.9 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.121 -0.945 . . . . 2.29 112.012 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB3' HD21 ' A' ' 35' ' ' LEU . 17.8 Cg_endo -63.32 -42.82 20.52 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.847 1.698 . . . . 1.2 112.354 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -57.09 -54.2 38.77 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.687 -0.688 . . . . 1.3600000000000001 113.841 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -73.36 3.17 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.531 0.567 . . . . 2.6099999999999999 112.531 -175.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.0 m -112.59 7.19 18.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 1.6499999999999999 111.073 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.49 0.16 78.02 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.077 -0.582 . . . . 0.95999999999999996 113.265 174.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.36 83.49 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.239 0.542 . . . . 1.7 111.248 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -91.38 91.64 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.626 -0.716 . . . . 2.3100000000000001 109.519 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.723 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -97.03 163.97 18.88 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.158 -0.928 . . . . 1.8300000000000001 110.377 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 6.9 Cg_endo -49.81 -50.67 12.59 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.219 2.613 . . . . 1.3500000000000001 113.048 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.72 ' HD1' ' H ' ' A' ' 81' ' ' ILE . 21.8 p90 -80.81 169.34 17.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.051 -0.352 . . . . 1.3799999999999999 110.051 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.711 ' O ' HG13 ' A' ' 81' ' ' ILE . 14.3 tptp -118.7 21.91 12.27 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.424 -0.51 . . . . 3.48 111.502 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.72 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.2 pp 62.5 -31.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.654 1.581 . . . . 2.5499999999999998 113.384 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG22 ' A' ' 85' ' ' THR . 15.8 m -62.45 175.25 0.8 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.394 0.616 . . . . 2.4500000000000002 111.742 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 2.5 p -63.38 -26.82 68.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 2.04 112.34 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -59.52 -29.09 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.89 0.7 . . . . 2.7599999999999998 112.89 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 82' ' ' SER . 8.8 t -81.41 -17.21 49.7 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.128 0.49 . . . . 2.0499999999999998 110.526 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 87' ' ' CYS . 55.5 t30 67.67 -15.37 0.19 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.621 0.971 . . . . 3.0499999999999998 113.621 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 86' ' ' ASN . 4.5 t 74.0 -23.31 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.561 0.744 . . . . 1.71 112.166 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 5.1 m-20 -60.55 -23.65 64.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.638 0.256 . . . . 2.7599999999999998 111.351 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -153.32 94.34 1.81 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.557 0.694 . . . . 2.21 109.93 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.572 ' HB ' ' CD2' ' A' ' 79' ' ' TYR . 5.2 pt -109.24 -30.78 2.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 114.81 -1.086 . . . . 2.1699999999999999 109.453 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-N 114.414 -1.266 . . . . 4.7800000000000002 111.136 -172.448 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 11.8 tpt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.311 0.577 . . . . 2.9100000000000001 111.653 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 4' ' ' GLY . 3.0 p -137.32 0.81 2.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.408 -0.814 . . . . 2.6299999999999999 110.922 170.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 7' ' ' GLN . 25.0 t 71.25 -33.57 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.836 -0.802 . . . . 0.81000000000000005 108.836 -169.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -77.0 -26.76 61.53 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.53 -1.428 . . . . 0.56999999999999995 109.53 172.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -67.94 -34.49 76.69 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 171.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.974 HG22 HG23 ' A' ' 47' ' ' VAL . 57.4 t -65.41 -42.12 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.078 -0.51 . . . . 1.1200000000000001 110.243 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 3' ' ' CYS . 55.3 mt-30 -56.66 -30.77 63.73 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.13 -0.486 . . . . 1.97 110.605 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' HA2' ' OE1' ' A' ' 12' ' ' GLN . . . -63.86 -9.5 33.86 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.962 -0.637 . . . . 0.81999999999999995 112.953 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.536 HD22 ' HB ' ' A' ' 34' ' ' ILE . 39.4 t-20 -88.84 -63.3 1.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.396 -0.594 . . . . 1.8600000000000001 109.396 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 81' ' ' ILE . 3.4 mm? -80.7 -20.81 42.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.161 0.801 . . . . 1.73 113.161 -169.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.85 -21.26 51.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 107.845 -1.169 . . . . 0.77000000000000002 107.845 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.512 ' OE1' ' HA2' ' A' ' 8' ' ' GLY . 1.2 mp0 -88.79 -40.4 13.21 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 113.289 -1.778 . . . . 2.1800000000000002 109.872 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 93.0 m -75.55 -23.98 56.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.729 -0.668 . . . . 1.23 111.746 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 1.7 mt -47.93 -33.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.06 0.392 . . . . 1.1100000000000001 112.06 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.27 9.24 3.3 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.092 -0.575 . . . . 1.45 113.796 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.937 ' HA ' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -145.03 -39.98 0.25 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.243 -1.021 . . . . 0.91000000000000003 108.243 170.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 48.6 tp -52.86 -30.34 33.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.314 -1.312 . . . . 1.4299999999999999 111.419 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.874 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 33.7 tt0 -96.92 -60.69 1.54 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 111.381 0.141 . . . . 2.0 111.381 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 18' ' ' GLN . 55.4 mtmt -130.78 28.98 4.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.152 0.427 . . . . 4.0899999999999999 112.152 -175.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA3' ' HA ' ' A' ' 16' ' ' PHE . . . -119.45 -161.02 11.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.046 -1.073 . . . . 1.99 113.051 -175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.93 -64.27 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 110.547 -1.021 . . . . 1.79 110.547 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -63.4 133.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.438 -0.881 . . . . 1.9199999999999999 109.828 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 62.5 t -92.7 121.77 65.41 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.755 0.312 . . . . 0.70999999999999996 110.555 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -80.64 148.84 18.22 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.138 2.559 . . . . 0.81000000000000005 112.301 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 35.9 Cg_endo -65.42 -14.75 46.53 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.985 2.456 . . . . 1.03 112.918 -176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -75.6 -50.17 16.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.921 -0.77 . . . . 0.91000000000000003 108.921 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -53.3 -47.53 69.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.308 -1.314 . . . . 0.73999999999999999 109.615 169.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 40.9 m -57.67 -44.33 85.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 1.3999999999999999 112.14 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.1 m -59.81 -38.18 81.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.688 0.28 . . . . 0.79000000000000004 110.745 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 33' ' ' ASN . . . -69.66 -40.13 77.24 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.802 -0.713 . . . . 0.56999999999999995 112.678 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 27' ' ' CYS . 10.1 t -64.52 -37.48 80.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.222 -0.658 . . . . 0.68000000000000005 109.222 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 8.3 mmpt? -64.09 -28.47 69.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.76 -0.655 . . . . 1.54 110.225 174.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 91.2 m-20 -66.2 -51.34 58.57 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 121.195 0.522 . . . . 2.1099999999999999 110.372 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' HB ' HD22 ' A' ' 9' ' ' ASN . 0.3 OUTLIER -71.65 -10.02 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.568 0.699 . . . . 0.65000000000000002 111.408 -178.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.736 HD21 HG13 ' A' ' 75' ' ' VAL . 2.2 mp -97.11 -68.97 0.77 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 1.9299999999999999 111.404 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.23 -43.52 33.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.617 -0.72 . . . . 2.4500000000000002 111.774 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 21.8 m -81.88 0.27 40.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.626 -0.261 . . . . 1.55 111.602 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -63.04 109.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.557 -1.275 . . . . 1.4299999999999999 107.557 169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 39' ' ' ARG . 29.5 ttt180 -61.15 -44.6 97.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.891 0.701 . . . . 4.4699999999999998 112.891 -165.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -164.96 -168.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 121.024 -0.27 . . . . 1.5900000000000001 110.292 -170.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -64.83 -37.74 88.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.014 0.435 . . . . 1.79 110.59 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.54 -19.01 64.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 1.4099999999999999 110.447 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.1 -39.05 14.9 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.874 -0.788 . . . . 1.72 108.874 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 41.0 ttm180 -63.08 -56.96 12.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.97 -1.013 . . . . 2.7000000000000002 112.326 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -83.43 15.41 3.06 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.378 -0.529 . . . . 3.54 111.155 -177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.17 -39.28 4.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.928 -0.578 . . . . 0.64000000000000001 109.828 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 6' ' ' VAL . 13.7 p -62.5 -30.36 48.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.851 -0.613 . . . . 0.69999999999999996 110.84 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -72.25 -38.23 68.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 1.78 111.131 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.3 t -63.71 -38.35 90.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.125 -0.489 . . . . 1.4099999999999999 110.219 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 6' ' ' VAL . 45.2 t -81.8 -32.41 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.359 -0.382 . . . . 1.1100000000000001 110.547 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -48.05 -38.5 17.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 171.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -60.94 -27.46 68.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.346 -0.843 . . . . 2.2999999999999998 112.197 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.18 -24.9 20.9 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.975 -0.453 . . . . 1.1000000000000001 110.636 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -75.44 -51.04 13.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.175 0.512 . . . . 1.1599999999999999 109.743 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.83 -2.81 38.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 1.1100000000000001 110.091 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.41 -0.44 35.06 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.428 -0.806 . . . . 1.0800000000000001 111.454 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.6 -9.44 44.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.513 0.673 . . . . 1.53 109.549 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.862 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 22.0 m -49.96 111.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.373 -1.285 . . . . 2.3599999999999999 112.733 -177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -122.77 103.84 8.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 4.6500000000000004 109.237 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 29.26 48.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.876 -0.889 . . . . 2.0099999999999998 110.876 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.862 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 4.0 tp -77.42 166.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.283 0.563 . . . . 3.54 111.553 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' H ' HG13 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -115.26 113.04 43.63 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.208 -0.906 . . . . 3.4100000000000001 110.409 176.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.09 -40.78 48.56 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.167 2.578 . . . . 2.4300000000000002 113.083 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -67.33 -31.2 71.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.958 0.409 . . . . 3.1000000000000001 110.717 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 5.7 m-20 -73.27 -18.56 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 1.3400000000000001 110.689 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -50.62 63.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.519 -0.31 . . . . 1.4299999999999999 110.829 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -82.75 3.56 28.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.973 0.416 . . . . 2.4100000000000001 110.69 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -86.88 -37.37 17.76 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.797 -0.638 . . . . 1.1399999999999999 111.188 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 70' ' ' PRO . 2.2 pp -64.16 -39.69 46.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.941 0.719 . . . . 2.29 112.941 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.609 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 Cg_endo -69.0 -7.14 20.02 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.358 1.372 . . . . 1.2 112.211 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.99 -57.94 1.0 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.718 -0.753 . . . . 1.3600000000000001 111.701 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -56.94 -37.59 71.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.197 0.444 . . . . 2.6099999999999999 112.197 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.0 m -88.82 8.41 29.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.146 0.424 . . . . 1.6499999999999999 112.146 -171.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.1 59.3 7.58 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.016 -0.834 . . . . 0.95999999999999996 111.016 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.736 HG13 HD21 ' A' ' 35' ' ' LEU . 14.7 t -110.59 -62.25 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.193 -0.504 . . . . 1.7 111.61 -171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.08 91.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.932 0.77 . . . . 2.3100000000000001 111.872 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 79' ' ' TYR . 3.8 pt -131.53 140.68 39.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.8300000000000001 110.441 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.4 Cg_exo -63.73 -38.85 37.54 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.991 2.461 . . . . 1.3500000000000001 111.886 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' CE1' HD12 ' A' ' 77' ' ' ILE . 7.2 p90 -83.88 171.97 12.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.252 -0.885 . . . . 1.3799999999999999 109.647 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -122.85 160.44 26.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.053 0.454 . . . . 3.48 110.96 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -67.28 -27.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.275 -0.875 . . . . 2.5499999999999998 109.386 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -52.45 132.98 35.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.479 -0.782 . . . . 2.4500000000000002 109.203 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -78.58 22.0 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.543 0.571 . . . . 2.04 112.543 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -88.64 13.13 12.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.861 -0.792 . . . . 2.7599999999999998 108.861 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.65 131.95 47.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.008 -0.997 . . . . 2.0499999999999998 111.996 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.6 t-20 -76.65 71.48 3.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.83 -0.804 . . . . 3.0499999999999998 108.83 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.4 t -52.73 -45.14 66.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.122 -0.945 . . . . 1.71 112.616 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.36 -17.02 51.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.567 0.58 . . . . 2.7599999999999998 112.567 -172.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.8 m -142.01 28.42 1.73 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.274 -0.57 . . . . 2.21 112.461 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 44' ' ' ARG . 45.0 pt -67.9 -19.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.378 -0.529 . . . . 2.1699999999999999 110.048 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.115 -0.945 . . . . 4.7800000000000002 110.804 177.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 10.0 tpt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 111.362 0.134 . . . . 2.9100000000000001 111.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 46' ' ' ALA . 13.8 m 76.2 -82.4 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 119.382 -0.342 . . . . 2.6299999999999999 111.833 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.46 -34.15 70.54 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.433 0.635 . . . . 0.81000000000000005 110.584 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -79.89 -24.01 60.76 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 110.695 -0.962 . . . . 0.56999999999999995 110.695 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 2' ' ' THR . 26.8 tt0 -67.86 -41.1 83.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.577 -0.898 . . . . 1.25 108.577 172.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.965 HG22 HG23 ' A' ' 47' ' ' VAL . 3.2 t -60.77 -41.47 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.298 -0.864 . . . . 1.1200000000000001 109.876 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -52.76 -28.31 21.74 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.386 -0.824 . . . . 1.97 110.117 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.42 87.19 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.964 -0.636 . . . . 0.81999999999999995 113.312 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.34 -29.99 25.86 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.615 0.707 . . . . 1.8600000000000001 110.436 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.675 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 2.8 mm? -79.72 -53.77 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 1.73 111.86 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -53.26 -43.73 67.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.41 0.522 . . . . 0.77000000000000002 112.41 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -69.73 -38.09 76.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 2.1800000000000002 110.843 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 69' ' ' LEU . 1.7 m -79.2 -19.11 51.61 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-O 119.241 -0.409 . . . . 1.23 111.689 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 17' ' ' LEU . 4.1 mt -41.58 -42.72 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 123.771 0.669 . . . . 1.1100000000000001 112.649 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -57.3 -34.91 68.8 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.495 -0.86 . . . . 1.45 112.916 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -93.82 -36.24 12.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.676 0.751 . . . . 0.91000000000000003 109.841 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 21.0 tp -54.56 -38.39 66.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.1 -1.409 . . . . 1.4299999999999999 111.531 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -110.46 -49.8 3.02 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.69 -0.686 . . . . 2.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 7.9 mtmp? -87.29 -36.06 18.1 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.937 -0.305 . . . . 4.0899999999999999 111.331 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 -172.85 21.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.852 -0.689 . . . . 1.99 111.908 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.14 -96.67 0.77 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.644 -0.788 . . . . 1.79 113.226 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.71 143.39 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.452 0.168 . . . . 1.9199999999999999 110.864 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 ' HG3' ' A' ' 72' ' ' LYS . 91.0 t -88.78 118.1 68.98 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.898 -0.408 . . . . 0.70999999999999996 109.898 175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 23' ' ' VAL . 4.8 Cg_exo -81.5 147.78 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.151 2.568 . . . . 0.81000000000000005 112.08 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HA ' ' HB2' ' A' ' 28' ' ' CYS . 18.4 Cg_endo -59.48 -11.21 13.13 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.184 2.589 . . . . 1.03 112.058 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -71.21 -47.22 58.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.418 -0.956 . . . . 0.91000000000000003 108.418 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.9 t -64.27 -44.2 92.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.661 -1.154 . . . . 0.73999999999999999 109.36 173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 32.8 m -56.72 -32.9 65.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.75 -0.659 . . . . 1.3999999999999999 111.803 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -70.96 -44.54 65.84 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.97 0.414 . . . . 0.79000000000000004 110.133 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' ASN . . . -64.64 -36.79 93.57 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.158 -0.544 . . . . 0.56999999999999995 112.401 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 27' ' ' CYS . 58.7 t -64.91 -46.37 91.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 110.037 -0.357 . . . . 0.68000000000000005 110.037 176.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -60.78 -31.03 70.4 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.87 0.367 . . . . 1.54 110.557 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 19.1 t-20 -62.35 -50.89 69.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.808 -0.633 . . . . 2.1099999999999999 109.787 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 HD12 ' CG2' ' A' ' 47' ' ' VAL . 4.9 mm -65.05 -13.6 15.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.204 -0.907 . . . . 0.65000000000000002 112.413 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 5.4 mp -88.06 -72.44 0.53 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.469 0.652 . . . . 1.9299999999999999 111.306 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -78.6 -36.91 43.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 2.4500000000000002 112.665 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.6 m -88.41 -5.35 58.33 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.239 0.459 . . . . 1.55 112.239 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 m -69.9 87.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.733 -1.21 . . . . 1.4299999999999999 107.733 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.538 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 55.1 mtm180 -59.88 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.601 -1.181 . . . . 4.4699999999999998 113.5 -164.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -93.53 -173.24 3.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.751 -0.659 . . . . 1.5900000000000001 112.148 -167.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 92.5 m -58.74 -51.33 70.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.539 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.78 -28.27 67.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 110.427 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 39' ' ' ARG . 54.1 m-20 -75.63 -47.23 27.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.754 -0.657 . . . . 1.72 110.006 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 44' ' ' ARG . 6.8 tpt180 -73.6 -30.29 62.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.314 0.578 . . . . 2.7000000000000002 110.559 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 41' ' ' THR . 24.6 ttt180 -68.33 -60.6 2.33 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.197 -0.911 . . . . 3.54 109.853 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 2' ' ' THR . . . -71.97 -25.29 61.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.374 -0.83 . . . . 0.64000000000000001 111.772 -174.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.965 HG23 HG22 ' A' ' 6' ' ' VAL . 9.2 p -65.8 -28.64 44.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.528 -0.469 . . . . 0.69999999999999996 109.856 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 46.9 t -83.11 -43.4 16.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 1.78 109.924 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -66.38 -24.02 66.42 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.295 -0.411 . . . . 1.4099999999999999 111.214 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' HB3' HG21 ' A' ' 6' ' ' VAL . 52.6 t -88.81 -32.43 17.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.839 -0.43 . . . . 1.1100000000000001 109.839 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 tm? -54.87 -52.33 63.18 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.151 0.501 . . . . 1.3300000000000001 109.776 175.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 15.2 ptmt -60.25 -35.64 75.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 111.323 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.02 70.99 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.246 . . . . 1.1000000000000001 110.743 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -66.15 -34.76 78.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 1.1599999999999999 110.816 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.78 64.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.991 -0.549 . . . . 1.1100000000000001 110.709 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.45 -2.36 35.27 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.059 -0.591 . . . . 1.0800000000000001 112.012 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.43 -44.04 25.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.321 0.582 . . . . 1.53 110.007 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.809 HG13 ' HB ' ' A' ' 61' ' ' ILE . 3.8 p -80.54 125.41 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.309 -0.86 . . . . 2.3599999999999999 110.568 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 59' ' ' ARG . 6.0 tpp180 -79.93 -15.87 56.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.739 0.78 . . . . 4.6500000000000004 110.554 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . . . -109.13 28.15 11.56 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 111.824 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.809 ' HB ' HG13 ' A' ' 58' ' ' VAL . 10.4 tp -59.35 140.82 17.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.651 . . . . 3.54 111.466 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -110.4 108.32 58.47 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.205 -0.907 . . . . 3.4100000000000001 108.579 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -61.11 -28.28 85.43 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.655 2.237 . . . . 2.4300000000000002 111.084 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.03 -40.74 87.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.82 -1.082 . . . . 3.1000000000000001 110.499 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -77.07 -29.08 54.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.682 -0.69 . . . . 1.3400000000000001 110.205 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.3 79.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 1.4299999999999999 110.706 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -73.82 -12.32 60.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.38 0.61 . . . . 2.4100000000000001 110.421 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . -80.07 -28.16 39.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.106 -0.497 . . . . 1.1399999999999999 111.082 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' A' ' 13' ' ' CYS . 32.0 mt -56.68 -54.09 57.56 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.139 0.422 . . . . 2.29 112.139 -174.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 18.2 Cg_endo -60.86 -21.57 71.09 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.088 1.859 . . . . 1.2 112.699 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 -47.17 5.44 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.948 -0.644 . . . . 1.3600000000000001 112.25 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 68' ' ' ALA . 30.4 mmmt -59.44 -37.2 77.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 2.6099999999999999 111.45 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 52.4 m -95.95 7.35 46.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.016 0.436 . . . . 1.6499999999999999 111.228 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.61 52.51 44.96 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.464 -0.789 . . . . 0.95999999999999996 113.33 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.555 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 3.3 m -122.44 -50.71 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.861 0.33 . . . . 1.7 111.537 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 47.8 t-20 55.4 101.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.889 0.743 . . . . 2.3100000000000001 112.345 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -99.69 142.6 24.9 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.382 -0.372 . . . . 1.8300000000000001 110.688 177.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.8 45.85 1.38 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.342 2.694 . . . . 1.3500000000000001 112.732 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.8 -179.56 3.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.389 . . . . 1.3799999999999999 109.993 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.817 ' HG2' HG23 ' A' ' 85' ' ' THR . 0.1 OUTLIER -92.08 -16.39 26.47 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.429 0.633 . . . . 3.48 110.563 -176.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 81' ' ' ILE . 39.4 mm 64.53 -1.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.41 -1.268 . . . . 2.5499999999999998 110.425 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' LYS . 10.4 p -102.74 173.73 6.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.351 -0.386 . . . . 2.4500000000000002 110.543 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 38.8 m -79.34 -37.85 36.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.541 -0.3 . . . . 2.04 110.348 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -77.99 56.33 1.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.271 0.557 . . . . 2.7599999999999998 111.247 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 80' ' ' LYS . 90.2 m -101.23 -42.54 6.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.0499999999999998 110.667 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 61.93 96.76 0.03 OUTLIER 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.671 -0.695 . . . . 3.0499999999999998 111.029 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' CYS . 24.8 m -112.94 14.05 19.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.936 -0.575 . . . . 1.71 111.332 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -78.39 -5.57 52.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 2.7599999999999998 110.651 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.6 m -149.71 85.02 1.42 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.356 0.598 . . . . 2.21 109.996 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 91' ' ' ASN . 47.1 pt -132.21 -41.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.252 -0.885 . . . . 2.1699999999999999 110.444 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 t-20 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.672 -0.68 . . . . 4.7800000000000002 109.654 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 46' ' ' ALA . 11.8 tpt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 122.505 1.145 . . . . 2.9100000000000001 112.292 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER -158.01 156.31 30.91 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.071 -1.877 . . . . 2.6299999999999999 106.188 166.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.1 t -66.02 5.93 0.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.708 0.766 . . . . 0.81000000000000005 109.558 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' THR . . . -103.09 -20.16 11.67 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.218 . . . . 0.56999999999999995 110.056 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' HG23 ' A' ' 2' ' ' THR . 27.4 tt0 -71.79 -44.47 63.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.972 HG22 HG23 ' A' ' 47' ' ' VAL . 21.4 t -65.97 -39.95 86.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 113.693 -1.594 . . . . 1.1200000000000001 110.49 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -62.12 -28.96 70.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 1.97 110.428 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.38 -22.52 58.87 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.236 -0.507 . . . . 0.81999999999999995 112.317 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 25.3 t-20 -69.42 -65.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.439 -0.578 . . . . 1.8600000000000001 109.439 175.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.625 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.1 mm? -66.66 -35.72 80.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.691 . . . . 1.73 111.995 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.78 -36.45 64.91 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.064 0.394 . . . . 0.77000000000000002 112.064 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 10.8 mm100 -82.78 -33.82 27.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.533 0.682 . . . . 2.1800000000000002 110.507 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HD23 ' A' ' 17' ' ' LEU . 80.5 m -83.25 -20.64 34.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.151 -0.931 . . . . 1.23 112.149 -172.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 10' ' ' LEU . 29.3 mt -50.14 -30.28 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 123.402 0.439 . . . . 1.1100000000000001 112.022 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.45 -66.47 2.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.274 -0.965 . . . . 1.45 112.161 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -62.32 -37.66 86.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 0.91000000000000003 110.471 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.764 ' HB3' HG23 ' A' ' 61' ' ' ILE . 2.6 mm? -60.46 -24.83 65.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.244 -0.889 . . . . 1.4299999999999999 111.4 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' HG3' HG13 ' A' ' 61' ' ' ILE . 23.3 mt-30 -100.46 -64.59 1.03 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.479 . . . . 2.0 110.984 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -57.32 -41.17 79.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.979 -1.009 . . . . 4.0899999999999999 111.774 -175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.1 67.76 1.59 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.681 -0.771 . . . . 1.99 112.353 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.54 139.1 2.98 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.858 -0.687 . . . . 1.79 111.659 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p 41.97 101.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.141 1.376 . . . . 1.9199999999999999 113.987 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 72' ' ' LYS . 60.3 t -71.55 123.6 89.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.70999999999999996 110.399 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.0 Cg_exo -75.77 139.6 22.52 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.712 2.275 . . . . 0.81000000000000005 112.199 -178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 14.8 Cg_exo -69.54 10.76 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.377 2.718 . . . . 1.03 111.809 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 24' ' ' PRO . 8.4 m -100.6 -49.27 4.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.352 -0.981 . . . . 0.91000000000000003 108.352 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -53.53 -50.86 64.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.854 -1.521 . . . . 0.73999999999999999 110.439 172.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.7 m -56.96 -32.08 65.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.081 -0.509 . . . . 1.3999999999999999 111.995 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.6 m -64.33 -43.19 95.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.79000000000000004 111.247 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.79 -37.17 66.29 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.122 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 13.4 t -65.38 -46.54 89.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.822 0.344 . . . . 0.68000000000000005 110.173 177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -26.36 67.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.54 110.098 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -69.14 -55.01 11.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.553 -0.536 . . . . 2.1099999999999999 109.553 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' A' ' 47' ' ' VAL . 6.2 mm -60.33 -29.27 43.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.953 -0.567 . . . . 0.65000000000000002 112.064 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.3 mp -84.69 -70.6 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.91 -0.586 . . . . 1.9299999999999999 111.508 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.49 -26.27 38.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.724 -0.671 . . . . 2.4500000000000002 112.77 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -101.77 13.91 33.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.307 0.484 . . . . 1.55 112.307 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 p -61.29 104.42 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.368 -0.975 . . . . 1.4299999999999999 108.368 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.817 ' HG2' HG23 ' A' ' 40' ' ' THR . 42.4 ttm105 -52.02 -58.62 5.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.749 -0.66 . . . . 4.4699999999999998 112.617 -168.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 39' ' ' ARG . 49.6 p -129.87 -172.83 2.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.136 -0.484 . . . . 1.5900000000000001 110.613 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 m -65.35 -45.48 83.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.45 -0.341 . . . . 1.79 110.295 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.89 67.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 1.4099999999999999 110.411 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 2.1 t70 -77.79 -38.53 46.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.753 -0.658 . . . . 1.72 109.466 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 47' ' ' VAL . 29.9 ttp-105 -87.21 -28.2 22.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.78 -0.645 . . . . 2.7000000000000002 111.387 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -70.22 -53.09 18.51 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.463 -0.569 . . . . 3.54 109.463 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -67.6 -32.46 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 111.394 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.972 HG23 HG22 ' A' ' 6' ' ' VAL . 4.3 p -62.51 -33.06 57.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 N-CA-C 110.159 -0.311 . . . . 0.69999999999999996 110.159 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 87' ' ' CYS . 48.5 t -74.63 -41.83 59.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.712 -0.477 . . . . 1.78 109.712 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -59.77 -30.91 69.2 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.005 -0.543 . . . . 1.4099999999999999 111.138 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.625 ' HB3' HG21 ' A' ' 6' ' ' VAL . 32.0 t -86.97 -34.85 19.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.841 0.353 . . . . 1.1100000000000001 110.169 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.9 tp -53.65 -45.14 70.12 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.821 -0.627 . . . . 1.3300000000000001 111.17 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.8 ptpt -58.04 -37.2 73.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 2.2999999999999998 111.19 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' ALA . . . -86.75 -19.24 29.39 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.678 -0.237 . . . . 1.1000000000000001 110.934 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.16 -43.57 28.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.1599999999999999 109.773 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.85 -31.13 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 1.1100000000000001 109.734 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.67 -6.21 89.5 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.689 -0.687 . . . . 1.0800000000000001 112.14 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' ALA . . . -86.1 3.73 41.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.722 0.296 . . . . 1.53 111.066 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -68.53 86.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.954 0.883 . . . . 2.3599999999999999 111.937 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -103.6 101.72 11.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.334 -0.848 . . . . 4.6500000000000004 109.291 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.76 -11.17 72.86 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.786 -0.926 . . . . 2.0099999999999998 110.786 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 17' ' ' LEU . 2.3 mp -93.77 140.77 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.381 -0.6 . . . . 3.54 109.381 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 4.7 m-20 -92.43 119.25 68.16 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.055 -0.52 . . . . 3.4100000000000001 110.5 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 62' ' ' ASN . 5.0 Cg_endo -77.24 -13.84 16.8 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.709 2.272 . . . . 2.4300000000000002 112.348 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 62' ' ' ASN . 4.4 p-10 -65.67 -28.06 68.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.125 0.488 . . . . 3.1000000000000001 109.875 174.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.647 ' HB2' HD13 ' A' ' 17' ' ' LEU . 88.4 m-20 -77.0 -20.76 55.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.679 -0.691 . . . . 1.3400000000000001 110.21 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.56 59.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.518 . . . . 1.4299999999999999 110.657 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -77.63 -33.65 53.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.752 0.787 . . . . 2.4100000000000001 109.891 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.23 -4.75 49.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.505 -1.225 . . . . 1.1399999999999999 110.791 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' A' ' 27' ' ' CYS . 38.1 tp -80.37 -57.51 0.63 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.331 -0.849 . . . . 2.29 112.131 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 18.0 Cg_endo -59.0 -26.18 80.63 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.218 1.945 . . . . 1.2 112.01 -178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -35.37 91.89 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.454 -0.794 . . . . 1.3600000000000001 112.569 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 23' ' ' VAL . 13.8 mmmm -82.09 -44.58 16.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.878 0.37 . . . . 2.6099999999999999 111.555 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -78.8 4.54 13.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.317 -0.401 . . . . 1.6499999999999999 111.478 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.56 35.54 90.12 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 116.115 -0.493 . . . . 0.95999999999999996 112.919 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.89 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.8 m -134.05 71.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.252 0.548 . . . . 1.7 111.519 -177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.13 91.55 8.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.627 0.727 . . . . 2.3100000000000001 110.626 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.2 157.76 82.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.274 -0.875 . . . . 1.8300000000000001 111.305 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 77' ' ' ILE . 58.4 Cg_endo -72.15 -25.38 19.12 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.665 2.243 . . . . 1.3500000000000001 113.13 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' HB2' ' CG2' ' A' ' 85' ' ' THR . 9.0 p90 -92.58 -179.0 5.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.686 -0.406 . . . . 1.3799999999999999 110.781 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 15.0 tppt? -125.73 166.64 16.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.119 0.485 . . . . 3.48 111.178 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.6 pt -84.55 -5.14 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.599 -0.728 . . . . 2.5499999999999998 110.944 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.1 m -71.08 165.91 22.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.751 -0.659 . . . . 2.4500000000000002 111.684 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LYS . 50.7 p -83.18 13.73 3.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 2.04 111.227 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -114.87 10.11 16.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.406 0.622 . . . . 2.7599999999999998 110.425 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 79' ' ' TYR . 29.9 m -73.38 -26.51 61.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.0499999999999998 112.044 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 t30 59.8 82.47 0.15 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.631 0.729 . . . . 3.0499999999999998 110.019 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.708 ' HA ' HG23 ' A' ' 90' ' ' ILE . 56.8 m -77.48 -5.16 48.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.236 -0.893 . . . . 1.71 111.263 -173.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -69.22 -33.98 74.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.938 -0.574 . . . . 2.7599999999999998 110.999 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -130.33 27.78 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.886 -0.325 . . . . 2.21 111.519 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 87' ' ' CYS . 37.1 pt -63.03 -31.35 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.065 0.459 . . . . 2.1699999999999999 110.709 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.507 -0.759 . . . . 4.7800000000000002 110.408 -175.167 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.821 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 28.9 mmm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.479 0.18 . . . . 2.9100000000000001 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.661 HG23 ' HB1' ' A' ' 46' ' ' ALA . 84.2 m -156.81 -85.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.861 0.319 . . . . 2.6299999999999999 111.861 -173.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HA ' HG12 ' A' ' 6' ' ' VAL . 3.9 t -85.5 -27.89 25.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.295 0.569 . . . . 0.81000000000000005 110.217 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.84 -18.43 63.46 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.513 -1.035 . . . . 0.56999999999999995 110.513 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.821 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 27.0 tt0 -74.43 -52.23 12.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.968 0.889 . . . . 1.25 109.293 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.906 ' HA ' HG12 ' A' ' 34' ' ' ILE . 12.5 p -62.68 -28.92 45.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.893 -1.503 . . . . 1.1200000000000001 111.018 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.62 -33.88 75.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.004 -0.544 . . . . 1.97 110.841 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.19 -25.88 57.88 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.021 -0.609 . . . . 0.81999999999999995 112.229 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.673 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 19.5 t-20 -70.46 -61.45 1.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.351 0.596 . . . . 1.8600000000000001 109.824 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.725 ' HG ' ' HB1' ' A' ' 54' ' ' ALA . 3.0 mm? -74.05 -24.08 59.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 1.73 112.26 -171.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.24 -18.38 65.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.025 0.75 . . . . 0.77000000000000002 113.025 -173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 5.4 mt-30 -96.99 -21.45 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.138 -0.625 . . . . 2.1800000000000002 110.907 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -106.51 -2.28 22.14 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.923 -0.581 . . . . 1.23 110.707 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.636 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 12.6 tt -55.23 -29.21 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 123.669 0.606 . . . . 1.1100000000000001 111.536 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.68 95.39 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.188 -1.006 . . . . 1.45 112.136 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' HA ' ' CA ' ' A' ' 20' ' ' GLY . 5.8 t80 -87.98 -34.0 18.21 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.964 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 14' ' ' ILE . 11.3 tp -58.01 -49.85 75.43 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.999 -1.455 . . . . 1.4299999999999999 111.298 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 60' ' ' GLY . 19.8 tt0 -90.81 -51.6 5.28 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.259 -0.882 . . . . 2.0 110.297 -176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -93.96 -70.13 0.72 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 4.0899999999999999 110.726 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 16' ' ' PHE . . . 145.11 152.51 5.64 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.749 -0.94 . . . . 1.99 110.749 -177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 16' ' ' PHE . . . 162.02 -112.93 0.54 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.407 -0.902 . . . . 1.79 112.069 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.83 150.87 23.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 110.21 -0.292 . . . . 1.9199999999999999 110.21 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' SG ' ' A' ' 13' ' ' CYS . 98.4 t -100.9 110.67 61.61 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 0.70999999999999996 110.551 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 72.1 Cg_endo -76.01 150.81 34.41 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.031 2.487 . . . . 0.81000000000000005 112.584 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 33.4 Cg_endo -64.92 -13.57 40.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.399 . . . . 1.03 111.987 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 m -72.82 -58.2 3.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.736 -0.838 . . . . 0.91000000000000003 108.736 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -48.52 -46.84 39.14 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.067 -1.424 . . . . 0.73999999999999999 109.945 171.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -52.8 -43.03 65.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 110.924 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -66.21 -38.65 88.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.313 -0.403 . . . . 0.79000000000000004 111.148 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.14 -36.98 81.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.56999999999999995 111.577 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.673 ' HA ' ' ND2' ' A' ' 9' ' ' ASN . 47.9 t -57.92 -46.82 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.865 -0.791 . . . . 0.68000000000000005 108.865 172.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 39.1 ttmt -58.94 -28.37 66.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.958 -1.019 . . . . 1.54 110.719 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 86.4 m-20 -73.68 -40.06 63.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.372 -0.531 . . . . 2.1099999999999999 111.578 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.906 HG12 ' HA ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -83.07 -32.23 9.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.96 0.41 . . . . 0.65000000000000002 111.676 179.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 77' ' ' ILE . 8.7 tp -91.83 -36.64 13.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.067 -0.515 . . . . 1.9299999999999999 111.684 -172.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.9 t30 -103.85 -51.08 3.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.595 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 48.4 m -89.21 21.2 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.509 -0.769 . . . . 1.55 112.901 -172.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.7 t -60.32 100.79 0.11 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.134 0.969 . . . . 1.4299999999999999 108.621 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HG2' HG23 ' A' ' 40' ' ' THR . 45.2 ttm105 -53.12 -52.5 58.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.116 -1.856 . . . . 4.4699999999999998 113.092 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 43' ' ' ASP . 78.2 p -124.43 171.07 10.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.317 0.58 . . . . 1.5900000000000001 112.276 -171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.2 m -59.61 -39.42 84.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 1.79 109.443 171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -28.84 70.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.197 -0.91 . . . . 1.4099999999999999 110.066 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 40' ' ' THR . 4.9 m-20 -74.81 -47.2 31.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 1.72 109.955 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 40' ' ' THR . 93.0 mtt180 -65.82 -42.06 91.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.126 -0.943 . . . . 2.7000000000000002 111.857 -174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 28.3 mtm180 -86.51 2.18 48.89 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.158 0.504 . . . . 3.54 111.139 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 2' ' ' THR . . . -103.65 -41.98 5.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.392 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' A' ' 6' ' ' VAL . 12.8 p -65.64 -33.72 65.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.77 -0.65 . . . . 0.69999999999999996 111.299 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 p -60.94 -46.07 92.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.78 111.108 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.0 m -53.03 -40.25 63.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.24 0.459 . . . . 1.4099999999999999 112.24 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 6' ' ' VAL . 42.9 t -88.12 -30.95 19.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.727 -0.389 . . . . 1.1100000000000001 111.041 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 HG22 ' A' ' 81' ' ' ILE . 59.2 tp -59.52 -31.91 69.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.604 0.716 . . . . 1.3300000000000001 109.662 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.678 ' HG3' ' HA ' ' A' ' 83' ' ' THR . 37.9 ttmt -56.87 -42.75 80.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.841 -1.072 . . . . 2.2999999999999998 110.798 173.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.83 -19.04 53.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.918 -0.583 . . . . 1.1000000000000001 110.309 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.725 ' HB1' ' HG ' ' A' ' 10' ' ' LEU . . . -85.77 9.32 16.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 1.1599999999999999 110.984 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.61 -37.47 2.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 1.1100000000000001 111.11 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.76 1.4 30.42 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.269 -0.967 . . . . 1.0800000000000001 113.84 -175.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ALA . . . -126.86 21.13 6.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.485 0.642 . . . . 1.53 111.474 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 58' ' ' VAL . 14.0 t -91.03 18.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.326 0.584 . . . . 2.3599999999999999 110.834 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 59' ' ' ARG . 1.2 mpp_? 67.54 -68.18 0.16 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.615 0.766 . . . . 4.6500000000000004 112.535 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -69.31 -26.39 74.63 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.355 -0.839 . . . . 2.0099999999999998 111.333 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mm 74.66 124.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.672 0.789 . . . . 3.54 112.334 174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' CB ' ' HB2' ' A' ' 65' ' ' ASN . 2.7 p-10 -114.73 88.11 15.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.952 -1.022 . . . . 3.4100000000000001 112.215 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.01 -61.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.247 1.964 . . . . 2.4300000000000002 110.875 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.22 -33.32 43.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.354 -0.385 . . . . 3.1000000000000001 110.323 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.526 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -65.44 -28.5 69.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.022 0.439 . . . . 1.3400000000000001 110.122 -172.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HB1' HG12 ' A' ' 81' ' ' ILE . . . -76.66 -38.53 54.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 1.4299999999999999 111.172 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.24 -21.27 50.17 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 2.4100000000000001 110.35 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.93 -17.5 52.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.039 -0.982 . . . . 1.1399999999999999 110.577 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 43.1 tp -60.51 -56.99 29.84 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.108 -0.951 . . . . 2.29 112.079 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 69' ' ' LEU . 36.8 Cg_endo -64.68 -21.3 65.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.263 1.975 . . . . 1.2 112.832 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.54 99.19 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.18 -0.533 . . . . 1.3600000000000001 112.745 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -83.95 25.69 0.79 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.489 0.552 . . . . 2.6099999999999999 112.489 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 28' ' ' CYS . 4.7 t -143.87 -34.95 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 110.314 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.49 9.84 28.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.346 -0.931 . . . . 0.95999999999999996 112.628 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 m -86.12 88.19 2.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.546 0.689 . . . . 1.7 110.787 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -94.76 102.36 14.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.461 -0.79 . . . . 2.3100000000000001 110.161 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD12 HD21 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -99.72 155.24 36.69 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.481 -0.781 . . . . 1.8300000000000001 111.16 179.158 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 9.1 Cg_exo -72.54 -28.96 13.88 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.882 2.388 . . . . 1.3500000000000001 113.064 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CE1' HG13 ' A' ' 77' ' ' ILE . 21.9 p90 -90.4 176.79 6.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.501 0.191 . . . . 1.3799999999999999 110.679 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 30.1 mmtp -126.44 179.6 5.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.422 0.629 . . . . 3.48 112.267 -176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.502 HG12 ' HB1' ' A' ' 66' ' ' ALA . 2.1 pp -96.86 4.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.109 -0.95 . . . . 2.5499999999999998 111.397 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 p -66.67 156.59 34.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 2.4500000000000002 111.849 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.678 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 17.1 p -68.53 -13.5 62.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 2.04 111.595 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t -101.1 11.67 39.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.082 0.468 . . . . 2.7599999999999998 110.58 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.3 m -70.52 141.5 51.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 2.0499999999999998 111.126 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 89' ' ' SER . 27.4 t-20 -62.95 122.47 16.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.692 -0.686 . . . . 3.0499999999999998 110.15 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.4 t -122.38 -36.18 2.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.908 0.385 . . . . 1.71 111.506 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -86.24 15.08 5.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.696 0.284 . . . . 2.7599999999999998 111.749 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.541 ' HB2' ' OD1' ' A' ' 86' ' ' ASN . 14.7 m -133.77 -81.56 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.147 -0.221 . . . . 2.21 110.56 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.506 HG13 ' H ' ' A' ' 91' ' ' ASN . 1.6 pt 29.91 -93.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.553 1.141 . . . . 2.1699999999999999 113.964 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' H ' HG13 ' A' ' 90' ' ' ILE . 6.7 t30 . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.527 0.731 . . . . 4.7800000000000002 110.711 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' THR . 4.6 ttt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.704 -0.109 . . . . 2.9100000000000001 110.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -168.24 -87.88 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.143 0.577 . . . . 2.6299999999999999 109.905 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.59 -28.65 68.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.384 -0.969 . . . . 0.81000000000000005 108.384 168.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.51 66.46 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.946 -1.025 . . . . 0.56999999999999995 111.514 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.868 ' HG3' HD11 ' A' ' 34' ' ' ILE . 3.8 pt20 -77.34 -32.45 55.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.726 -0.842 . . . . 1.25 108.726 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 HG23 ' A' ' 47' ' ' VAL . 21.9 t -62.73 -43.68 98.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.611 -0.722 . . . . 1.1200000000000001 109.51 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -57.29 -40.72 78.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.321 -0.854 . . . . 1.97 109.93 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.39 -12.83 47.42 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.996 -0.621 . . . . 0.81999999999999995 113.178 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 31' ' ' VAL . 32.4 t-20 -81.74 -65.84 0.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.664 . . . . 1.8600000000000001 109.209 172.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 69' ' ' LEU . 49.1 mt -80.83 -27.63 36.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.227 0.825 . . . . 1.73 113.227 -169.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -26.01 68.35 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.159 0.504 . . . . 0.77000000000000002 110.581 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -81.71 -25.77 35.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.665 -0.698 . . . . 2.1800000000000002 111.031 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 3.6 m -99.91 -8.54 23.88 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.471 -0.331 . . . . 1.23 111.775 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.509 ' HA ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 mt -53.87 -37.26 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.632 0.253 . . . . 1.1100000000000001 110.667 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.06 30.9 1.56 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-O 121.9 0.722 . . . . 1.45 112.956 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.9 OUTLIER -154.2 -44.22 0.09 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.913 -1.514 . . . . 0.91000000000000003 106.913 174.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 10.6 tp -41.6 -56.51 2.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.079 -1.873 . . . . 1.4299999999999999 110.656 171.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -68.3 0.71 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.247 -0.888 . . . . 2.0 110.995 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -55.92 -64.89 0.71 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.34 -0.845 . . . . 4.0899999999999999 112.334 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.01 92.16 2.21 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.044 -0.598 . . . . 1.99 111.767 -175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.68 -94.91 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 1.79 112.601 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.41 148.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 1.9199999999999999 110.707 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.494 HG13 ' SG ' ' A' ' 13' ' ' CYS . 72.8 t -90.25 119.24 69.24 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.169 -0.469 . . . . 0.70999999999999996 110.127 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.08 153.48 32.25 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.804 2.336 . . . . 0.81000000000000005 112.351 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.0 -8.35 13.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.054 2.503 . . . . 1.03 111.755 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.5 m -81.64 -48.33 11.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.215 -1.031 . . . . 0.91000000000000003 108.215 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.5 t -56.96 -51.9 67.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.537 -1.211 . . . . 0.73999999999999999 109.172 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.3 m -57.6 -33.06 67.82 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.986 -0.552 . . . . 1.3999999999999999 112.441 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.4 m -67.99 -41.16 82.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.884 0.373 . . . . 0.79000000000000004 110.607 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.35 -35.68 59.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.955 -0.64 . . . . 0.56999999999999995 112.244 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 27' ' ' CYS . 48.8 t -62.14 -58.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.362 -0.236 . . . . 0.68000000000000005 110.362 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 18.0 ptpt -63.7 -13.55 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.54 110.738 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.802 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 52.5 t-20 -74.09 -64.63 0.97 Allowed 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 109.12 -0.696 . . . . 2.1099999999999999 109.12 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.868 HD11 ' HG3' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -54.4 -22.8 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 112.666 0.617 . . . . 0.65000000000000002 112.666 -179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -91.67 -69.9 0.72 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.562 -0.455 . . . . 1.9299999999999999 112.06 174.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -81.2 -52.95 6.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.937 -0.574 . . . . 2.4500000000000002 112.049 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.802 ' HB2' ' HA ' ' A' ' 33' ' ' ASN . 30.4 m -74.1 -11.77 60.41 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.436 0.532 . . . . 1.55 112.436 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 78.7 p -70.08 119.09 13.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.09 -1.078 . . . . 1.4299999999999999 108.09 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -106.45 -55.94 2.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.267 0.84 . . . . 4.4699999999999998 113.267 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 66.3 p -85.64 -177.23 6.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 1.5900000000000001 112.59 -167.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 m -65.88 -42.06 90.79 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.564 -0.744 . . . . 1.79 109.901 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -68.18 -11.86 59.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.313 0.578 . . . . 1.4099999999999999 110.412 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 5.8 m-20 -85.51 -48.67 8.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.246 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 47' ' ' VAL . 94.6 mtt180 -105.31 -17.3 14.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.4 0.889 . . . . 2.7000000000000002 113.4 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -97.14 -26.25 15.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.282 -0.567 . . . . 3.54 110.195 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -85.99 -22.99 27.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.285 -0.416 . . . . 0.64000000000000001 110.206 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.908 HG23 HG22 ' A' ' 6' ' ' VAL . 10.9 p -69.74 -42.22 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 116.355 -0.384 . . . . 0.69999999999999996 111.049 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.6 p -69.55 -35.0 75.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.143 0.497 . . . . 1.78 110.392 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 t -65.2 -37.42 87.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 1.4099999999999999 110.849 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.766 ' HB3' HG21 ' A' ' 6' ' ' VAL . 53.9 t -84.33 -38.29 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.639 -0.255 . . . . 1.1100000000000001 110.738 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.1 tp -49.53 -34.73 18.17 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.243 175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -52.76 -44.26 66.37 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.409 -0.814 . . . . 2.2999999999999998 111.767 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.97 -41.31 26.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.673 0.273 . . . . 1.1000000000000001 110.678 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -64.7 -41.79 95.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.172 -0.467 . . . . 1.1599999999999999 111.514 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.13 -10.55 59.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 1.1100000000000001 110.82 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 -5.11 47.95 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.829 -0.7 . . . . 1.0800000000000001 111.711 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.19 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.15 0.5 . . . . 1.53 110.684 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.032 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.5 m -55.36 96.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.07 -0.968 . . . . 2.3599999999999999 112.431 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -103.62 93.8 5.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.455 -0.943 . . . . 4.6500000000000004 108.455 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.18 32.21 5.62 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.591 -1.004 . . . . 2.0099999999999998 110.591 -172.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.032 ' HB ' ' HB ' ' A' ' 58' ' ' VAL . 7.4 tp -61.53 142.0 16.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.681 0.753 . . . . 3.54 111.3 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -91.46 115.04 63.68 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.144 -0.935 . . . . 3.4100000000000001 108.549 167.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -56.27 -32.25 87.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.741 2.294 . . . . 2.4300000000000002 111.821 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.303 -0.862 . . . . 3.1000000000000001 110.299 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -84.36 -13.14 53.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.764 . . . . 1.3400000000000001 110.202 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 81' ' ' ILE . . . -69.46 -24.46 63.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.268 -0.878 . . . . 1.4299999999999999 110.226 172.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -88.51 -4.61 58.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.699 0.762 . . . . 2.4100000000000001 109.257 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.47 -6.01 31.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 1.1399999999999999 109.561 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 10' ' ' LEU . 8.5 tt -64.09 -46.75 80.3 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.102 -0.954 . . . . 2.29 110.324 176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' LEU . 11.4 Cg_endo -55.37 -27.04 56.07 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.266 1.978 . . . . 1.2 111.818 170.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 73' ' ' CYS . . . 118.51 122.47 3.15 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.716 -0.754 . . . . 1.3600000000000001 113.886 172.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.02 14.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.341 0.591 . . . . 2.6099999999999999 110.396 167.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' A' ' 71' ' ' GLY . 3.9 m -93.13 13.03 22.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.236 -0.893 . . . . 1.6499999999999999 110.732 -172.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.53 -6.94 74.82 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.95999999999999996 112.149 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.75 90.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.504 0.669 . . . . 1.7 111.659 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -89.03 91.82 8.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.156 -0.683 . . . . 2.3100000000000001 109.156 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 79' ' ' TYR . 6.2 pt -78.37 145.75 68.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.438 -0.801 . . . . 1.8300000000000001 111.881 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 26.6 Cg_exo -63.49 -48.83 5.2 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.52 2.813 . . . . 1.3500000000000001 113.687 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.682 ' CE1' HD12 ' A' ' 77' ' ' ILE . 2.0 p90 -70.66 162.44 28.98 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.592 -0.443 . . . . 1.3799999999999999 110.277 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 14.3 tppt? -110.02 165.78 11.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 69' ' ' LEU . 34.2 pt -72.49 -9.74 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.49 -0.323 . . . . 2.5499999999999998 111.796 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -59.34 123.87 18.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.502 -0.555 . . . . 2.4500000000000002 109.502 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.7 p -71.99 8.23 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.33 0.493 . . . . 2.04 112.33 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -94.4 -7.18 42.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.495 -0.321 . . . . 2.7599999999999998 110.985 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.3 t -79.61 154.71 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.709 -0.849 . . . . 2.0499999999999998 108.709 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.98 130.5 34.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.333 0.587 . . . . 3.0499999999999998 112.075 -171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.539 ' HA ' ' CG2' ' A' ' 90' ' ' ILE . 1.4 t -86.21 -13.54 46.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.155 -0.93 . . . . 1.71 109.577 175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.34 -22.74 12.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.05 -0.977 . . . . 2.7599999999999998 112.721 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.1 p -148.76 -42.41 0.15 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.035 -0.416 . . . . 2.21 110.729 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.539 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.4 pt 47.99 -171.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.688 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-N 114.578 -1.192 . . . . 4.7800000000000002 109.839 176.713 . . . . . . . . 2 2 . 1 stop_ save_